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ABSTRACT 
Fetal Alcohol Spectrum Disorder (FASD) is an umbrella term referring to a range of physical, 
behavioural, and cognitive deficits resulting from prenatal alcohol exposure. The resulting 
abnormalities are heterogeneous and often attributed to timing and dosage of alcohol exposure. 
However, the specific effects of developmental timing are not well-known.  
This research used C57BL/6J (B6) as an animal model for early (human trimester one) and mid-
gestation (human trimester two) alcohol exposure. Pregnant B6 mice were injected with 2.5 g/kg 
ethanol on gestational day (GD) 8 and 11 (trimester one equivalent), or on GD 14 and 16 
(trimester two equivalent). Resulting pups were followed from birth to adulthood using FASD-
relevant behavioural tests. At postnatal day (PD) 70, whole brain tissues were extracted. A third 
group of dams were injected on GD 16 (short-term). Two hours post injection, fetal brains were 
removed. Brains were used for genome-wide expression analysis, including microRNAs. 
Downstream analyses were completed using software packages and online databases.  
All ethanol-treated pups showed motor skill delays, increased activity, and spatial learning 
deficits. Gene expression analysis resulted in altered expression of 48 short-term genes between 
ethanol and control mice treated during the second trimester. Fifty-five and 68 genes were 
differentially-expressed in the long-term analyses of mice treated during trimester one and two, 
respectively. Genes involved in immune system response were disrupted across all treatments. 
Disrupted short-term processes included cytoskeleton development and immunological 
functions. Processes altered in long-term exposures included stress signaling, DNA stability, and 
cellular proliferation. MicroRNA analyses returned eight and 20 differentially-expressed 
miRNAs in trimesters one and two, respectively. Target filtering of trimester one microRNAs 
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and mRNAs resulted in inverse relationships between miR-532-5p and Atf1, Itpripl2, and Stxbp6. 
Trimester two target filtering resulted in miR-302c targeting Ccdc6.  
Gene expression and microRNA results demonstrate the stage-specific genes and processes 
altered during neurodevelopment upon ethanol exposure. Certain cellular processes are disrupted 
no matter the timing of ethanol exposure. Given that microRNAs are fine-tuners of gene 
expression, they may play an important role in the maintenance of FASD. Furthermore, 
transcriptomic changes in the brain may explain the observed behavioural effects of prenatal 
ethanol exposure. 
 
Keywords 
Fetal Alcohol Spectrum Disorder (FASD), Ethanol, C57BL/6J, Neurodevelopment, Behaviour, 
Brain, Gene Expression, Microarray, MicroRNA, Transcriptome. 
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Introduction 
1.1 Fetal alcohol spectrum disorders (FASD) 
1.1.1 Clinical background on FASD 
The maternal consumption of alcohol during pregnancy may lead to neurodevelopmental 
abnormalities in exposed children
1,2
. Children exposed to ethanol prenatally may acquire a 
continuum of permanent birth defects known as Fetal Alcohol Spectrum Disorders (FASD)
3,4
. 
FASD affects approximately one in 100 live births
5
. FASD-related abnormalities may include 
physical, behavioural, and cognitive dysfunctions of varying degrees
2,6–9
. Growth deficiency, low 
birth weight, spatial learning delays, neuromuscular coordination deficits, central nervous system 
damage, and craniofacial malformations are key features of FASD
9–15
. Children and adults who 
have been exposed to alcohol in utero may experience problems in attention span, judgment, 
communication, executive functioning, memory, and social adaptation
16–18
. Once affected by 
alcohol, a child is affected for life, and there is no cure. Even with behavioural interventions, 
individuals with FASD may live with lifelong learning disabilities and poor social skills
9
.  
The spectrum of disabilities resulting from prenatal alcohol exposure ranges from mild 
defects, defined as Fetal Alcohol Effects (FAE), to more severe and diagnosable cases of Fetal 
Alcohol Syndrome (FAS). FAE are characterized by the occurrence of minimal abnormalities; 
meanwhile, FAS is the most severe form on the FASD spectrum
19,20
. FAS is characterized by all, 
or a combination of the following: severe mental illness, craniofacial abnormalities, intrauterine 
growth retardation, depression or psychosis, and antisocial behaviour
6,19,21
. Unlike any other 
forms of FASD, FAS is an official International Classification of Diseases (ICD) diagnosis
22
. 
Other conditions resulting from in utero alcohol exposure include Alcohol-Related 
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Neurodevelopmental Disorder (ARND) and Alcohol-Related Birth Defects (ARBD)
7
. 
Hyperactivity, anxiety, emotional problems, and learning disabilities are common across the 
FASD spectrum
7,14,19
. Due to the behavioural heterogeneity in individuals with FASD, it is 
difficult to diagnose children with different types of FASD. To overcome this limitation, a 
quantitative behaviour checklist is used to categorize abnormalities observed in children who 
have been exposed to alcohol prenatally
19
. In this way, cases can be distinguished based on 
child-specific behavioural manifestations of FASD disabilities. Specific classifications across the 
FASD spectrum allow for more thorough insight into how an individual was developmentally 
influenced by alcohol, both physically and mentally.  
1.1.2 FASD is a wide-spread and costly disorder  
The prevalence of FASD in Canada and the United States is approximately 9.1 in 1000 
live births, as reported by the Public Health Agency of Canada
5
. In the late 1980’s, this number 
was 1.9 per 1000 live births
3
. The number of individuals affected with FASD has been steadily 
increasing. One possibility for the increasing rate of FASD is an increasing rate of disregard for 
proper lifestyle habits during pregnancy. Also, pregnant women may be unaware of their 
pregnancies and may continue to consume alcohol throughout early pregnancy. Other 
possibilities for the increasing numbers of FASD could be due to increased awareness and self-
reporting, resulting in more diagnoses. FASD is the most common, preventable cause of mental 
retardation in Canada and the United States
23
. In Canada, the annual cost of FASD amounts to 
5.3 billion dollars
5
. 
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1.1.3 Current treatments for FASD exclude biological mechanisms 
 There is no treatment or cure for physical defects and central nervous system (CNS) 
damage resulting from fetal alcohol exposure. However, the severity of learning disabilities can 
be diminished. Parents and teachers can help children who have been characterized with FASD. 
A multi-disciplinary approach is needed to characterize deficits in children with FASD
7,18,24
. In 
the same way, a multi-disciplinary approach is also needed to help a child with FASD reach his 
or her full potential. Other than parents and teachers, individuals who may be involved include 
psychologists, social workers, and health counsellors. Techniques used by clinicians to evaluate 
children with FASD may involve measuring a child’s growth rate and examining his or her facial 
features
25
. Psychologists, speech-language pathologists, and occupational therapists may assess 
CNS damage to help characterize the severity of defects resulting from prenatal alcohol 
exposure
26
. Across a population, children with FASD have highly variable IQ scores
27–29
. 
Individual learning profiles of each child must be developed and implemented. However, many 
children with FASD are ineligible for special services because their intellectual abilities often 
fall within the average range of intelligence
30
. These children ― who were exposed to alcohol 
prenatally, but still have average intelligences ― benefit from IQ and achievement 
measurements
30
. Functional classroom assessments, family information, and school assessment 
processes allow educators and counsellors to work together to assess the impact of 
environmental conditions on a child’s abilities. This helps to evaluate which conditions may 
disrupt effective functioning and learning. The efficacy of Child Friendship Training has been 
reported upon; this type of training improves knowledge of appropriate social behaviour in 
children with FASD
31
. Another method, Cognitive Control Therapy, is often used to teach 
4 
 
 
 
progressive skill-building that focusses on the child’s ability to understand his or her own 
learning style and challenges
30
.  
1.1.4 Difficulty in diagnosing FASD based on phenotypes  
Prenatal alcohol exposure is the most common preventable cause of cognitive disabilities 
in the western world
23
. However, FASD is difficult to properly diagnose, particularly because it 
shares traits with other complex disorders such as Attention Deficit Hyperactive Disorder 
(ADHD)
32
. ADHD is diagnosed in up to 94% of individuals who have experienced heavy in 
utero alcohol exposure
32
. Often, children with FASD have co-morbid ADHD, and can be 
diagnosed improperly. FASD-affected children may receive incorrect or insufficient treatment. 
Rasmussen and colleagues analyzed 52 children with FASD, and found that 63% received a co-
morbid diagnosis of ADHD
33
. The authors also found that children with FASD and ADHD 
performed worse than children with FASD but without ADHD on sensory/motor, cognitive, 
communication, memory, executive functioning, attention, and adaptive behaviour tasks
33
. 
Another study found that out of 2,231 FASD-affected youth, 41% were diagnosed with ADHD, 
17% were diagnosed with learning disorders, and 16% were diagnosed with oppositional-
defiant/conduct disorder
11
. Although researchers make efforts to identify behavioural 
characteristics differentiating children with FASD and ADHD, the psychological services are not 
always available
11,34
. Maternal self-reported drinking as a means of predicting behavioural 
dysfunctions in “at-risk” children can be misconstrued35. Other difficulties in the characterization 
of FASD include absence of craniofacial malformations in children who have undergone in utero 
alcohol exposure, coupled with the unavailability of maternal drinking data
34
. Also, an increase 
in binge drinking among women of child-bearing age, coupled with the unawareness of 
5 
 
 
 
pregnancy early in the first trimester, could contribute to the pervasiveness and eventual 
mischaracterization of FASD
36–38
.  
A further complication resulting in difficulty in characterization of FASD includes the 
inconsistency of symptoms due to dosage-specific effects of alcohol. Since the 1960’s, 
researchers have reported on the relevance of a multitude of factors in determining the severity 
of FASD abnormalities; factors include: quantity, frequency, and timing of alcohol
39
. For 
instance, facial dysmophology is caused by alcohol exposure during early gestation 
(gastrulation)
40
. Heavy drinking increases the likelihood of FASD in offspring; children 
prenatally exposed to high amounts of alcohol perform worse on measures important for reading 
and arithmetic skills than children exposed to low amounts of alcohol
41
. Dosage- and timing-
specificity may be attributable to disruption of specific neurodevelopmental patterns that occur 
during fetal development. Though the timing- and dosage-specificity underlying FASD is not 
well-established, women have been advised that no amount of alcohol is safe to consume during 
pregnancy
38
. Researchers suggest that, in addition to genetic background, the timing and dosage 
of prenatal alcohol exposure is an important factor in determining the variation in behavioural 
manifestations related to FASD
3,5,42
. 
1.2 Ethanol exposure can lead to adverse effects in the fetus 
1.2.1 Ethanol’s mechanism of action  
Prenatal alcohol exposure leads to alterations in fetal brain structures that give rise to 
developmental and behavioural abnormalities in children
19
. The metabolism of alcohol in the 
maternal liver involves the oxidation of ethanol into acetaldehyde by an enzyme called alcohol 
dehydrogenase (ADH); ADH is further oxidized into acetate by another enzyme, acetaldehyde 
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dehydrogenase (ALDH)
43
. The intermediary compound, acetaldehyde, is harmful to the fetus
43
. 
Acetaldehyde leads to increased accumulation of oxygen radicals, which have harsh implications 
on the developing brain. For instance, DNA replication and DNA repair enzymes can be 
impaired
44,45
. Tissue damage may be a direct result of the accumulation of reactive oxygen 
species (ROS) through the process of ethanol oxidation. Accumulation of acetaldehyde can result 
from ADH conversion; the ADH complex is used to convert ethanol to acetaldehyde 90% of the 
time
43
. Acetaldehyde can result in protein adducts, which lead to cellular damage, and 
subsequent oxidative stress.  
1.2.2 Ethanol toxicity in the developing fetus 
In a developing fetus, morphological changes occur in multiple areas of the brain due to 
ethanol toxicity. It is well-established that prenatal alcohol exposure can alter brain development, 
leading to neurodegeneration in humans
46–49
, and in mice
21,50–55
. Ethanol can lead to reductions 
in cerebellar volume and surface area, reductions in basal ganglia, decreases in dendritic 
complexity, abnormalities in grey and white matter distribution and density, and apoptosis in 
sensitive brain regions
2,52,55
. The affected brain areas are necessary for hormone regulation, 
sensory information processing, learning, and memory. Ethanol (or its metabolites) can pass 
through the blood-brain barrier and disturb the developing fetal brain. The basis for the observed 
behavioural heterogeneity in FASD is unknown. Certain time points during pregnancy are 
critical stages of neurodevelopment, and are particularly sensitive to environmental toxins (eg. 
alcohol)
2
. Alcohol exposure at critical stages during pregnancy may lead to the spectrum of 
abnormalities observed in children with FASD.  
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1.3 Binge drinking and its adverse effects on offspring 
Binge drinking is defined as a pattern of alcohol consumption that raises blood alcohol 
concentration (BAC) to 0.08 gram percent or above, which is equivalent to the consumption of 
five or more drinks within a couple of hours of each drink
56
. This definition has been revised to 
three or more drinks per occasion; this level of drinking highly correlates with child 
dysmorphology and behavioural alterations
57
. Binge drinking has been identified as the most 
damaging form of alcohol consumption because it produces a high BAC in the mother, which 
can have adverse effects on the developing fetus
58,59
. Peak BACs are higher in binge models of 
alcohol exposure than more moderate, continuous-drinking paradigms; these data correlate with 
increased atherosclerotic plaque development in binge versus continuous models of FASD in 
mice
60
. Alcohol-induced neuronal loss in developing rats leads to increased brain damage 
following maternal binge drinking
61
. Binge drinking is particularly harmful to the developing 
fetus because alcohol takes longer to metabolize at higher BACs, particularly in women
62
. Also, 
the specific gestational time of binge drinking may correlate with key stages of brain 
development, which may lead to more severe deficits in offspring. On another note, there is a 
strong association between binge drinking and unplanned pregnancy
63
. In cases of unplanned 
pregnancy, women may consume alcohol without knowledge of pregnancy. These women may 
continue to drink heavily into their pregnancies, having exposed their fetuses to the teratogenic 
effects of alcohol. 
1.4 Timing and dose-dependent effects of alcohol on neurodevelopment 
The neurodevelopmental effects of alcohol are specific to the timing of exposure and the 
developmental processes that occur during specific times. One of the critical points during 
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neurodevelopment occurs during the embryonic stage of gestation (first trimester)
2
. Exposure to 
alcohol during gastrulation negatively impacts formation of germ layers and reduces neural 
progenitors
64
. These reductions lead to long-term effects on the forebrain and brainstem
65,66
. 
Maternal binge drinking during the early stage of embryogenesis is also associated with a high 
incidence of craniofacial malformations and mental disabilities
67,68
. Another critical stage during 
fetal development occurs in humans from 7-20 weeks of gestation (second trimester). At this 
stage, the fetal brain undergoes neuroepithelial cell proliferation and migration
69
. Most of the 
areas of the nervous system (except cerebellum) begin to differentiate
2,64,70
. Prenatal ethanol 
exposure can alter neuronal migration and lead to reductions in the numbers of neurons and glial 
cells in the neocortex, hippocampus, and sensory nucleus in the fetal brain
64,70
. Such disturbances 
to brain development can lead to long-term abnormalities in brain size and likely contribute to 
cognitive deficits in individuals with FASD
48
.  
Dosage is also an important factor that influences the severity of neurodevelopmental 
deficits associated with prenatal alcohol exposure. Alcohol may affect the developing fetus in a 
dose-dependent manner. Binge alcohol consumption produces more severe deficits in offspring 
development and behaviour than daily moderate consumption
59,60
. Exposure to heavy drinking (> 
48-60 grams ethanol/day) may cause FAS, whereas moderate drinking (between 24-48 grams 
ethanol/day) can result in “alcohol effects”71. Binge drinking, with intakes of 4-5 drinks of 
ethanol per sitting (> 90 grams ethanol/day), can result in greater peak BACs than other forms of 
alcohol consumption
72
. It is difficult to define and characterize developmental risks associated 
with binge drinking in human subjects due to inconsistencies in dosage and timing. 
 
9 
 
 
 
1.5 Using mouse models to study FASD 
1.5.1 The impact of the C57BL/6J mouse in FASD research 
FASD, specifically when studied in the C57BL/6J (B6) mouse, has been examined by 
various methods. The B6 mouse is the most widely used inbred strain and was the first to have 
its genome sequenced
73
. The B6 mouse is commonly used in alcohol-related research. Years ago, 
alcohol’s causative role in FAS was examined through administration of ethanol injections in 
pregnant mice
74
. B6 mice were often used in ethanol preference tests to study defects in 
locomotor activity and passive avoidance behaviour
1
. Using B6 mice in ethanol preference 
models was beneficial since B6 mice prefer to drink ethanol to water ~70% of the time
75
. 
Therefore, these mice are useful for studies on FASD. Once the genetics of alcohol metabolism 
were elucidated, more researchers used mice for molecular studies of ethanol exposure. The 
results of this research led to identification of polymorphisms in the ADH genes, which are 
associated with the conversion of ethanol to acetate; ADH genes were detected in human 
subjects, and could be subsequently used for knockout studies in mice
76
. Throughout the years, 
studies have continued using B6 mouse models to identify FASD-related phenotypes through 
various means. Some of the studies included proteomics screenings of amniotic fluid
77
, 
behavioural testing
78
, placental biomarker identification
79
, dendrite sectioning
55
, candidate gene 
selection
80,81
, and more recently, genome-wide studies
82–84
.  
1.5.2 Advantages of a mouse model for complex disorders 
Although studies use a variety of model organisms, there are many advantages to using a 
mouse model: 
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1. Mouse genomes and human genomes both contain the same approximate number of 
genes (~30,000), of which 95-99% are homologous
85
. 
2. Genetic determinants of diseases in humans are highly conserved in mice86–88.  
3. The B6 strain has been used successfully in replicating a variety of FASD-related 
phenotypes with well-defined experimental tools
1,78,89–91
. 
4. The effects of prenatal ethanol exposure on neurodevelopment are well-studied in B6 
mice
21,51,92–95
. 
5. The B6 mouse has been used to examine transcriptomic alterations in the brain using 
high-density, mouse-specific arrays
80,81,96–98
. 
6. Using the B6 mouse allows for precise control of ethanol timing and dosage21. 
7. Many behavioural tests used for mice are well-established and representative of 
human behaviours
89,91,99–101
. 
1.5.3 Differences in dosage of ethanol in producing FASD-relevant phenotypes 
Various ethanol dosages, resulting in varying BACs, have been examined in mice. BACs 
must remain above a toxic threshold of neurodegeneration, in the range of 180-200 mg/dl, to 
produce FASD-relevant behavioural deficits in mice
21
. This toxic threshold was proposed by 
Ikonomidou and colleagues, who found that ~200 mg/dl was the minimum condition for 
triggering neurodegeneration
21
. With a dose of 2.5 g/kg of ethanol, given once, BAC barely 
crosses the toxic threshold for neurodegeneration. When 2.5 g/kg ethanol is given twice, spaced 
two hours apart, BAC rises to ~500 mg/dl and remains above 200 mg/dl for ~14 hours. This 
double injection paradigm allows for enough ethanol to raise the BAC above 200 mg/dl. Also, 
this paradigm gives a second boost of alcohol, allowing the BAC to remain > 200 mg/dl for 
several hours. The maintenance of increased BAC occurs because the degenerative response 
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becomes progressively more severe. This effect results in long-lasting behavioural deficits, 
neurodevelopmental abnormalities, and gene expression changes in the offspring
91,102
. In 
addition to dose, the method of ethanol delivery is important. Researchers have consistently used 
injections to administer ethanol to pregnant females
21,103,104
. The most widely used routes of 
injection in mice include subcutaneous (sc) and intraperitoneal (ip) injections
105
. However, 
because ip injections can result in direct ethanol injection into the womb and severe discomfort 
for the female, sc injections provide a safer route of administration
105
.  
1.5.4 A variety of mouse-specific behaviour tests to model FASD  
It is well-known that individuals with FASD have a range of behavioural deficits, 
depending on the timing and dosage of prenatal alcohol exposure. In order to characterize these 
disabilities, a variety of mouse-specific behaviour tests can be used. Behavioural traits that can 
be measured include: developmental milestones, activity, anxiety-related behaviours, and 
learning and memory. Activity and anxiety-related behaviours can be measured using an 
Actitrack apparatus (PanLab Harvard Apparatus, Holliston, MA). An Elevated Plus Maze (EPM) 
and a Light/Dark Box (LDB) and can also be used to measure anxiety-related behaviours
99,100
. 
Spatial learning and memory can be assessed in mice using a Barnes Maze
89
.  
Developmental milestone assessment on neonatal and postnatal mice will be completed 
following a protocol outlined by Hill and colleagues
101
. The milestones outlined in this protocol 
are: surface righting, negative geotaxis, cliff aversion, forelimb grasp, air righting, open field 
traversal, eye opening, and ear twitching. The milestones are assessed from postnatal day (PD) 2-
21. Each of the tasks represents an examination of FASD-relevant milestones that are delayed in 
children exposed to alcohol prenatally. Some of the delays represent deficits in strength, reflex, 
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motor coordination, and balance
44,106–108
. The usefulness of these tasks has been demonstrated in 
previous studies of complex disorders, including FASD
91,109,110
. 
As juveniles, mice can be assessed at PD 25-30 for exploratory behaviour to examine 
general activity and anxiety-related traits in a novel, open-field, environment using the locomotor 
apparatus
91
. PD 25-30 corresponds to the prepubescent period in mice
111
. The prepubescent stage 
is a common time for diagnosing ADHD in children
112,113
. At PD 25-30, anxiety can assessed 
concurrently using the locomotor apparatus. Anxiety disorders manifest in childhood, but rise 
into adolescence
114
. Examining anxiety-related traits in mice between PD 30-35 will allow for 
assessment at adolescence. In this case, the EPM and LDB, which are popular tools to assess 
anxiety-related traits in rodents, are used beginning PD 30
99,100
. The locomotor apparatus, EPM, 
and LDB rely on the rodent’s innate aversion to brightly illuminated or open areas; these tests 
also rely on the spontaneous exploratory behaviour of the animals
100
. Anxiety-relevant results 
from each of these tests should be complementary. Due to the complexity and 
multidimensionality associated with anxiety-related traits, it is beneficial to use more than one 
tool to generate data regarding anxiety-related behaviours in mice
115
.  
Spatial learning and memory are assessed using a Barnes Maze, beginning PD 45-50
89
. 
The timing corresponds to early adulthood in mice, and allows for the comparison of these 
behaviours to adult humans
36
. Although learning disabilities are observable in children with 
FASD, the reasoning behind testing at young adulthood is to examine whether disabilities 
persists from birth to adulthood. In the Barnes Maze, mice rely on spatial orientation to learn the 
location of a target hole
89
. Given that mice have dichromatic vision, four spatial reference points 
― coloured black, orange, or blue ― are used to visually create shade/shape-differences across 
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walls. An overhead light and white noise are generated to motivate mice to learn the spatial 
orientation of a target hole in order to escape the open field area.    
1.6 Evidence for ethanol’s effect on gene expression 
 Along with behavioural abnormalities, molecular pathways are differentially affected by 
prenatal alcohol exposure
43,82
. Cellular death, resulting from prenatal ethanol exposure, is 
dependent on the ability to transcribe and translate genes
116
. Strongly-supported ethanol targets 
include enzymes that bind alcohol (i.e. ADH)
43
, and postsynaptic receptors such as N-methyl-D-
asparate (NMDA)-type glutamate receptors and γ-aminobutyric acid type A (GABAA) 
receptors
117,118
. Treatment of animals with ethanol alters the expression and function of genes 
and proteins
87,119,120
. Even with the accumulation of knowledge surrounding ethanol’s effects on 
genes, it is not well-understood which genes are affected by ethanol. Also, specific gene 
knockouts do not necessarily implicate any of the resulting proteins as direct targets of ethanol 
action
120,121
. A protein’s particular role may be downstream from the initial binding sites for 
alcohol. Candidate gene studies are not sufficient to explain complex mechanisms of ethanol’s 
neurotoxic effects. Complex disorders, such as FASD, are multifactorial, with multiple gene 
interactions underlying its phenotypes
122
. A polymorphism or misregulation of a single gene is 
not enough to explain the wide spectrum of FASD phenotypes. Also, a candidate gene approach 
to conducting genetic studies focuses on associations between genetic variation within pre-
defined genes-of-interest and phenotypes or disease states. This approach fails to elucidate the 
molecular underpinnings of complex disorders for various reasons. Spectrum disorders, like 
FASD, typically vary in severity of symptoms, which results in difficulty in defining an 
appropriate phenotype. Also, these disorders vary in their aetiological mechanisms, which may 
involve various biological pathways. Finally, complex diseases are likely caused by 
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dysregulation of several, and even numerous, genes, each with a small overall contribution and 
relative risk
123
. To combat these issues, genome-wide approaches have been undertaken. 
However, previous genome-wide studies lack consistent and comprehensive dosage regimens. In 
particular, reports are not consistent when comparing behaviours and transcriptomes in ethanol 
and control subjects between different time points. With the increase in knowledge from gene 
chip analysis (microarray) studies, the gene expression changes resulting from prenatal ethanol 
exposure can be better understood. Once ethanol-responsive genes and pathways are identified, 
insight into causes, therapies, and treatments may be possible. 
1.7 Microarrays to study global gene expression patterns 
1.7.1 Microarrays as a means of studying complex disorders 
Microarrays, commonly known as DNA chips, are defined as a collection of microscopic 
DNA spots attached to a solid surface. They are used to measure the expression levels of large 
numbers of genes simultaneously. Each of the DNA spots contains picomoles of a specific DNA 
sequence known as a probe. A probe is a short section of a gene, or other DNA element, that is 
used to hybridize a complementary DNA (cDNA) or complementary RNA (cRNA) sample under 
high stringency conditions. Detection of hybridization is usually through a fluorophore-labeled 
target, which is used to determine relative abundance of nucleic acid sequences in the target. 
Microarrays have been used extensively for humans and mice, in the search for gene expression 
changes associated with complex disorders such as: aging, cancer, obesity, schizophrenia, 
Alzheimer’s Disease, autism, alcoholism and, more recently, FASD124–131. As a disclaimer in this 
thesis, when referring to gene expression, I specifically mean mRNA levels (i.e. the 
transcriptome). The application of microarrays to mice, particularly the B6 mouse, is well-
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documented; mouse microarrays are useful for examining the underlying biological mechanisms 
governing complex phenotypes, which include abnormalities resulting from prenatal alcohol 
exposure
91,132–134
. Complementary DNA microarrays allow for the quantification of large 
numbers of messenger RNA transcripts for the purpose of large-scale insight into cellular 
processes involved in the regulation of gene expression
135
.  
 1.7.2 Overview on functional, pathway, and network analysis of microarray data 
Following the identification of differentially-expressed genes (DEGs) using microarrays, 
various software programs can be used to determine the importance of specific pathways and 
networks in relation to behavioural phenotypes. For functional characterization of DEGs, the 
following databases are applicable: The Database for Annotation, Visualization and Integrated 
Discovery (DAVID)
136
, Gene Ontology Enrichment (GE) (Partek Inc., St. Louis, MO, USA), and 
Ingenuity Pathway Analysis (IPA) (Ingenuity® Systems, Redwood, CA). The freely available 
DAVID program relies on functional annotation clustering, which uses a p-value to examine the 
significance of gene-term enrichment using a modified Fisher’s exact test136,137. A p < 0.05 
suggests that an input gene is significantly more enriched than by random chance. The Partek 
Genomics Suite software version 6.6 (Partek Inc., St. Louis, MO) tool, GE, returns a list of 
functions based on the DEGs. The higher the enrichment score, the more overrepresented a 
functional group is in the gene list. This score is calculated using a chi-squared test, which 
compares the proportion of the gene list in a group to the proportion of the background in the 
group
138
. An enrichment score > 1 indicates that the functional category is over expressed, while 
a score of 3 corresponds to significant over expression (p < 0.05). IPA, a commercially available 
tool, is regarded as a high-quality functional analysis and knowledge discovery program. In IPA, 
a p-value is associated with a function, and is calculated using a right-tailed Fisher’s exact test139. 
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The p-value is calculated by considering the number of focus genes that participate in a process, 
versus the total number of genes that are known to be associated with that process. The p-value 
identifies significant over-representation of focus genes in a given process. Over-represented 
functional processes are those that have more focus genes than expected by chance (right-
tailed)
139
. 
To identify genes in already-established pathways, Pathway Express (Intelligent Systems 
and Bioinformatics Laboratory, Michigan, USA), Pathway Enrichment (PE), and IPA will be 
used. The freely available Pathway Express database is considered as a high-throughput pathway 
visualization tool that focuses on pathways alone (no functional characterization). By default, 
Pathway Express uses hypergeometric distribution for p-value calculation
140
. The impact factor 
associated with a pathway is a probabilistic term that takes into consideration the proportion of 
DEGs in the pathway. Essentially, Pathway Express quantifies the influence of DEGs on a given 
pathway. The quantification of DEGs, in addition to the p-value, is used to distinguish between 
pathways that have the same proportion of DEGs
141
. Pathway Enrichment is a new feature 
incorporated in Partek software. PE generates an enrichment score, in addition to a p-value, for 
each pathway. This score is the negative natural log of the enriched p-value (Fisher’s exact 
test)
142
. Both PE and Pathway Express rely on information from the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database (Kanehisa Laboratories, Tokyo, Japan); therefore, the 
results should be similar between the programs. Canonical pathway assessment using IPA results 
in a list of significant pathways that are altered based on the input genes. Canonical pathways are 
determined based on two parameters: a ratio of the number of genes from the data set that map to 
the pathway, divided by the total number of genes that map to the canonical pathway, and a p-
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value calculated using Fisher’s exact test that determines the probability that the association 
between the genes in the data set and canonical pathway is due to chance alone
143
. 
Two tools, GeneMANIA (Donnelly Centre for Cellular and Biomolecular Research, 
Toronto, Ontario) and IPA, can be used for network analysis of inputted genes that have shown 
to interact with other molecules. GeneMANIA incorporates a linear-regression algorithm. This 
algorithm is used to calculate a functional association network of inputted genes with other genes 
that are known to interact with the input genes; GeneMANIA uses this algorithm to predict gene 
function
144
. To complement GeneMANIA results, IPA can be used to further identify interacting 
networks. IPA has been successfully used by various researchers to examine networks of 
interacting genes that may play a role in a variety of diseases and disorders including FASD
94,145–
148
. IPA links genes and molecules by interactions, which are based on current knowledge from 
records maintained in the Ingenuity Pathways Knowledge Base. Highly-interconnected networks 
are likely to represent significant biological function
149,150
. In IPA, each network is limited to 
~35 genes, by the algorithm. A p-score, which is derived from a p-value, is calculated using 
Fisher’s exact test. This score is assigned to each network, and is simply a measure of the 
number of focus genes in a network (user-specified genes)
151
. Another way to define the score is, 
the likelihood that the focus gene within the network was found by random chance
152
. A high 
number of focus genes leads to a higher network score. The network score is equal to the 
negative exponent of the respective p-value such that a score of 3 corresponds to a p-value of 
10E-3
153
. Therefore, a network is considered significant with a p-score > 2. The combination of 
results from the DEG list, along with the functional, pathway, and network analyses, will give 
insight into FASD-relevant genes. 
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For a gene to be determined relevant to FASD-related phenotypes, it must be 
differentially-expressed on the microarray. Also, the gene must be implicated in 
neurodevelopment or behaviour, implicated in a top pathway or network, or involved in an 
inverse relationship with a differentially-expressed microRNA (miRNA). If the gene is classified 
as a central “hub” molecule in one of the top three networks, it may also be worthy of 
investigation. For the purpose of this study, a “hub” is defined as a molecule that appears in a top 
IPA network with strong intramodule connectivity to all other genes in the same module  
(analogous to the definition of a “hub” node in protein-protein interaction networks); a hub does 
not necessarily need to be altered, itself
154. Previous studies have defined “hubs” as nodes with 
connectivity greater than five molecules
155–157
. In my thesis, a hub is restricted to a minimum of 
10 interactions in order to provide a stringent analysis. A hub molecule is linked to dysregulated 
gene(s), which suggests that there are common mechanisms associated with neurodevelopmental 
ethanol exposure. The hub genes identified in this thesis are based on the number of interactions 
in the network
158
.  
1.8 Examining microRNAs (miRNAs) in the maintenance of FASD 
1.8.1 MiRNAs and their role in the brain 
 In an attempt to explain the maintenance of gene expression changes in the adult brain 
following prenatal ethanol exposure, I will assess the importance of miRNAs in this role. 
MiRNAs are short (~17-25 nucleotides) endogenous noncoding RNAs that post-transcriptionally 
repress expression of protein-coding genes by base-pairing with the 3’ untranslated region (UTR) 
of the target messenger RNA (mRNA)
159,160
. The ability of one miRNA to target multiple 
mRNAs suggests that miRNA are exceptionally important regulators of various cell processes. 
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MiRNAs can suppress gene expression through multiple mechanisms such as translational 
inhibition and mRNA degradation
161
. This degree of coverage implicates miRNAs in a vast 
regulator RNA network that enables flexible control of mRNA expression, especially in the 
brain. The brain is composed of 100-200 billion neurons, and each is connected to 5000-200,000 
neurons
162–164
. Local control of gene expression upon synaptic activation and/or inhibition, 
coupled with gene expression, may be influenced by miRNAs. MiRNA genes are encoded within 
the genome, suggesting that their transcription may be tightly coordinated with their transcription 
of other genes (i.e. targets).  
 MiRNAs have been referred to as “master regulators of gene expression”, thus it may be 
useful to examine their roles in complex disorders. MiRNAs appear to be responsible for fine 
regulation of gene expression, thereby “tuning” the cellular phenotype during delicate cellular 
processes such as development and differentiation
165
. Given that many miRNAs are conserved in 
sequence between distantly-related organisms, they may participate in essential processes
166,167
. 
During neurodevelopment, miRNAs are expressed in neurons and show distinct expression 
patterns within the developing CNS
168,169
. MiRNA expression in the CNS demonstrates their 
relevance to brain development and function. Researchers have implicated various miRNAs and 
their target genes ― particularly GABA and NMDA-related genes ― in psychopathology 
including: Tourette’s syndrome170, schizophrenia171, bipolar disorder171, autism172 and Rett 
Syndrome
173
 .  
1.8.2 MiRNAs are ethanol-responsive 
One of the first pieces of evidence that miRNAs mediate ethanol’s teratogenic effects 
came from Sathyan and colleagues, who screened ~200 mouse miRNAs for ethanol sensitivity in 
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fetal neural stem cells
174
. Following this discovery, it was demonstrated that, between the latter 
half of the first trimester to the middle half of the second trimester period in mice, ethanol altered 
approximately 3% of the assessed mature miRNAs in whole brain RNA samples
175
. More 
recently, reseachers showed that differentiated neurons exposed to “chronic intermittent ethanol” 
resulted in significant alterations in ~11% of detected miRNAs
176
. Although only a small subset 
of miRNAs is known to be regulated by ethanol, these studies provide evidence for the 
dysregulation of miRNAs in FASD. The number of ethanol-sensitive miRNAs increases with 
developmental stage, which may reflect increasing complexity and diversity of miRNAs during 
neuronal maturation
176
. MiRNAs exhibit development stage-specific sensitivity to ethanol
175,176
. 
Some miRNAs are ethanol-sensitive over multiple developmental stages
174,176
. There is evidence 
for regional specificity of dysregulated miRNAs in the brains of ethanol individuals
177
. However, 
a global analysis of miRNA regulation in the whole brain will strive to complement and compare 
the results to global gene expression results. 
MiRNAs may play an important role in the maintenance of FASD. Some miRNAs play 
important roles in early neural tube patterning, telencephalic neurogenesis, and early 
differentiation, which occur during fetal development
178,179
. MiRNA knockouts in mice result in 
FAS-like phenotypes such as fetal growth retardation and microcephaly
180
. Studies suggest that 
GABAA receptors (GABAAR) and nicotinic acetylcholine receptors (nAChRs) mediate ethanol 
effects on miRNA expression
174,181
. Several ethanol-sensitive miRNAs are localized within 
chromosomal regions that are susceptible to epigenetic modification. Therefore, ligand-gated ion 
channel receptors, such as GABAARs and nAChRs, and epigenetic modifications, are potential 
mediators of ethanol’s effects on fetal miRNA182.   
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1.8.3 Detecting globally disrupted miRNAs in the brain using arrays 
There are several miRNA:mRNA target strategies that could be employed to examine the 
relationship between genes and miRNAs. There are various bioinformatic miRNA target 
prediction programs that produce lists of predicted targets for a given miRNA. For instance, 
TargetScan uses the Ensembl database to define 3’ UTRs in order to identify genuine miRNA 
targets
183
. Prediction program rates of false positives range between 24-70%
184
. Experimental 
data are necessary to identify genuine miRNA targets. One experimental strategy to identify 
miRNA targets includes gene-specific experimental confirmation with well-established 
techniques such as quantitative reverse transcription PCR (qRT-PCR) to assess individual 
miRNA:mRNA interactions
185
. However, this strategy would not give a global picture of all 
possible miRNA:mRNA interactions in a specific state. Additionally, demonstrating individual 
miRNA:mRNA interactions misses the capacity to regulate complex genetic networks. 
Uncovering such networks requires large-scale and unbiased methods of miRNA target 
identification, followed by downstream gene expression analysis (microarray and qRT-PCR). 
Quantitative RT-PCR may be useful in the downstream confirmation of specific miRNAs.  
Only in the past decade have miRNA chips been used to study global changes in response 
to ethanol exposure
174,185
. When coupled, miRNA and gene expression arrays are useful for 
detecting inverse relationships between genes and miRNAs
188
. Launched in 2011, the Affymetrix 
GeneChip miRNA 2.0 Array (Affymetrix, Santa Clara, CA) offers the broadest coverage of 
known miRNA, encompassing 131 organisms on one array, and allowing for downstream, 
independent interrogation of mouse-specific miRNA expression
189
. An overall analysis of 
mouse-specific miRNA alterations in response to prenatal ethanol exposure will be useful in 
determining molecular changes associated with FASD. MiRNAs that are found to be 
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differentially-expressed ― using the same fold change and p-value criteria as those used in gene 
expression analysis ― can be submitted to IPA Target Filtering. Target Filtering is used to 
predict miRNA:mRNA inverse relationships.  
1.9 Background on FASD summarized 
FASD represents a major health concern in the developing world. FASD is the leading 
cause of preventable birth defects in North America, affecting approximately one in 100 
individuals, and costing Canada 5.3 billion dollars annually
5
. Given the rise in binge-drinking 
among women of child-bearing age
190,191
, FASD remains a major health concern. The correlation 
between binge-drinking and risky behaviour, including unplanned pregnancy, further increases 
the chances of birthing a child with FASD
192
. Difficulties arise in the study of FASD in human 
populations. The biological mechanisms governing this disorder are not well-elucidated, and 
require the use of a model organism. Given these issues, researchers should focus on the 
developmental understanding of prenatal ethanol exposure, including its effects on behaviour and 
the brain transcriptome. A more-comprehensive understanding of FASD needs to be generated, 
with a focus on timing, mechanism, and potential molecular targets for corrective measures. 
1.10 Hypothesis and objectives 
1.10.1 Hypothesis 
 Prenatal alcohol exposure (binge) during the first and second term of gestation causes 
FASD-related behavioural abnormalities, and involves immediate and lifelong changes in brain 
gene expression affecting specific molecular pathways and networks.  
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1.10.2 Specific objectives 
1. To establish if 
a) binge-like prenatal ethanol exposure alters developmental milestones, and 
b) leads to behavioural abnormalities associated with FASD in C57BL/6J mice. 
1. To establish if binge-like prenatal ethanol exposure leads to immediate (fetal) and long-
term (adult) alterations in genome-wide gene expression in the brain, including miRNAs. 
2. To establish if the changes observed in 2. are specific to molecular pathways and 
networks related to behaviour and/or neurodevelopment. 
3. To establish if changes in 3. may account for changes in behaviours observed in 1.a and 
1.b. 
4. To establish any role for miRNAs in altered gene expression in response to binge-like 
prenatal ethanol exposure. 
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2.   Materials and Methods  
2.1 Animals 
2.1.1 Animal care and use 
This research uses C57BL/6J mice. All animal protocols were approved by the Animal 
Use Subcommittee at the University of Western Ontario (Appendix A) and complied with the 
ethical standards outlined by the Canadian Council on Animal Care. Mice were originally 
obtained from Jackson Laboratories (The Jackson Laboratory, Bar Harbor, ME) and 
subsequently bred at the Health Sciences Animal Care Facility at the University of Western 
Ontario (SOP #2007-059-10). Males and females were housed in separate (same-sex) cages. 
Food and water were provided ad libitum. Eight-week-old B6 females were time-mated 
overnight with 8-12-week-old B6 males. The following morning, gestational day (GD) 0, males 
were removed from cages and females remained alone for the duration of their pregnancies. 
Cages were standardized between animals and included only nestlets and bedding. Mice were 
kept on a 14/10 hour light/dark cycle at a temperature of 21-24°C with 40-60% humidity.  
2.1.2 Experimental design  
Pregnant dams were randomly divided into three groups. These included: 1) trimester two 
treatment, short-term exposure (T2-S), 2) trimester one treatment, long-term exposure (T1-L), 
and 3) trimester two treatment, long-term exposure (T2-L). Each experimental group consisted of 
two randomly assigned subgroups of dams: ethanol-exposed (ethanol) and saline-exposed 
(control). The experimental design is shown in Figure 1 and includes subjects, treatments, 
groups, experimental tests, and criteria for FASD-relevant candidate genes and miRNAs.  
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To assess the immediate effects of ethanol exposure on the developing brain, a group of 
pregnant dams (T2-S) was randomly assigned to two subgroups: ethanol and control. Dams were 
subcutaneously injected at GD 16 with 2.5 g/kg of ethanol in 0.15 M saline at 0 h and 2 h. 
Matched control dams were injected with 2.5 g/kg saline at 0 h and 2 h on GD 16. Two hours 
following the second injection, dams from both subgroups were euthanized by CO2 asphyxiation 
and cervical dislocation. Fetal brains from the two groups of dams were extracted and used for 
gene expression arrays (Figure 1). 
To model acute, binge-like ethanol exposure during the first trimester equivalent (T1-L) 
dams were subcutaneously injected at GD 8 and 11 with 2.5 g/kg of ethanol in 0.15 M saline at 0 
h and 2 h
21,193–195
. Matched control dams were injected with 2.5 g/kg saline on GD 8 and 11 at 0 
h and 2 h. Mothers were allowed to give birth, and T1-L offspring were followed from birth (PD 
2) until early adulthood (PD 70) using a battery of behavioural tests. At PD 70, animals were 
euthanized by CO2 asphyxiation, followed by cervical dislocation. Whole brains were used for 
transcriptome analysis, which included gene expression arrays and miRNA arrays (Figure 1).  
To model binge-like ethanol exposure during the second trimester equivalent (T2-L), 
dams were injected with 2.5 g/kg of ethanol in 0.15 M saline at 0 h and 2 h on GD 14 and 
16
21,158
. Matched controls were injected with 2.5 g/kg saline at 0 h and 2 h on GD 14 and 16. 
Once again, mothers were allowed to give birth, and T2-L offspring were followed from PD 2-70 
using a battery of behavioural tests. At PD 70, mice were euthanized by CO2 asphyxiation and 
cervical dislocation. Whole brains were dissected for gene expression and miRNA analysis 
(Figure 1).  
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Figure 1. Experimental layout showing short-term (T2-S) and long-term (T1-L and T2-L) 
groups, behavioural and transcriptomic experiments, and criteria for relavant 
transcriptomic changes following prenatal ethanol exposure. The number of mice (n) used 
for behavioural experiments are shown. The number (n) of individual mice (biological replicates) 
is shown for each molecular experiment. For array experiments, six individuals were segregated 
onto two arrays with three pooled mice on each array. T2-S = trimester two, short-term effect 
(pink). T1-L = trimester one, long-term effect (blue). T2-L = trimester two, long-term effect 
(green). miRNA = microRNA. mRNA = messenger RNA. qRT-PCR = quantitative reverse 
transcription PCR. Gene expression and qRT-PCR were completed on T2-S samples. Behaviour, 
gene expression, miRNA analysis, and qRT-PCR (genes and miRNAs) were completeted on T1-
L and T2-L. Genes and miRNAs were considered candidates for Fetal Alcohol Spectrum 
Disorder (FASD) if they were: implicated in neurodevelopment or behaviour and/or if they were 
found in a top pathway/network or had an inverse miRNA:mRNA relationship. 
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2.2 Behaviour testing 
2.2.1 Developmental milestone assessment 
T1-L and T2-L ethanol and control mice were followed from PD 2-21 for the 
achievement of developmental milestones
101
. Achievement was based on the ability of a pup to 
display a positive response for two consecutive days. For each milestone, the number of days to 
reach the milestone was recorded. The second consecutive day was recorded as the day of 
acquisition of the milestone. Testing commenced at 10:00 am each day, with the dam placed in a 
separate cage throughout the testing procedure.  
a) Surface righting 
Beginning on PD 2, the pup’s ability to right itself on a plastic surface was evaluated. 
Pups were placed on their backs with all four limbs held to the top and, once released, the time 
(seconds) taken to roll over and place all four paws on the surface was measured. This test 
measures the development of the vestibular reflex and motor coordination. Positive responses 
were noted when pups were able to complete the task for two consecutive days in < 1 second. 
b) Negative geotaxis  
On PD 2, the pup’s ability to rotate its body 180° while on a sloped platform was 
measured. Pups were placed on a mesh wire platform, angled at 45° from the horizontal, with 
their nose pointed towards the ground. The latency to rotate the body until the nose pointed 
upward was recorded. Latency to rotate the body is considered a measurement of vestibular and 
postural reflexes. Positive responses were noted once pups were able to complete the task for two 
consecutive days in < 30 seconds. 
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c) Cliff aversion 
Beginning on PD 2, the pup’s ability to avert a cliff was assessed. Pups were placed on 
the end of a 2-inch-high platform with their noses and fore-digits suspended over the edge of the 
simulated cliff. The latency to back away from the edge of the cliff, turn, and crawl away was 
measured. This test is considered an evaluation of sensory and motor coordination development. 
Positive responses were noted when pups completed the task < 30 seconds for two consecutive 
days. 
d) Forelimb grasp 
On PD 4, the pup’s ability to grasp a wire rod and suspend its own bodyweight was 
evaluated. Pups were placed with their forepaws on a rod held 10 cm above a 5-cm-deep pile of 
woodchip bedding. Once released, the time the pup remained grasping onto the rod was 
recorded. A minimum of 1 second indicated a positive response. This task assesses balance, 
coordination, and motoric strength. 
e) Auditory startle 
Beginning on PD 7, pups were tested for an auditory reflex in response to a loud noise. 
An auditory reflex was assessed in the form of a rapid involuntary jump or “startle” in response 
to a clapping noise. One clap was performed 10 cm from the pup, and a positive response 
(startle) was recorded for two consecutive days. 
f) Ear twitch 
On PD 7, pups were tested for the presence of a tactile reflex of the ear. The edge of a 
fine filament was gently rubbed against the pup’s ear three times. A positive response was 
recorded when the ear twitched rapidly in response to the brushing motion, for two consecutive 
days. 
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g) Open field taversal 
On PD 8, the pup’s locomotion and ability to extinguish pivoting behaviour was assessed. 
Pups were placed in the center of a 13-cm circle, and the latency to exit the circle was measured. 
All four paws must be outside the perimeter of the circle to consider the milestone reached. A 
positive response was noted once the pup exits the circle in < 30 seconds for two consecutive 
days. 
h) Air righting 
Beginning PD 8, pups were tested for the achievement of vestibular reflex function and 
motor coordination using the air righting task. Pups were held upside down, 10 cm above a 5-
cm-deep pile of woodchip bedding, and released. A positive response was noted when a pup 
could right its body in the air such that it landed on the bedding on all four paws.  
i) Eye opening 
Beginning PD 10, pups were examined daily for eye opening. The first day in which both 
eyes were opened was considered achievement of this milestone. 
2.2.2 Open-field activity  
 The daytime and overnight activity of each mouse was assessed using a Panlab Infrared 
(IR) Actimeter (Harvard Panlab, Holliston, MA) from PD 28-35. The open-field apparatus 
consisted of a 450 (W) mm x 450 (D) mm square arena with 450 (H) mm x 350 (W) mm acrylic 
walls mounted to the base. Thirty-two IR beam sensors were located around the perimeter of the 
apparatus to provide sensitive movement detection. Movement was recorded using Actitrack 
Tracking Software (PanLab, Holliston, MA, USA). 
 
30 
 
 
 
a) Daytime novel activity  
Daytime activity levels were assessed from PD 28-30. The Actimeter was used to 
measure a mouse’s locomotor response to a novel environment. Locomotor response was 
represented by recording breaks in the IR beams (beam breaks) within the recording frame of the 
apparatus (Figure 2). Total locomotor activity, as measured by the total number of beam breaks, 
was recorded using Actitrack software. Testing commenced at 10:00 am, and lasted for 15 
minutes for each individual. The arena and Plexiglas walls of the apparatus were wiped with 
30% isopropanol following each test in order to remove olfactory cues and excrement. Solutions 
of 10-30% isopropanol are sufficient for removal of olfactory cues
91,196
. 
b) Overnight home cage activity  
At PD 30-35, mice were introduced into a simulated home cage 24 hours prior to 
overnight activity testing. The simulated home cage included standard woodchip bedding, food 
pellets, and water. Following acclimation, the home cage was placed in the Actimeter for 12 
hours overnight. The period of recording consisted of a 2-hr light period (6:00 pm -8:00 pm) and 
a 10-hr dark period (8:00 pm – 6:00 am), spanning the overnight phase. The IR beams detected 
locomotor patterns of a mouse’s nocturnal activity while encaged. A measurement of total 
locomotor activity (total number of beam breaks) was recorded using the Actitrack software. 
Data from the analysis software were analyzed as a whole (one 12-hr period) and in blocks 
(twelver 1-hr periods). 
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Figure 2. A photograph of the Panlab Infrared (IR) Actimeter apparatus used to measure 
novel, open-field activity in mice. The total number of IR beam breaks was recorded for each 
15-minute period. A C57BL/6J mouse is depicted at the top corner of the arena. The Panlab 
Actimeter was acquired from Harvard Panlab, Holliston, MA. 
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2.2.3 Anxiety-related traits  
a) Panlab infrared actimeter 
The IR Actimeter was used to assess thigmotaxis in mice at PD 28-30. The amount of 
time spent in the center versus the periphery of the locomotor apparatus in the 15 minute period 
was recorded (Figure 2). This measurement relied on the rodent’s natural tendency to stay in the 
periphery of an open field arena and not venture into the middle of the open field. 
b) Elevated plus maze  
An EPM was used as a measure of anxiety-related behaviour in mice at PD 35-40 
(Figure 3). The maze comprised of 4 adjoining, cardboard arms (2 open, 2 enclosed) that stood 
50 cm above the ground. Closed arms were 50 cm (L) x 10 cm (W) x 40 cm (H). Open arms were 
50 cm (L) x 10 am (W). The arms were connected in a plus-formation such that the mice were 
able to cross between arms. The EPM relies on the rodent’s natural tendency to seek dark, 
sheltered areas, and avoid bright (200 lx), exposed, and high-altitude areas
197
. At the beginning 
of the trial, a mouse was placed facing an open arm at the intersection of the apparatus. The 
mouse’s movement was recorded by AnyMAZE Video Tracking software (San Diego 
Instruments, San Diego, CA). Testing was conducted for a single, 5-minute period for each 
mouse. A 5-minute interval is considered capable of revealing differences in anxiety-related 
traits across mice
197
. In between trials, the Plexiglas cover on the maze was wiped with 30% 
isopropanol.   
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Figure 3. A photograph of the Elevated Plus Maze (EPM) apparatus used to assess anxiety-
related traits in mice. The time spent in the closed arms versus the open arms in a 5-minute 
period was recorded. A C57BL/6J mouse is depicted in the top closed arm of the EPM. 
Plexiglas, in a plus-formation, covers the white arms of the maze.  
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c) Light/dark box 
At PD 35-40, the LDB was used as a measure of exploratory behaviour and anxiety-
related behaviour in a novel, illuminated environment (Figure 4). The apparatus was constructed 
following a design by Bourin and Hascoet, which included two compartments consisting of a 27 
cm (L) x 27 cm (W)  x 27 cm (H) light arena (plastic), and a 18 cm (L) x 27 cm (W) x 27 cm (H) 
dark arena (cardboard)
100
. A 7.5 cm x 7.5 cm opening was created between the light and dark 
regions. At the beginning of each trial, the mouse was placed in the light area facing the opening. 
The mouse was allowed to freely explore both areas for 5 minutes, with an overhead light at 200 
lx. Movement was recorded by AnyMAZE Video Tracking software. In between trials, the 
plastic arena was wiped with 30% isopropanol 
 
 
 
 
 
 
 
 
 
 
 
 
 
35 
 
 
 
 
 
 
 
 
                                
Figure 4. A photograph of the Light/Dark Box (LDB) used to assess anxiety-related traits 
in mice. The time spent in the closed area (black cardboard box) versus the open area (white 
plastic box) in a 5-minute period was recorded. A C57BL/6J mouse is depicted in bottom right 
corner of the LDB. Arrows point to the dark and light areas of the LDB. 
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2.2.4 Spatial learning and memory  
From PD 45-70, the Barnes Maze was used as a test of spatial learning, short-term recall, 
and long-term recall. The maze was constructed by Ph.D. candidate, Morgan Kleiber, according 
to Sunyer and colleagues
89
 (Figure 5). The apparatus was comprised of a circular wood platform 
with a 92-cm-diameter, punctuated with 20 equally-spaced holes (each 5 cm in diameter) along 
the periphery of the platform (7.5 cm between holes). The platform stood 105 cm above the 
ground. One of the holes along the perimeter was a target hole, through which mice were able to 
enter an escape box. Black cardboard sheets were placed underneath the other 19 holes. The 
escape box was painted black to remain visually indistinguishable from other holes. 
Experimenter-prepared visual cues were constructed and placed around the testing room to 
provide spatial details regarding the location of the target hole. Aversive stimuli were added to 
the test, in the form of a 150 W bright light. An 85 dB white noise was generated using 
AnyMAZE software. AnyMAZE was also used to track the mouse’s movements during each 
trial. Upon the mouse’s entry into the escape box, the light and white noise were turned off for a 
period of 1 minute to allow the mouse to acclimatize to the box. The platform and escape box 
were wiped with 30% isopropanol between trials. 
a) Learning 
Mice were given four trials over four acquisition days (learning days) to learn the 
location of the target hole. At the beginning of each trial, a mouse was placed in the center of the 
maze inside a cylindrical start-chamber for 10 seconds. Once the start-chamber was removed, the 
mouse was allotted 3 minutes to explore the maze and locate the target hole. If the mouse entered 
the target hole within the 3 minute period, the overhead light and white noise were terminated. 
The mouse was allotted 1 minute in the escape box following its entry. If the mouse did not 
37 
 
 
 
locate the target hole within the 3 minute period, the mouse was guided to the escape box 
following the trial and allowed to remain inside the box for 1 minute. Each mouse was trained on 
the Barnes Maze for four consecutive days, with each training day consisting of four 3-minute 
trials. There was a 15 minute interval between trials. After each trial, the mouse was returned to 
its home cage. The latency (seconds) to enter the escape box was measured using AnyMAZE 
software.  
      b)   Memory 
The fifth (short-term recall) and twelfth (long-term recall) days of Barnes Maze testing 
are referred to as “probe” trials. Good memory on probe trials in the Barnes Maze is defined as 
selective search for the former location of the target, compared with equivalent locations in other 
zones
198
. On probe days 5 and 12, the escape box was removed, and the target hole was covered 
with black cardboard. Each mouse was given one 1-minute trial on each day to explore the maze 
(Figure 5). The number of explorations to each hole was recorded.  
            2.2.5 Statistical analysis of behavioural data 
For each behavioural test, data were analyzed using appropriate analysis of variance 
(ANOVA) methods depending on the number of independent variables (sex, treatment, repeated 
day of testing). Where data were analyzed across days, repeated measures ANOVA (RM-
ANOVA) with “treatment” as the between-subjects factor. “Day” (Barnes maze) or “hour” 
(Overnight home-cage activity) was used as the within-subjects factor was used. All data were 
reported as mean ± standard error of the mean (SEM). For the Barnes Maze probe trials, a 
Bonferroni correction was applied to correct for multiple testing. Effects of litter were analyzed 
using “litter” as a covariate in the ANOVA; however, no litter effects were observed for any of 
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the behavioural measures. Data were stratified by sex only if sexually dimorphic effects were 
observed. All statistical analyses were performed using Statistical Package for the Social 
Sciences (SPSS) version 16 (SPSS Inc., Chicago, IL). 
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Figure 5. A photograph of the Barnes Maze used to assess spatial and learning memory in 
mice. Spatial cues, consisting of various shapes and colours, are displayed around the testing 
room. All holes, except the target hole, are covered with black cardboard cut-outs. The target 
hole leads to a black escape box, positioned underneath the platform. Arrow points to the 
location of the target hole.   
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2.3 Gene expression analysis 
2.3.1 Tissue extraction and RNA isolation 
Whole brains (T2-S, T1-L, and T2-L) were harvested, snap-frozen in liquid nitrogen, and 
stored at -80°C. Total RNA was extracted using Trizol
®
 according to the manufacturer’s 
instructions (Invitrogen, Carlsbad, CA). To check the quality of RNA, 2 μl of each sample was 
quantified using the ND-1000 Spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, 
DE) and Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Palo Alto, CA) at the London 
Regional Genomics Center (LRGC) (University of Western Ontario, London, Ontario). An 
automated gel image was generated based on the results of the electropherogram, in order to 
visualize the quality of the RNA sample as if it were electrophoresed through on a standard 1% 
agarose gel. RNA was shown to be of good quality by A260/A280 ratio in the range of 1.8-2.1, 
which is indicative of pure RNA
199
. Also, only those samples with concentrations > 100 ng/µl, 
ratios of A260/A230 between 2.0-2.2, and RNA Integrity Numbers within the range of 8-9.5 
were used for analysis. If a sample with A260/A280 < 1.8 was identified following microarray 
analysis, it was discarded in qRT-PCR confirmation experiments. 
2.3.2 Microarray preparation 
Whole brain RNA from B6 mice was sent to LRGC for hybridization to Affymetrix 
Mouse Gene 1.0 ST arrays, which are high-density oligonucleotide arrays. Each chip contained 
three pooled samples (three different mice) of RNA. Pooling samples allowed for reduction of 
litter effects between mice. For each experiment, one control and one experimental array were 
analysed, along with a biological replicate of each. For T2-S mice, 4 gene chips were used (2 
control, 2 ethanol), with a total of 12 RNA samples (different mice). For T1-L and T2-L, 8 arrays 
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were used (2 control, 2 ethanol per group), with a total of 24 RNA samples (different mice). A 
biological replicate was preferred to a technical replicate because biological diversity is 
controlled by using different samples (ie. mice) of the same treatment. For the entire experiment, 
a total of 12 microarrays and 36 RNA samples were used. In order to pool samples for each 
array, 2 µl of RNA was diluted to 100 ng/µl. The concentrations of the diluted samples were 
double checked. If inaccurate, the original RNA was diluted again using the correct 
concentration. Samples were then pooled (~100 ng/µl).  
Microarray cDNA synthesis, in vitro transcription, cRNA fragmentation, and 
hybridization reactions were carried out at LRGC. Using 200 ng of total RNA, the RNA was first 
reverse transcribed to single-stranded complementary DNA (sscDNA) using the Ambion WT 
Expression Kit for Affymetrix GeneChip Whole Transcript WT Expression Arrays (Applied 
Biosystems, Carlsbad, CA) and the Affymetrix GeneChip WT Terminal Labeling kit and 
hybridization manual (Affymetrix, Santa Clara, CA). First-cycle cDNA was transcribed in vitro 
to cRNA, and used to synthesize 5.5 μg of sscDNA that was subsequently end-labeled (biotin) 
and hybridized for 16 hours at 45°C to Affymetrix Mouse Gene 1.0 ST arrays. Liquid-handling 
steps were performed by a GeneChip Station 450. The arrays were stained using Streptavidin-
Phycoerythrin, which binds to the biotin molecules and emits a fluorescence when run through 
the GeneChip Scanner 3000 7G using Command Console version 1.1 (Affymetrix In., Santa 
Clara, CA, USA). The scanner output the raw intensity values and images for each probe into a 
probe level (.CEL) file, which allowed visualization of the fluorescence.   
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2.3.3 Microarray data analysis  
Probe-level (.CEL) data were generated using Affymetrix Command Console version 1.1 
and probes were summarized to gene-level data using Partek Genomics Suite software version 
6.6 (Partek Inc., St. Louis, MO). Array analysis for each of the experiments (T2-S, T1-L, and T2-
L) was completed. Data were background corrected, quantile-normalized, summarized, and log2-
transformed. Subsequent statistical analyses were performed using Partek software to determine 
gene-level ANOVA p-values and fold changes. Because prenatal ethanol exposure has been 
shown to produce subtle changes in gene expression
94,158
, a ± 1.2 fold change and p < 0.05 were 
used as criteria for building gene lists for functional, pathway, and network analyses. Un-
annotated genes and standards were removed from the gene lists. All data files from the array 
experiments have been deposited in the National Center for Biotechnology Information Gene 
Expression Omnibus, under the accessions: GSE34469 (T1-L and T2-L) and GSE43324 (T2-S). 
Complete lists of DEGs identified for T2-S, T1-L, and T2-L are given in Appendices B, C, and 
D, respectively.  
2.3.4 Statistical analysis of microarray data 
 Statistical analysis of microarray data is necessary to make inferences about a 
phenomenon based on empirically measured data. Microarrays measure the mRNA levels of 
thousands of genes, and are then analyzed to identify genes that are correlated to a phenotype of 
interest. Here, gene-level summarization was performed using an ANOVA to compare ethanol 
and control data. The ANOVA condensed the dataset into a manageable set of DEGs based on 
certain criteria: a fold-change and an alpha level of significance (based on the ANOVA). The 
inputted data from the arrays (.CEL file extension) were normalized using an internal algorithm. 
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The using the GeneChip-Robust Multiarray Averaging algorithm, with GC-content background 
correction (GC-RMA) ― which accounts for probe GC-content200 ― was used since it has been 
shown to perform well by other researchers
201,202
. GC-RMA incorporates probe sequence 
composition into background adjustment based on the assumption that probe affinity is 
dependent on its base composition and the position of each base along the probe; herein, this 
suggests that the probe sequence can significantly affect the intensity of the signal generated 
from that probe, independent of the level of quantity of its target
203
. Researchers have reported 
on the use of GC-RMA and its outstanding performance in detecting low-intensity, DEGs, and 
its consistency with qRT-PCR
202,204
.  
Partek is an exploratory data tool used for the identification of DEGs using ANOVA
205
. 
The ANOVA is a powerful method of data analysis that is motivated by consideration of the 
experimental design
206
. The challenge with an ANOVA is to detect as many real differences as 
possible while maintaining control over the rate of false detection. The most popular approach to 
rectify this is to apply a false discovery rate (FDR) correction; an FDR correction generates a list 
of DEGs such that the expected proportion of false detections on the list is bounded at a user-
defined level
207
. In Partek analysis, the ANOVA was performed on all genes. A table was created 
that allowed the investigator to browse and create gene lists from the results based on p-value 
and fold change.  
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2.3.5 Functional, pathway, and network analysis of differentially-expressed genes 
(DEGs) 
Once identified by Partek, DEGs were analyzed using three functional characterization 
tools. The functional annotation and clustering tool, DAVID
137,208
, was used. DAVID uses a 
modified version of Fisher’s exact test to identify statistically significant Gene Ontology (GO) 
terms including biological process (BP), cellular component (CC), and molecular function 
(MF)
209
. Other annotations used to group genes in DAVID include: BioCarta pathways 
(BioCarta LLC, San Diego, California, USA), KEGG pathways, Protein Sequence Analysis and 
Classification (InterPro) (Wellcome Trust Genome Campus, Cambridgeshire, United Kingdom), 
Simple Modular Architecture Research Tool (SMART)
210,211
, and Swiss-Prot and Protein 
Information Resource (SP PIR) (Georgetown University Medical Center, Washington, DC, 
USA). Using the Gene Enrichment tool, Partek was used to identify over-represented GO terms 
associated with genes showing altered expression. Finally, IPA was used to cluster genes based 
on biological functions. Upregulated and downregulated gene lists (± 1.2 fold change, p < 0.05) 
were assessed concurrently for each analysis.  
To characterize sets of functionally related DEGs, three sets of pathway analysis 
programs were used. Pathway Express was used. Gene sets (± 1.2 fold change and p < 0.05) 
were inputted into the Pathway Express tool to translate these lists into functional profiles (using 
GO terms) in order to characterize the impact of prenatal ethanol exposure. For each GO 
category, statistical significance values were calculated using a Fisher’s exact test140. The results 
from Pathway Express were complemented using the Pathway Enrichment tool in Partek. PE 
also relies on the KEGG database to assign enriched pathways for each of the DEG lists. Lastly, 
canonical pathways were assessed using IPA. The goal of using three pathway tools was to 
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compare the results, and to generate biologically meaningful and comprehensive data from each 
of the gene lists.  
Network analysis of the DEGs was completed using two programs. The publically 
available pathway tool, GeneMANIA, was used to find genes (using a linear regression-based 
algorithm) that were related to the input genes; such an analysis gives input on specific genetic 
interactions, pathways, co-expression, co-localization, and protein domain similarity in mice
212
. 
The gene lists were further inputted into IPA to identify networks in which genes and proteins 
have been reported to interact with each other, whether directly or indirectly. By employing 
various functional, pathway, and network analyses on the lists of DEGs, this method gave 
comprehensive insight into the biological mechanisms underlying FASD. 
2.3.6 Confirmation of gene expression by quantitative RT-PCR (qRT-PCR) 
 Excess RNA extracts that were used for array hybridization were also used to confirm the 
expression of selected genes by qRT-PCR. Complementary DNA was synthesized using 2 µg of 
total whole brain RNA using a High-Capacity cDNA Reverse Transcription kit (Applied 
Biosystems, Foster City, CA) according to the manufacturer’s protocol. Gene-specific TaqMan® 
Assay Reagents and TaqMan Gene Expression Assay products were used on a StepOne
TM
 Real 
Time PCR System (Applied Biosystems, Foster City, CA). Primers and 6-carboxyfluorescein 
(FAM)-labeled probes for specific genes (Table 1) were obtained from Applied Biosystems 
Inventoried Assays and used as per the manufacturer’s instructions. Reactions were multiplexed 
with Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) or Actin, beta (Actb) using gene-
specific primers and VIC-labeled probes. Reactions were performed using a standard ramp speed 
protocol using 10 μl volumes. PCR cycling consisted of a 10 minute initiation at 95°C, followed 
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by 40 cycles consisting of a 15 second denaturation at 95°C and an anneal and extension at 60°C 
for 60 seconds. Experiments included six biological replicates per treatment (only five biological 
replicates were available for T2-L ethanol samples) and three technical replicates per sample. 
Relative expression was calculated according to the comparative CT method
213
 using StepOne
TM
 
version 2.0 software from Applied Biosystems. All PCR data are reported as mean ± SEM 
relative expression values. Significant differences were assessed using a student’s t-test in SPSS.    
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Table 1. Candidate genes for FASD selected for confirmation by quantitative RT-PCR. 
Group
a
 Gene 
Symbol
b
 
Gene Name Reference 
Gene
c
 
T2-S Ccl3 Chemokine (C-C motif) ligand 3 Actb 
Ccnt1 Cyclin T1 Gapdh 
Gpr50 G protein-coupled receptor 50  Gapdh 
Lair1 Leukocyte-associated immunoglobulin-like receptor 1 Gapdh 
Pip5k1b Phosphatidylinositol-4-phosphate 5-kinase, type I, beta Actb 
Rybp RING1 and YY1 binding protein Gapdh 
Slitrk2 SLIT and NTRK-like family, member 2 Gapdh 
Trdn  Triadin Actb 
T1-L Atf1 Activating transcription factor 1 Actb 
Ceacam1 Carcinoembryonic antigen-related cell adhesion molecular 1 
(biliary glycoprotein) 
Actb 
Eomes Eomesodermin (Xenopus laevis) homolog Gapdh 
Htr5a 5-hydroxytryptamine (serotonin) receptor 5A, G-protein 
coupled 
Gapdh 
Map3k1 Mitogen-activated protein kinase kinase kinase, E3 ubiquitin 
protein ligase 
Actb 
Stxbp6 Syntaxin binding protein 6 (amisyn) Actb 
Synpr Synaptoporin Gapdh 
Tnfrsf19 Tumor necrosis factor receptor superfamily, member 19 Gapdh 
T2-L Camk1g Calcium/calmodulin-dependent protein kinase 1G Gapdh 
Ccdc6  Coiled-coil domain containing 6  Actb 
Cdkn1a Cyclin-dependent kinase inhibitor 1a Gapdh 
Egr3  Early growth response 3 Gapdh 
Homer1 Homer homolog 1 (Drosophila) Gapdh 
Hsp90aa1 Heat shock protein 90kDa alpha (cytosolic), class A member 
1 
Actb 
Hspa5 Heat shock 70kDa protein 5 (glucose-regulated protein, 
78kDa) 
Actb 
Manf Mesencephalic astrocyte-derived neurotrophic factor Gapdh 
Tbxa2r Thromboxane A2 receptor Actb 
Xbp1 X-box binding protein 1 Actb 
 
a
Groups: T2-S = trimester two, short-term effect. T1-L = trimester one, long-term effect. T2-L = trimester two, long-
term effect.  
b
Genes are listed in alphabetical order for each group.  
c
Reference gene was either Actin, beta (Actb) or Glyceraldehyde-3-phosphate dehydrogenase (Gapdh). 
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2.4 MicroRNA analysis 
 2.4.1 Experimental design and miRNA arrays  
The RNA samples used for long-term gene expression analyses (T1-L and T2-L) were 
also used for global miRNA analysis using miRNA arrays. For each long-term group, each array 
contained three pooled samples of RNA, corresponding to the animals used in gene expression 
experiments. For each group, two biological replicates of a control and ethanol array were 
performed (n = 4 arrays per group; total n = 8 arrays). All sample labeling, hybridization, and 
processing were performed at LRGC. One microgram of total RNA was labeled using the Flash 
Tag Biotin HSR kit (Genisphere, Hatfield, PA, USA) and hybridized to Affymetrix MiRNA 2.0 
arrays for 16 hours at 45°C. Probe level (.CEL file) data were generated using Affymetrix 
Command Console version 1.1 (Affymetrix In., Santa Clara, CA). Probes were summarized to 
gene-level data in Partek using the Robust Multiarray Averaging (RMA) algorithm
200
. Partek 
software was used to determine differences between ethanol and control samples using one-way 
ANOVA and corresponding p-values and fold changes. For each group, the miRNAs on the 
array were filtered using stringency criteria including a p < 0.05 and ± 1.2 fold change. The 
miRNA expression array results for both groups (T1-L and T2-L) were deposited within the 
NCBI GEO database under accession number GSE34413. 
2.4.2 MiRNA target filtering and selection criteria 
Data generated using T1-L and T2-L miRNA arrays were analyzed using IPA. 
Concurrently, T1-L and T2-L gene lists from gene expression analyses (± 1.2 fold change, p < 
0.05) were combined with their corresponding miRNA list in IPA’s Target Filter analysis. Target 
filtering was performed to generate a list of interactions between genes and miRNAs in each 
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group. Results were filtered based on a moderate or high confidence of interaction and an inverse 
miRNA to target mRNA expression relationship
214
.  
2.4.3 Confirmation of miRNAs using quantitative RT-PCR 
 Excess RNA extracts that were used for miRNA array hybridization were also used to 
confirm the expression of selected miRNAs by qRT-PCR. Complementary DNA was 
synthesized using 2 µg of total whole brain RNA using the Applied Biosystems TaqMan Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA, USA) and sequence-specific step-loop 
reverse transcription primers from TaqMan MicroRNA Assays (Applied Biosystems, Foster 
City, CA, USA) according to the manufacturer’s protocol. All qRT-PCR primers and miRNA-
specific TaqMan probes were selected using the Applied Biosystems (Carlsbad, CA, USA) 
search engine to identify previously characterized TaqMan MicroRNA Assays. FAM-labeled 
probes for miRNA 1192 (miR-1192, T1-L), miRNA 532-5p (miR-532-5p, T1-L), and miRNA 
302c (miR-302c, T2-L) were obtained from Applied Biosystems Inventory Assays and used as 
per the manufacturer’s instructions. Small nucleolar RNA 202 (snoRNA 202) was chosen as an 
endogenous control
95,215
. The target and control reactions were performed in separate tubes on 
the same plate for each sample as per the manufacturer’s protocol. Three technical replicates 
were used for both the endogenous control and gene of interest for each sample. As with qRT-
PCR for genes, six biological samples were used for each treatment (except for T2-L ethanol 
samples, where only five experimental samples were used). Quantitative PCR reactions were 
performed on the StepOne Real-Time PCR System according to the manufacturer’s protocol. 
Reactions were run following a standard ramp speed protocol using 20 μl volumes. Fold change 
was calculated using the ∆∆CT method
216
. Data were analysed using Applied Biosystems 
DataAssist
TM
 Software version 3.0. Statistical significance was assessed using a two-tailed t-test.   
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3. Results 
3.1 Overview on presentation of results 
This chapter includes results on behaviours and brain gene expression, including 
miRNAs, using B6 mice, following in vivo binge-like ethanol treatment at two stages of 
neurodevelopment. The timings include, GD 8 and 11 (representing human trimester one), and 
GD 14 and 16 (representing human trimester two). All behavioural testing was performed on 
resulting trimester one and two progeny. Behavioural testing began at early development (PD 2) 
until maturity (PD 70), at which time mice were euthanized for brain transcriptome analysis. A 
separate experiment assessed gene expression patterns 2 hrs following ethanol treatment on GD 
16 to represent short-term effects of ethanol exposure. The results are now published in the 
Journal of Neurodevelopmental Disorders
158
, Journal of Behavioural and Brain Science
217
, and 
Disease Models and Mechanisms
95
. I have obtained permission for using copyright images from 
the editor of the Journal of Behavioural and Brain Science for inclusion in this thesis (Appendix 
E). This copyright includes the adaptation of any images from the article. A copyright approval 
was not required from other journal editors since I have not included images from these articles. 
For specifics on authorship, please refer to co-authorship statement (p. ix). 
3.2 FASD-relevant behaviours are altered in mice following gestational ethanol exposure  
3.2.1 Developmental milestone achievement is delayed following prenatal ethanol 
exposure 
All pups from trimesters one and two were evaluated from PD 2-21 for the ability to 
reach critical developmental milestones. The day each specific milestone was achieved (second 
consecutive day), for each group, is shown in Table 2
217
. Ethanol exposure during the first 
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trimester equivalent significantly delays the abilities of pups to right themselves when placed on 
their backs (F1,46 = 29.90, p < 0.001), grasp a rod with their forelimbs (F1,46 = 15.50, p < 0.001), 
extinguish pivoting behaviour by transversing out of a 15-cm-diameter circle (F1,46 = 15.10, p < 
0.001), and right themselves in the air when dropped from upside down from 5 cm (F1,46 = 23.71, 
p < 0.001). A significant interaction between sex and treatment was observed for the ability of 
the pup to right itself in the air when dropped (F1,46 = 7.60, p = 0.008), with control males taking 
longer to right themselves than control females; however, ethanol females took longer to right 
themselves than ethanol males. Ethanol pups from trimester two were significantly increased, 
compared to control pups, in the time it took to surface right (F1,54 = 4.93, p = 0.03), turn 180°C 
upward when placed downward on a 45° screen (F1,54 = 34.88, p < 0.001), crawl away from the 
edge of a cliff (F1,54 = 25.10, p < 0.001), grasp the rod (F1,54 = 6.65, p = 0.01), transverse out of 
the circle (F1,54 = 17.02, p < 0.001), right themselves in the air (F1,54 = 10.06, p = 0.003) and 
open their eyes for the first time (F1,54 = 6.21, p = 0.02). Post-hoc testing using all four groups 
(trimester one control and ethanol; trimester two control and ethanol) revealed that the only 
developmental milestone in which trimester one and two ethanol mice were significantly 
different was forelimb grasp (F3,100 =  19.66, p < 0.001).     
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Table 2. Developmental milestone achievement of postnatal day ethanol and control pups. 
Treatment Control    Ethanol    
Sex Male  Female  Male  Female  
 
T1  
(n=11) 
T2  
(n=18) 
T1  
(n=12) 
T2  
(n=10) 
T1  
(n=13) 
T2  
(n=11) 
T1  
(n=14) 
T2  
(n=20) 
Milestone
a
          
Surface righting 6.5±0.4 8.7±0.3 6.4±0.4 8.4±0.3 ***9.1±0.4 *8.9±0.3 ***8.7±0.5 *9.7±0.3 
Negative geotaxis
#
 7.0±0.4 6.2±0.4 7.5±0.4 7.4±0.3 6.6±0.5 ***9.5±0.7 6.6±0.4 ***9.4±0.3 
Cliff aversion 9.0±0.4 7.9±0.5 9.7±0.4 6.4±0.9 9.1±0.5 ***9.7±0.4 8.7±0.3 ***10.4±0.4 
Forelimb grasp 9.6±0.6 10.0±0.7 9.3±0.4 9.4±0.8 ***11.5±0.7 11.1±0.5 ***11.9±0.5 11.6±0.3 
Auditory startle 14.7±0.2 13.9±0.4 13.8±0.5 14.0±0.3 13.1±0.5 13.4±0.8 13.8±0.6 14.2±0.4 
Ear twitch 9.8±0.3 9.3±0.3 9.5±0.3 10.4±0.5 9.3±0.4 10.4±0.3 9.9±0.5 10.4±0.3 
Open field traversal 10.6±0.6 10.9±0.4 11.4±0.4 10.0±0.4 ***12.5±0.3 ***12.4±0.6 ***12.8±0.4 ***12.5±0.4 
Eye opening 14.7±0.1 13.8±0.2 14.3±0.1 14.2±0.3 14.5±0.1 *14.6±0.2 14.6±0.2 *14.4±0.2 
Air righting 12.9±0.7 12.1±0.6 11.0±0.6 12.4±0.5 ***14.1±0.5 **14.0±0.7 ***15.2±0.4 **14.2±0.4 
 
a
Mean (± SEM) number of days to complete each task was compared across males and females from trimester one (T1) and trimester two (T2) ethanol and 
control pups. *p < 0.05; **p < 0.01; ***p < 0.001. Number (n) of mice used for each test are shown. 
#
Negative geotaxis is the only developmental milestone in which T1 and T2 ethanol mice were significantly different (p < 0.001). 
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3.2.2 Locomotor activity is altered in mice following gestational ethanol exposure  
a) Daytime novel activity is increased in ethanol-treated mice 
Spontaneous activity of control and ethanol juveniles (PD 28-30) from trimesters one and 
two was assessed over a 15 minute period in a novel, open-field environment. Two-way 
ANOVA did not result in a significant effect of sex or an interaction between sex and treatment. 
Therefore, the groups were collapsed and a one-way ANOVA with “treatment” as the main 
factor was applied. One-way ANOVA showed a significant effect of treatment in trimester one 
(F1,46 = 6.48, p = 0.01) and trimester two (F1,54 = 69.89, p < 0.001), where the number of beam 
breaks was increased in ethanol mice (T1-L: 2835.58 ± 136.81; T2-L: 3429.13 ± 93.81 beam 
breaks) versus control mice (T1-L: 2332.12 ± 142.89; T2-L: 2291.54 ± 98.57 beam breaks). 
There were no significant differences between T1-L and T2-L control mice. A significant 
difference was found between trimester one and two ethanol mice (F3,100 = 25.22, p = 0.001), 
with trimester two ethanol mice displaying increased activity compared to trimester one treated 
mice (Figure 6)
217
. 
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Figure 6. Bar graph of locomotor activity in a novel, open-field encironment in ethanol and 
control mice. Mean (± SEM) infrared beam breaks (total no. beam breaks) of ethanol and 
control mice from trimester one (T1) and trimester two (T2) over a 15 min period (n = 20-28 
mice per group). *p < 0.05; **p < 0.01; ***p < 0.001.  
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b) Overnight home cage activity is disrupted in ethanol-treated mice 
Locomotor activity in a familiar environment (home cage) was assessed in ethanol and 
control mice at PD 30-35. For both groups, a two-way ANOVA for total 12-hour activity did not 
identify any significant effects of treatment, sex, or an interaction between treatment and sex. 
The data were further analyzed in twelve 1-hour measurements. Two-way RM-ANOVA with 
“hour” as the within-subjects factor, and “sex” and “treatment” as between-subjects factors 
detected significant main effects of hour and treatment. A significant main effect of treatment in 
trimester one was found (F1,46 = 12.09, p = 0.001), with ethanol mice demonstrating increased 
activity (4160.01 ± 192.89 beam breaks) throughout the nocturnal phase, versus control mice 
(3190.38 ± 201.47 beam breaks) (Figure 7)
217
. The pattern in trimester two mice resulted in a 
nominally significant increase in activity levels (F1,54 = 3.311, p = 0.074) in ethanol mice 
(4762.62 ± 258.37 beam breaks) compared to control mice (4080.70 ± 271.47 beam breaks) 
(Figure 8)
217
. For overnight activity levels, a comparison between trimester one and two ethanol 
mice was not carried out due to observed discrepancies between males and females, and 
statistical differences between control mice. 
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Figure 7. Line graph of locomotor activity in a familiar home-cage environment in 
trimester one ethanol and control mice. Mean (± SEM) infrared beam breaks (no. beam 
breaks) by ethanol and control mice from trimester one (A) females (n = 26) and (B) males (n = 
20). *p < 0.05; **p < 0.01. Lights were off between 8:00 pm - 6:00 am. 
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Figure 8. Line graph of locomotor activity in a familiar home cage environment in 
trimester two ethanol and control mice. Mean (± SEM) infrared beam breaks (no. beam 
breaks) by ethanol and control mice from trimester two (A) females (n = 28) and (B) males (n = 
26). *p < 0.05; **p < 0.01. Lights were off between 8:00 pm - 6:00 am. 
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3.2.3 Anxiety-related behaviours are dependent upon timing of ethanol exposure 
a) Open field testing 
To evaluate the effects of novelty-induced, anxiety-related traits in the open field task, 
thigmotaxis was examined during open-field testing. No statistically significant effect of 
treatment was observed between ethanol (214.46 ± 23.60 s) and control (185.88 ± 19.50 s) mice 
in trimester one (F1,46 = 0.92, p = 0.34). A significant main effect of treatment was observed in 
trimester two (F1,54 = 59.65, p < 0.001), with ethanol offspring spending significantly more time 
(477.31 ± 26.94 s) in the center zone than control mice (175.52 ± 28.30 s). Trimester two ethanol 
mice also spent significantly more time in the center zone (F3,100 = 34.34, p < 0.001) than ethanol 
and control trimester one mice (Figure 9)
217
. 
b) Elevated plus maze 
In the EPM, there were no statistically significant differences (F1,46 = 1.109, p = 0.30) in 
the amount of time spent in the open arms versus the closed arms between ethanol (94.42 ± 5.66 
s) and control mice (86.94 ± 3.96 s) from trimester one. Similarly, in trimester two, there were no 
significant differences (F1,54 = 0.11, p = 0.74) in the amount of time spent in the open arms 
versus the closed arms of the EPM between ethanol (69.45 ± 3.89 s) and control mice (68.96 ± 
4.17 s). 
c) Light/dark box 
 
A LDB was further used to evaluate anxiety-related phenotypes that have been observed 
in daytime open-field activity data. Trimester one ethanol (146.12 ± 7.58 s) and control (160.90 
± 7.92 s) mice were not significantly different (F1,46 = 1.82, p = 0.18). Trimester two ethanol 
mice spent significantly (F1,54 = 7.08, p = 0.01) more time (average: 152.46 ± 4.65 s) in the light 
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area of the box than control mice (average: 134.50 ± 4.89 s) (Figure 10)
217
. A comparison 
between trimester one and two ethanol mice was not performed because data for trimester one 
and two control mice were statistically different (p = 0.016). 
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Figure 9. Bar graph of time spent in the centre of a novel, open-field environment in 
ethanol and control mice. Mean (± SEM) time in seconds (s) spent in the centre of the 
apparatus of ethanol and control mice from trimester one (T1) and trimester two (T2) over a 15 
min period (n = 20-28 mice per group). ***p < 0.001. 
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Figure 10. Bar graph of time spent in the light area of a light/dark box in ethanol and 
control mice. Mean (± SEM) time in seconds (s) spent in the centre of the apparatus of ethanol 
and control mice from (A) trimester one and (B) trimester two over a 5 min period (n = 20-28 
mice per group). *p < 0.05. 
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3.2.4 Ethanol-treated mice exhibit learning and memory deficits in the Barnes maze 
a) Learning is disrupted following gestational ethanol exposure 
Mixed-model ANOVA showed a significant interaction of treatment by acquisition day 
on latency to reach the escape box. There was no significant effect of sex or an interaction 
between sex and treatment observed for any treatment time. Trimester one ethanol mice 
displayed increased latency (day 3 average: 24.81 ± 2.37; day 4 average: 24.33 ± 2.43 s) to reach 
the escape box than control mice (day 3 average: 12.68 ± 2.47; day 4 average: 13.29 ± 2.54 s) on 
acquisition days three (F1,46 = 12.54, p = 0.001) and four (F1,46 = 9.86, p = 0.003) (Figure 
11A)
217
. Ethanol mice from trimester two had significantly increased latency (average: 109.09 ± 
7.91 s) to reach the target hole on day one (F1,54 = 10.60, p = 0.002) versus control mice 
(average: 71.74 ± 8.31 s), but performed similarly to control mice on days two to four (Figure 
11B)
217
. A comparison between trimester one and two ethanol mice revealed significant 
differences on learning days three (F3,100 = 10.01, p < 0.001) and four (F3,100 = 14.36, p < 0.001), 
with trimester two ethanol mice displaying increased latency to the target hole versus trimester 
one treated mice.  
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Figure 11. Line graph of latency to reach the target of the Barnes Maze in ethanol and 
control mice. Average latencies in seconds (s) to the target represent mean latencies (± SEM) of 
four trials per day across four acquisition days for ethanol and control mice from (A) trimester 
one and (B) trimester two. Data shown are collapsed across sex (n = 20-28 mice per group). **p 
< 0.01; ***p < 0.001. 
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b) Short-term and long-term recall is delayed in ethanol-treated mice 
Short-term and long-term retention of memory in the Barnes Maze was assessed on days 
5 and 12, respectively. The number of explorations to each hole was calculated. On probe day 5 
(short-term recall), trimester one ethanol mice were not significantly different from control mice 
in the number of explorations to any holes. A main effect of sex (F1,46 = 5.33, p = 0.025) was 
found, with females (average: 2.46 ± 0.13 explorations) exhibiting significantly more 
explorations to the target hole than males (average: 2.05 ± 0.12 explorations). No significant 
interaction between sex and treatment was observed (Figure 12A)
217
. On probe day 12 (long-
term recall), a significant main effect of sex (F1,46 = 4.22, p = 0.046) was found, with females 
(average: 2.64 ± 0.15 explorations) exhibiting more explorations to the target hole than males 
(average: 2.21 ± 0.15 explorations). A significant effect of treatment (F1,46 = 7.17, p < 0.05) was 
observed at position +2 (near the target hole), with control mice demonstrating more explorations 
than ethanol mice (Figure 12B)
217
. There were no statistically significant differences between 
trimester one and two ethanol mice. 
 No significant effects of sex or an interaction between sex and treatment were observed 
for the number of explorations made by ethanol and control trimester two mice on probe day 5. 
A significant effect of treatment was observed for the number of explorations to the adjacent 
hole (position -1) to the target location (F1,54 = 14.27, p < 0.001), with control mice performing 
more explorations than ethanol mice. Significant effects of treatment were also observed for 
positions on the opposite side of the platform, with ethanol mice pursuing significantly more 
explorations to the opposite side of the target hole than control mice (Figure 13A)
217
. Although 
no main effects of sex were observed, a significant interaction between sex and treatment on 
probe day 12 (F1,54 = 6.03, p = 0.02) was observed. Significant effects of treatment were 
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observed for the explorations to the target hole (F1,54 = 12.29, p = 0.02) and the hole adjacent to 
the target (position -1) (F1,54 = 6.17, p = 0.002), with control mice spending significantly more 
time within the target hole area than ethanol mice (Figure 13B)
217
. There were no statistically 
significant differences between trimester one and two ethanol mice. 
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Figure 12. Line graph comparing the number of hole explorations in the Barnes Maze 
between trimester one ethanol and control mice. Mean (± SEM) number of explorations to 
each hole of the Barnes Maze for ethanol and control mice on (A) day 5 and (B) day 12. Data 
shown here are collapsed across sex (n = 20-26 mice per group). ***p < 0.001.  
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Figure 13. Line graph comparing the number of hole explorations in the Barnes Maze 
between trimester two ethanol and control mice. Mean (± SEM) number of explorations to 
each hole of the Barnes Maze for ethanol and control mice on (A) day 5 and (B) day 12. Data 
shown here are collapsed across sex (n = 26-28 mice per group). *p < 0.05; ***p < 0.001. 
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  3.2.5 Summary of behavioural results  
 Ethanol exposure during the first and second term of gestation led to a variety of 
behavioural abnormalities in offspring (Table 3). These abnormalities were dependent upon the 
timing of prenatal ethanol exposure. First and second trimester ethanol exposure resulted in 
developmental milestone deficits, increased activity levels, and spatial learning delays. Spatial 
learning delays were not consistent between treatments. In terms of latency to the target hole in 
the Barnes Maze, trimester-two-ethanol mice were able to “catch up” to control mice by the end 
of the learning trials. When examining memory using the Barnes Maze, short-term and long-term 
recall (probe) trials demonstrated that the initial learning delays were persistent in ethanol mice. 
Trimester one ethanol mice were significantly delayed in reaching the target hole compared to 
matched controls. However, memory testing revealed that these mice do not exhibit memory 
deficits. When treated during the first trimester equivalent, ethanol mice were not significantly 
different from control mice in anxiety-related behaviours. Ethanol exposure during the second 
trimester appeared to reduce anxiety-related behaviours. These findings indicate that 
neurodevelopmental timing of ethanol exposure leads to heterogeneity in behaviours reminiscent 
of FASD. 
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Table 3. A comparison between trimester one and two ethanol exposure on offspring 
behaviours. 
 
Behaviours
a
 Postnatal Day Trimester 1
b
 Trimester 2
b
 
Developmental milestones 2-21 Delayed  
(motor skill) 
Delayed  
(motor skill)  
Activity (daytime) 28-30 Increased Increased 
Activity (overnight) 30-35 Increased and 
decreased 
Mostly increased 
(males) 
Anxiety-related (Open-field) 35-40 No difference Decreased 
Anxiety-related (EPM) 35-40 No difference No difference 
Anxiety-related (LDB) 35-40 No difference Decreased  
Spatial learning (Barnes Maze) 45-55 Delayed (days 3-4) Delayed (day 1) 
Short-term memory (Barnes Maze) 50-60 No difference Delayed 
Long-term memory (Barnes Maze) 57-67 Generally no 
difference 
Delayed  
 
a
Behaviours are listed by day of testing. EPM = Elevated Plus Maze. LDB = Light/Dark Box.  
b
Results are given for ethanol mice compared to control mice. No difference = no observable differences between 
ethanol and control mice for a behaviour. 
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3.3 Changes in gene expression following prenatal ethanol exposure 
 3.3.1 Overall patterns of gene expression changes  
The overall patterns of gene expression were assessed in each of the different groups (T2-
S, T1-L, and T2-L). The general trend for the Partek analysis resulted in a range from a +3.01-
fold increase (Odorant binding protein 2B) to a -3.01-fold decrease (Stomatin (EPB72)-like 3) in 
T1-L. In T2-L, DEGs ranged from a +1.65-fold increase (Olfactory receptor, family 2, subfamily 
AP, member 1) to a -1.97-fold decrease (Myosin, light chain 1, alkali; skeletal, fact). The 
ANOVA gene list from T2-S ranged from a +7.49-fold increase (X (inactive)-specific transcript 
(non-protein coding)) from matched controls to a -2.75-fold decrease (Carbonic anhydrase III, 
muscle specific).  
There was no overlap of specific genes altered between all three groups when using cut-
off values of ± 1.2-fold change and p < 0.05 (Figure 14). There were no DEGs between ethanol 
and control mice in any of the groups using a FDR-corrected p-value of 0.05 and a ± 1.2-fold 
change cut-off. Further analysis was restricted to an unadjusted p < 0.05 with the same fold 
change. Using this cut-off, one gene, Triadin (Trdn), overlapped between T1-L and T2-S 
(Figure 14). Using these criteria, T2-S, T1-L, and T2-L resulted in the altered expression of 48, 
55, and 68 genes, respectively (Appendices B-D). These changes ranged from a +1.43-fold 
increase from matched controls (SLIT and NTRK-like family, member 2 or Slitrk2) to a -1.91-fold 
decreased (Trdn). In T1-L, the range was from a +1.44-fold increase from matched controls 
(Predicted gene 3696) to a -1.39-fold decrease (Proliferating cell nuclear antigen or Pcna) in 
T1-L. In T2-L, the range was between a +1.34-fold increase from matched controls (Predicted 
gene 9875) to a -1.78-fold decrease (Stromal cell-derived factor 2-like-1 or Sdf2l1). In this 
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assessment, the distribution of upregulated and downregulated genes was not equal across 
groups. In T1-L, 10 genes (18.2%) were increased. In T2-L, 27 genes (39.7%) were increased. 
And, in group T2-S, 30 genes (62.5%) were increased. Apart from gene annotations identified on 
the Mouse Gene 1.0 ST arrays, there were various miRNAs discovered. T2-S gene expression 
analysis resulted in differential expression of Mir-380, Mir-540, Mir-99a, Mir-337 and Mir-665 
(Appendix B). As part of the long-term gene lists for T1-L and T2-L, Mir-451 and Mir-342 were 
identified, respectively (Appendices C-D).  
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Figure 14. A venn diagram of overlapping differentially-expressed genes (DEGs) compared 
across trimester two short-term (T2-S), trimester one long-term (T1-L), and trimester two 
long-term (T2-L) treatments. Adapted from GeneVenn
® 
(http://genevenn.sourceforge.net/). 
Gene lists included T2-S (pink), T1-L (blue) and T2-L (green). No genes were in common 
between T2-S, T1-L, and T2-L (purple), or between T1-L and T2-L (dark blue), or between T2-S 
and T2-L (dark green). One gene (Triadin) is in common between T2-S and T1-L (dark pink). 
ANOVA lists generated from Partek Genomics Suite software using a cut-off of p < 0.05 and ± 
1.2-fold change.    
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3.3.2 Molecular analysis of short-term (T2-S) DEGs 
a) Immediate effects of ethanol on cellular functions 
Functional analysis of T2-S was completed using DAVID, Partek (GE), and IPA. Using 
DAVID, T2-S data resulted in two significant categories (Table 4). Genes identified in the 
keyword, “Nucleus” are involved in DNA or RNA binding, regulation of p53 transcription and 
apoptosis, and mismatch repair. The SMART term, Dual specificity phosphatase, catalytic 
domain (“DSPc”) included genes involved in protein-tyrosine phosphorylation, which can affect 
protein interactions, cellular localization, protein stability, and enzymatic activity.  
Analysis of genes disrupted in T2-S using GE revealed 63 significantly disrupted 
molecular functions. Here, the GO categories were primarily associated with the top function, 
protein phosphorylation (Table 5). These GE results are complementary to DAVID analysis, 
which implicated Dual specificity phosphatase 19 (Dusp19) and Slingshot homolog 2 
(Drosophila) (Ssh2) in the “DSPc” SMART term. Generally, the GE processes altered in the 
fetal brain are involved in mitogen-activated protein kinase (MAPK) activity, including calcium 
stimulation of MAPK. Two processes are involved in each of G-protein coupled receptor 
activity, and lipid transport. The last three of the top 10 processes are involved in stress response, 
chromatin binding, and actin cytoskeleton development.  
Functional analysis of T2-S using IPA resulted in the identification of five functions in 
each of three categories: Diseases and Disorders, Molecular and Cellular Functions, and 
Physiological System Development and Function (Table 6). Two miRNAs appear in each of the 
top five functions of Diseases and Disorders, and are involved in post-transcrpitional regulation 
of gene expression by affecting the stability and translation of mRNAs.  
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Table 4. Top significant annotation clusters resulting from The Database for Annotation, 
Visualization and Integrated Discovery (DAVID) functional analysis of trimester two short-
term (T2-S) differentially-expressed genes (DEGs). 
Category
a
 Term p-value Genes
b
 
SP PIR  Nucleus 0.039 Gpkow, Jmy, Rybp, Crem, Ccnt1, Zfp600, Magohb, Nol4, 
Nap1l3, Zc3h18, Tdg, Zmat5 
SMART DSPc 0.043 Dusp19, Ssh2 
 
a
Category includes information from the Swiss-Prot and Protein Information Resource (SP PIR keyword) and 
Simple Modular Architecture Research Tool (SMART) genomic database. 
b
Genes included G patch domain and KOW motifs (Gpkow), Junction mediating protein, p53 cofactor (Jmy), RING1 
and YY1 binding protein (Rybp), cAMP responsive element modulator (Crem), Cyclin T1 (Ccnt1), Zinc finger 
protein 600 (Zfp600), Mago-nashi homolog B (Drosophila) (Magohb), Nucleolar protein 4 Nucleosome assembly 
protein 1-like-3 (Nol4), Zinc finger CCCH-type containing 18 (Zc3h18), Thymine-DNA glycosylase (Tdg), Zinc 
finger, matrin-type 5 (Zmat5), Dual specificity phosphatase 19 (Dusp19), and Slingshot homolog 2 (Drosophila) 
(Ssh2). 
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Table 5. Top ten functions of short-term (T2-S) differentially-expressed genes (DEGs) 
identified using Gene Ontology Enrichment (GE). 
Gene Ontology Function Type
a
 Enrichment 
Score
b
 
p-value Genes
c
 
Protein tyrosine/serine/threonine 
phosphatase activity 
MF 6.25 0.002 Dusp19, Ssh2 
Regulation of DNA-dependent 
transcription in response to stress 
BP 5.13 0.006 Jmy 
Calcium-dependent protein kinase C 
activity 
MF 5.13 0.006 Ccl3 
Bombesin receptor signaling pathway BP 5.13 0.006 Nmbr 
Bombesin receptor activity MF 5.13 0.006 Nmbr 
Negative regulation of chromatin binding BP 5.13 0.006 Tdg 
Protein tyrosine/threonine phosphatase 
activity 
MF 5.13 0.006 Dusp19 
Glycolipid transporter activity MF 4.85 0.008 Gltpd1 
Glycolipid transport BP 4.85 0.008 Gltpd1 
Regulation of lemellipodium assembly BP 4.85 0.008 Ssh2 
 
a
Type indicates a biological process (BP), cellular component (CC), or molecular function (MF).  
b
Enrichment score = Significant genes in a category/All significant genes, vs All genes in the category/All genes on 
the chip.  
c
Genes included Dual-specificity phosphatase 19 (Dusp19), Slingshot homolog 2 (Drosophila) (Ssh2), Junction 
mediating protein, p53 cofactor  (Jmy), Chemokine (C-C motif) ligand 3 (Ccl3), Neuromedin B receptor (Nmbr), 
Thymine-DNA glycosylase (Tdg), and Glycolipid transfer protein domain containing 1 (Gltpd1). 
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Table 6. Functional characterization of short-term (T2-S) differentially-expressed genes (DEGs) using Ingenuity Pathway 
Analysis (IPA). 
Diseases and Disorders     
Name p-value # genes Genes
a
 Function Annotation 
Developmental Disorder 1.14E-03 – 3.29E-02 5 mir-379, mir-99, Tdg, 
Trdn, Crem 
Hypertrophy of skeletal muscle 
 
Hereditary Disorder 1.14E-03 – 2.29E-03 2 mir-379, mir-99 Nemaline myopathy 
Skeletal and Muscular Disorder 1 .14E-03 – 4.12E-02 5 mir-379, mir-99, Trdn, 
Crem, Ccl3 
Muscular hypertrophy 
Connective Tissue Disorder 1.34E-03 – 4.12E-02 3 mir-379, mir-99, Ccl3 Adjuvant arthritis 
Dermatological Diseases 1.34E-03 – 1.34E-03 2 mir-379, mir-99 Dermatomyositis 
Molecular and Cellular Functions  
Name p-value # genes Genes
a
 Function Annotation 
Cell Cycle 2.10E-03 – 4.93E-02 1 Crem Arrest in G2/M phase 
Cellular Assembly/Organization 2 .10E-03 – 2.29E-02 1 Pip5k1b Formation of actin comet 
Cellular Function/Maintenance 2.10E-03 – 3.11E-02 2 Pip5k1b, Ccl3 Formation of microvilli 
Antigen Presentation 4 .20E-03 – 8.38E-03 1 Ccl3 Migration of dendritic precursors 
Cellular Movement 4.20E-03 – 4.93E-02 2 Ccl3, Ccnt1 Th1 cell transmigration 
Physiological System Development and Function  
Name p-value # genes Genes
a
 Function Annotation 
Nervous System 
Development/Function 2.10E-03 – 1.05E-02 
 
1 Ccl3 
 
Astrocyte/microglia accumulation 
Tissue Development 2.10E-03 – 2.70E-02 3 Ccl3, Bcap31, mir-99 Embryonic stem cell adhesion 
Hematological System 
Development/Function 4.20E-03 – 4.93E-02 
 
3 Ccl3, Ccnt1, Lair1 
 
T lymphocyte trafficking  
Hematopoiesis 4 .20E-03 – 1.05E-02 1 Ccl3 Migration of dendritic precursors 
Immune Cell Trafficking 4 .20E-03 – 4.93E-02 2 Ccl3, Ccnt1 Natural Killer cell migration 
 
a
Genes included  microRNA-379 (mir-379), microRNA-99a (mir-99), Thymine-DNA glycosylase (Tdg), Triadin (Trdn), cAMP responsive element modulator 
(Crem), Chemokine (C-C motif) ligand 3 (Ccl3), Phosphatidylinositol-4-phosphate 5-kinase, type I, beta (Pip5k1b), Cyclin T1 (Ccnt1), B-cell receptor-
associated protein 31 (Bcap31), and Leukocyte-associated immunoglobulin-like receptor 1 (Lair1).
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b) Immediate effects of ethanol on cellular pathways 
Pathway analysis of T2-S was performed using Pathway Express, Pathway Enrichment, 
and IPA. T2-S analysis did not result in any statistically significant KEGG pathways in Pathway 
Express. The top nominally significant pathway “regulation of actin cytoskeleton” (Impact factor 
= 2.72, p = 0.066), was consistent with functional analysis that implicated Dusp19 and Ssh2 in 
actin cytoskeleton development.   
As with Pathway Express, there were no statistically significant T2-S pathways found 
using PE. The top nominally significant pathways that were identified included: “regulation of 
actin cytoskeleton” (p = 0.066), with Phosphatidylinositol-4-phosphate 5-kinase, type I, beta 
(Pip5k1b) and Ssh2, “base excision repair” (p = 0.069), with Thymine-DNA glycosylase (Tdg), 
and “nicotine addiction” (p = 0.080), with Hippocalcin (Hpca).  
T2-S exposure was not significantly associated with any canonical pathways in IPA 
(Table 7). However, the top associated pathway, termed, Actin Cytoskeleton Signaling, was 
nominally significant (p = 7.04E-02), with Pip5k1b and Ssh2. Other pathways that included 
immune cell communication, natural killer cell signaling, and p53 signaling were not statistically 
significant. However, these pathways were complementary to IPA functional analysis (Table 6), 
which implicated each of the genes listed in Table 7 in such processes. 
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Table 7. Top canonical pathways resulting from Ingenuity Pathway Analysis (IPA) of 
short-term (T2-S) differentially-expressed genes (DEGs). 
Canonical Pathway Name
a
 p-value Genes
b
 
Actin Cytoskeleton Signaling 7.04E-02 Pip5k1b, Ssh2 
Communication between Innate and Adaptive Immune Cells 1.26E-01 Ccl3 
Regulation of Actin-based Motility by Rho 0.15 Pip5k1b 
p53 Signaling 0.17 Jmy 
Natural Killer Cell Signaling 0.173 Lair1 
 
a
Canonical pathways were identified in Ingenuity Pathway Analysis using the Core Analysis feature. The list of 
DEGs was generated using Partek software, using a ± 1.2 fold change and p < 0.05. 
b
Genes included Phosphatidylinositol-4-phosphate 5-kinase, type I, beta (Pip5k1b), Slingshot homolog 2 
(Drosophila) (Ssh2), Chemokine (C-C motif) ligand 3 (Ccl3), Junction mediating protein, p53 cofactor (Jmy), and 
Leukocyte-associated immunoglobulin-like receptor 1 (Lair1). 
 
 
 
 
 
 
79 
 
 
 
c) Immediate effects of ethanol on cellular networks 
Network analysis for T2-S was completed using GeneMANIA and IPA’s Core Analysis 
network feature. However, there were no significant GeneMANIA networks identified. The top 
T2-S IPA networks with a network score > 3 are reported in Table 8. The top network was 
termed: Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders (Figure 
15), and included 13 DEGs out of 34 network genes. Of the DEGs, six genes are downregulated 
while seven genes are upregulated. The second network, termed, Cellular Development, Cellular 
Growth and Proliferation, Hematological System Development and Function, was comprised of 
35 network genes (Figure 16). More genes were upregulated than downregulated in this 
network, with a 3:2 ratio. The top significant IPA networks from T2-S were merged into one 
large interacting network to identify “hub” genes. Figure 17 shows the identified hub molecules 
that have > 10 interactions with other genes, including those that were differentially-expressed in 
the fetal brain following GD 16 ethanol exposure. 
d) Candidate gene selection and confirmation of specific genes disrupted following 
immediate ethanol exposure 
Based on the criteria given in the Methods and Materials section (Figure 1), the selected 
candidates for confirmation are reported in Table 9. Here, the functional (NCBI, DAVID, GO 
Enrichment, GeneMANIA), pathway (IPA, Partek Pathway, Pathway Express), and network 
(IPA) characterization of genes was summarized. The resulting expression changes and p-values 
for the eight T2-S genes chosen for confirmation are shown in Table 10. No genes from T2-S 
were confirmed. A series of box plots illustrating the variability across biological replicates in 
qRT-PCR demonstrates the similarity in  ∆CT  values across replicates (Figure 18). 
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Table 8. Top Ingenuity Pathway Analysis (IPA) networks identified in short-term (T2-S) 
analysis of differentially-expressed genes (DEGs). 
Network No. Focus 
Molecules
a
 
Top Function
b
  Input Genes
c
 Score
d
 
1 13 Cellular Compromise, Cell 
Death, Free Radical Scavenging 
Bcap31, Hpca, Tdg, mir-
99, Zc3h18, Crem, mir-
379, mir-337, Lair1, Jmy, 
Ccl3, Nmbr, Rybp 
28 
2 5 Cellular Development, Cellular 
Growth and Proliferation, 
Hematological System 
Development and Function  
Ccnt1, Zmat5, Trdn, 
Sprr2a, Pip5k1b 
8 
 
a
Number (No.) Focus Molecules indicates the number of genes that were differentially expressed (Partek: ± 1.2 fold 
change, p < 0.05) in fetal brain (GD 16) as a result of ethanol exposure in the second trimester equivalent. 
b
Top Function represents the name of the network in IPA. 
c
Input genes included B-cell receptor-associated protein 31 (Bcap31), Hippocalcin (Hpca), Thymine-DNA 
glycosylase (Tdg), microRNA 99a (mir-99), Zinc finger CCCH-type containing 18 (Zc3h18), cAMP responsive 
element modulator (Crem), microRNA 379 (mir-379), microRNA 337 (mir-337), Leukocyte-associated 
immunoglobulin-like receptor 1 (Lair1), Junction mediating protein, p53 cofactor (Jmy), Chemokine (C-C motif) 
ligand 3 (Ccl3), Neuromedin B receptor (Nmbr), RING1 and YY1 binding protein (Rybp), Cyclin T1 (Ccnt1), Zinc 
finger, matrin-type 5 (Zmat5), Triadin (Trdn), Small proline-rich protein 2A (Sprr2a), and Phosphatidylinositol-4-
phosphate 5-kinase, type I, beta (Pip5k1b).  
d
Score is equal to the negative exponent of the respective p-value such that a score of 3 corresponds to a p-value of 
10E-3. Network 1 score of 28 is equivalent to p = 10E-28. Network 2 score of 8 is equivalent to p = 10E-8. 
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Figure 15. First network resulting from Ingenuity Pathway Analysis (IPA) of short-term 
(T2-S) differentially-expressed genes (DEGs). Network name: Cellular Compromise, Cell 
Death, Free Radical Scavenging. Highlighting (red and green) represents input genes. Red 
indicates downregulation and green indicates upregulation in ethanol mice versus control mice. 
DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p < 0.05. A 
single-headed arrow indicates the action of one gene on another. A double arrow-headed line 
indicates that the two genes act on each other. Dashed lines indicate an indirect interaction, and 
solid lines indicate direct interactions. E = expression, L = proteolysis, LO = localization, PD = 
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PR = protein-
RNA binding, PP = protein-protein interaction, I = inhibition, M = biochemical modification, RB 
= regulation of binding, T = transcription, TR = translocation.  Refer to Appendix F for a full 
IPA legend on relationship types, molecular shapes, and relationships.  
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Figure 16. Second network resulting from Ingenuity Pathway Analysis (IPA) of short-term 
(T2-S) differentially-expressed genes (DEGs). Network term: Cellular Development, Cellular 
Growth and Proliferation, Hematological System Development and Function. Highlighting (red 
and green) represents input genes. Red indicates downregulation and green indicates 
upregulation in ethanol mice versus control mice. DEGs were identified using Partek Genomics 
Suite with a ± 1.2 fold change and p < 0.05. A single-headed arrow indicates the action of one 
gene on another. A double arrow-headed line indicates that the two genes act on each other. 
Dashed lines indicate an indirect interaction, and solid lines indicate direct interactions. E = 
expression, L = proteolysis, LO = localization, PD = protein-DNA binding, A = activation, P = 
phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-protein 
interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T = 
transcription, TR = translocation.  Refer to Appendix F for a full IPA legend on relationship 
types, molecular shapes, and relationships. 
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Figure 17. A merged network from Ingenuity Pathway Analysis (IPA) of short-term (T2-S) 
differentially-expressed genes (DEGs). Highlighting (red and green) represents input genes. 
Red indicates downregulation and green indicates upregulation in ethanol mice versus control 
mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p < 0.05. 
A single-headed arrow indicates the action of one gene on another. A double arrow-headed line 
indicates that the two genes act on each other. Dashed lines indicate an indirect interaction, and 
solid lines indicate direct interactions. E = expression, L = proteolysis, LO = localization, PD = 
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PR = protein-
RNA binding, PP = protein-protein interaction, I = inhibition, M = biochemical modification, RB 
= regulation of binding, T = transcription, TR = translocation.  Refer to Appendix F for a full 
IPA legend on relationship types, molecular shapes, and relationships. 
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Table 9. Candidate gene selection criteria for confirmation of specific short-term (T2-S) 
differentially-expressed genes (DEGs). 
Candidate 
Genes
a
 
Neurodevelopment and/or behaviour Tool
b
 
Network 
(IPA)
c
 
Ccl3 facioscapulohumeral musclular dystrophy; 
microglia, astrocyte and dendrite development; 
ethanol and taste aversion; immune response 
osteoclast differentiation
218
 
IPA 
 
 
PubMed 
1 
Ccnt1 immune cell trafficking; cellular movement  
snRNA binding  
IPA 
Partek GE 
2 
Gpr50 component of adaptive thermogenesis
219
 
K/O mice have increased activity levels
220
 
PubMed  
PubMed 
None 
Lair1 Natural Killer cell signaling 
feeding behaviour and body weight regulation
221
 
IPA 
PubMed 
 
1 
Pip5k1b regulation of actin cytoskeleton 
 
associated with autism
222
 
IPA,  
P. Express 
PubMed 
2 
Rybp histone H2A monoubiquitination 
required for mouse eye development
223
 
Partek GE 
PubMed 
1 
Slitrk2 excitatory and inhibitory synapse formation
224
 
candidate for schizophrenia
225
 and bipolar 
disorder
226
 
PubMed  
 
PubMed 
None 
Trdn hypoplasia of forebrain; hypertrophy of skeletal 
muscle 
IPA 2 
 
a
Genes are listed alphabetically. Genes include SLIT and NTRK-like family, member 2 (Slitrk2), Cyclin T1 (Ccnt1), 
Leukocyte-associated immunoglobulin-like receptor 1 (Lair1), RING1 and YY1 binding protein (Rybp), G protein-
coupled receptor 50 (Gpr50), Triadin (Trdn), Chemokine (C-C motif) ligand 3 (Ccl3), Phosphatidylinositol-4-
phosphate 5-kinase, type I, beta (Pip5k1b). 
b
Tools used to analyse candidate genes (by neurodevelopment and behaviour) include PubMed, Ingenuity Pathway 
Analysis (IPA), Partek Gene Ontology Enrichment, and Pathway Express. 
c
IPA networks are shown in Figures 15-16.  
 
 
 
85 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10. A comparison between short-term (T2-S) qRT-PCR and microarray results for 
candidate genes. 
Genes
a
 
Array  
Fold Change 
Array  
p-value 
qRT-PCR  
Fold Change 
qRT-PCR  
p-value 
Ccl3 1.22 0.034 -1.16 0.414 
Ccnt1 1.22 0.014 -0.99 0.541 
Gpr50 1.34 0.020 -1.06 0.670 
Lair1 1.25 0.019 -0.92 0.355 
Pip5k1b -1.22 0.014 -1.35 0.307 
Rybp 1.35 0.030 -1.01 0.218 
Slitrk2 1.43 0.046 -0.99 0.684 
Trdn -1.91 0.032 N/A N/A 
 
a
Genes are listed alphabetically. Genes include SLIT and NTRK-like family, member 2 (Slitrk2), Cyclin T1 (Ccnt1), 
Leukocyte-associated immunoglobulin-like receptor 1 (Lair1), RING1 and YY1 binding protein (Rybp), G protein-
coupled receptor 50 (Gpr50), Triadin (Trdn), Chemokine (C-C motif) ligand 3 (Ccl3), Phosphatidylinositol-4-
phosphate 5-kinase, type I, beta (Pip5k1b). 
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Figure 18. Box plot analysis of qRT-PCR                                                                                      
results for trimester two short-term (T2-
S) genes using Statistical Package for the 
Social Sciences v.16.6. All control and 
ethanol replicates were included in the 
analysis. Data are represented by average 
∆CT per treatment, generated using StepOne 
Real-time PCR software. An “o" represents 
a minor outlier (± 1.5 interquartile range). 
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      3.3.3 Molecular analysis of first trimester long-term (T1-L) DEGs 
 
 
a) First-trimester effects of ethanol on cellular functions 
As outlined for the short-term experiment (T2-S), T1-L gene lists were subjected to 
functional analysis using DAVID, GE, and IPA. Functional annotation clustering was performed 
on T1-L DEGs using DAVID (Table 11). The SP PIR keyword, “coenzyme A”, emphasized a 
role for synthesis and oxidation of fatty acids in FASD. The three genes that are part of this 
keyword are involved in processes including ketogenesis and antioxidant detoxification. One of 
these genes, N-acetyltransferase 1 (Nat1), is involved in folate catabolism. Two of the five 
categories listed in Table 11 include genes involved in ribosomal functions. “Base excision 
repair” was previously identified in T2-S analysis of pathways, albeit not statistically significant.  
GO Enrichment was used to evaluate over-represented molecular functions, cellular 
components, and biological processes using Partek. T1-L GE analysis returned a list of 104 
significant functions. The top 10 significant GO categories and shown in Table 12. The gene, 
Cleavage and polyadenylation factor I subunit 1 (Clp1), was identified in three of the top 10 
functions, and involved tRNA splicing and mRNA 3’end formation. The gene, SET domain 
containing 2 (Setd2), was involved in two of the top 10 processes, one of which included histone 
methylation. In general, the top 10 GE functions were involved in cellular maintenance and 
protein kinase activity.  
Using the Core Analysis tool within IPA, a list of T1-L processes was generated for three 
different categories: Diseases and Disorders, Molecular and Cellular Functions, and 
Physiological System Development and Function (Table 13). Carcinoembryonic antigen-related 
cell adhesion molecular 1 (biliary glycoprotein) (Ceacam1) was the only significant gene in 
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Diseases and Disorders. Ceacam1 was also identified in the second significantly GE function, 
“positive regulation of MAP kinase activity” (Table 12). Other genes in this category were 
previously identified in DAVID analysis (Table 4): Methyl-CpG binding domain protein 4 
(Mbd4) was part of the GO BP “base excision repair”, and Pleiotropic regulator 1 (Plrg1) was 
involved in the GO CC “ribonucleoprotein”; Mitogen-activated protein kinase kinase kinase, E3 
ubiquitin protein ligase (Map3k1) and Activating transcription factor 1 (Atf1) were involved in 
“TNF/Stress related signaling”. Ceacam1, Map3k1, Eomesodermin (Xenopus laevis) homolog 
(Eomes), and pre-B lymphocyte 1 (Vpreb1) appear in at least three of the five top disrupted 
processes, adding to their importance in cellular disruption following prenatal ethanol exposure 
in the first trimester equivalent. The function with the highest number of genes implicated in this 
category included “Tissue Morphology”.  
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Table 11. Top significant annotation clusters resulting from The Database for Annotation, 
Visualization and Integrated Discovery (DAVID) functional analysis of trimester one long-
term (T1-L) differentially-expressed genes (DEGs). 
Category
a
 Term p-value Genes
b
 
SP PIR keyword Coenzyme A 0.035 Hmgcs2, Atf1, Nat1 
GO MF 
Structural constituent of 
ribosome 
0.037 Rpl36a, Gm12191, Gm4987 
BIOCARTA 
TNF/Stress related 
signaling 
0.042 Map3k1, Atf1 
GO CC 
Ribonucleoprotein 
complex 
0.043 
Gm12191, Gm4987,  Rpl36a, 
Sfrs1, Clp1, Nat1, Rcl1, Plrg1 
GO BP Base-excision repair 0.048 Mbd4, Pcna 
 
a
Category includes information from the Swiss-Prot and Protein Information Resource (SP PIR keyword), Gene 
Ontology’s (GO) molecular function (MF), cellular component (CC) and biological process (BP), BioCarta 
references, and Simple Modular Architecture Research Tool (SMART) genomic database. 
b
Genes included 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2), Activating transcription 
factor 1 (Atf1), N-acetyltransferase 1 (arylamine N-acetyltransferase) (Nat1), Ribosomal protein L36a (Rpl36a), 
predicted genes Gm12191 and Gm4987, Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein 
ligase (Map3k1), Serine/arginine-rich splicing factor 1 (Sfrs1), Cleavage and polyadenylation factor I subunit 1 
(Clp1), RNA terminal phosphate cyclase-like 1 (Rcl1), Pleiotropic regulator 1 (Plrg1), Methyl-CpG binding domain 
protein 4 (Mbd4), and Proliferating cell nuclear antigen (Pcna). 
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Table 12. Top ten significant functions of trimester one long-term (T1-L) differentially-
expressed genes (DEGs) from Gene Ontology Enrichment (GE). 
Gene Ontology Function Type
a
 Enrichment 
Score
b
 
p-value Genes
c
 
Homeostasis of number of cells BP 7.23 0.0007 Vpreb1, 
Gcnt4 
Positive regulation of MAP kinase activity BP 5.43 0.004 Ceacam1, 
Map3k1 
Histone H3-K36 methylation BP 4.96 0.007 Setd2 
Mesoderm morphogenesis BP  4.96 0.007 Setd2 
G-protein coupled receptor signaling 
pathway, coupled to cyclic nucleotide second 
messenger 
BP 4.96 0.007 Htr5a 
tRNA-intron endonuclease complex CC 4.96 0.007 Clp1 
Targeting of mRNA for destruction involved 
in RNA interference 
BP 4.96 0.007 Clp1 
ATP-dependent polydeoxyribinucleotide 5’-
hydroxyl-kinase activity 
MF 4.96 0.007 Clp1 
mRNA 5’-splice site recognition BP 4.96 0.007 Srsf1 
Type 1 melanocortin receptor binding  MF 4.96 0.007 Mrap2 
 
a
Type indicates a biological process (BP), cellular component (CC), or molecular function (MF).  
b
Enrichment score = Significant genes in a category/All significant genes, vs All genes in the category/All genes on 
the chip.  
c
Genes included pre-B lymphocyte 1 (Vpreb1), Glucosaminyl (N-acetyl) transferase 4, core 2 (Gcnt4), 
Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), Mitogen-activated 
protein kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), Serine/arginine-rich splicing factor 1 (Sfrs1), 
Cleavage and polyadenylation factor I subunit 1 (Clp1), SET domain containing 2 (Setd2), 5-hydroxytryptamine 
(serotonin) receptor 5A, G protein-coupled (Htr5a), and Melanocortin 2 receptor accessory protein 2 (Mrap2). 
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Table 13. Functional characterization of trimester one long-term (T1-L) differentially-expressed genes (DEGs) using Ingenuity 
Pathway Analysis (IPA). 
Diseases and Disorders     
Name p-value # genes Genes
a
 Function Annotation 
Inflammatory Response 5.87E-03 – 4.32E-02 1 Ceacam1 Priming of Th1 helper cells 
Connective Tissue Disorders 1.17E-02 – 1.17E-02 1 Ceacam1 Infection of blood  
Hematological Disease 1.17E-02 – 1.17E-02 1 Ceacam1 Infection of blood 
Infectious Disease 1.17E-02 – 4.32E-02  1 Ceacam1 Infection of blood, spleen, liver 
Developmental Disorder 1.75E-02 – 3.19E-02 2 Setd2, Trdn Hypoplasia of forebrain 
Molecular and Cellular Functions  
Name p-value # genes Genes
a
 Function Annotation 
Cell Death/Survival 6.49E-04 – 3.17E-02 4 Map3k1, Mbd4, Plrg1, Atf1 Cervical ganglion neuron apoptosis 
Cell-To-Cell Signaling and 
Interaction 
2.94E-03 – 5.87E-03 2 Map3k1, Ceacam1 Intercellular junction restoration 
Cellular Assembly and 
Organization 
2.94E-03 – 8.80E-03 1 Map3k1 Permeability of mitochondria 
Cellular Development 2.94E-03 – 4.04E-02 3 Eomes Expansion of pre-B2 lymphocytes 
Cellular Growth/Proliferation 2.94E-03 – 4.04E-02 2 Eomes, Vpreb1 Expansion of thymocytes 
Physiological System Development and Function  
Name p-value # genes Genes
a
 Function Annotation 
Connective Tissue 
Development/Function 
6.49E-04 – 2.90E-02 4 Mbd4, Ceacam1, Map3k1, 
Plrg1 
Cell viability of fibroblasts 
Hematological System 
Development/Function 
2.94E-03 – 4.32E-02 5 Vpreb1, Ceacam1, Eomes, 
mir-451, H2-T23 
Function of memory T lymphocytes 
Hematopoiesis 2.94E-03 – 4.04E-02 3 Eomes, Vpreb1, mir-451 Expansion of thymocytes 
Humoral Immune Response 2.94E-03 – 1.46E-02 2 Vpreb1, Map3k1 Expansion of pre-B2 lymphocytes 
Tissue Morphology 2.94E-03 – 4.60E-02 5 Adamts9, Vpreb1, Eomes, 
Ceacam1, Map3k1 
Abnormal morphology of 
trophoectoderm 
 
a
Genes from Partek  Genomics Suite, ± 1.2 fold change, p < 0.05; Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), 
SET domain containing 2 (Setd2), Triadin (Trdn), Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), Methyl-CpG binding 
domain protein 4 (Mbd4), Pleiotropic regulator 1 (Plrg1), Activating transcription factor 1 (Atf1), Eomesodermin (Eomes), pre-B lymphocyte 1 (Vpreb1), 
microRNA 451 (mir-451), Major histocompatibility complex, class I, E (H2-T23), and ADAM metallopeptidase with thrombospondin type 1 motif, 9 (Adamts9).
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b) First-trimester effects of ethanol on cellular pathways 
As in T2-S analysis, the list of T1-L DEGs was subjected to pathway analysis using 
Pathway Express, PE and IPA’s canonical pathway tool. The gene list was subjected to Pathway 
Express to observe which pathways were enriched. For T1-L, the only significant KEGG 
pathway was “base excision repair” (Impact factor = 5.92, p = 0.003), with 2 input genes: Mbd4 
and Pcna. Mbd4 and Pcna were also identified in DAVID analysis under the GO BP “base 
excision repair”. Given MBD4’s role in DNA mismatch repair, and PCNA’s role in increasing 
DNA polymerase processibility, it stands to reason that these two genes play an important role in 
regulating DNA repair. Of note, the nominally significant pathway “mismatch repair” (Impact 
factor = 2.99, p = 0.05) was listed as the second pathway altered in the adult brain as a result of 
trimester one ethanol exposure, with Pcna as the only gene implicated in this pathway.  
Next, Partek’s Pathway Enrichment tool was used to generate KEGG pathways that were 
significantly altered as a result of prenatal ethanol exposure. The enrichment results for T1-L are 
presented in Table 14, and include four significant pathways. The top pathway was “base 
excision repair”, with Mbd4 and Pcna. Pcna was also part of the second significant pathway, 
“HTLV-I infection”, with Major histocompatibility complex, class I, E (H2-T23). Given its role 
in cell immunity, H2-T23 was previously identified in IPA functional analysis as the driver 
behind, “function of memory T lymphocytes” (Table 13). Meanwhile, 3-hydroxy-3-
methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2) was implicated in the last pathway, 
“synthesis and degradation of ketone bodies”. Hmgcs2’s role in fatty acid synthesis complements 
results from DAVID that identified this gene in “coenzyme A” function (Table 11).  
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Lastly, using IPA, significant canonical pathways altered in T1-L were identified (Table 
15). Four of the five pathways were involved in lipid synthesis and other fatty-acid-related 
processes. The second top pathway, IL-1 Signaling, included Map3k1, which has been 
implicated in PE analysis under “HTLV-I Infection” (Table 14). Map3k1’s prominence in these 
pathways signifies its role in immune system response. 
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Table 14. Significant pathways resulting from Pathway Enrichment (PE) analysis of 
trimester one long-term (T1-L) differentially-expressed genes (DEGs). 
Pathway Name Enrichment 
Score
a
 
p-value Genes
b
 
Base excision repair 5.11 0.006 Mbd4, Pcna 
HTLV-I infection 4.48 0.011 Atf1, H2-T23, 
Map3k1, Pcna 
Caffeine metabolism 3.54 0.029 Nat1 
Synthesis and degradation of ketone bodies 3.44 0.032 Hmgcs2 
 
a
Enrichment score = Significant genes in a category/All significant genes vs All genes in the category/All genes on 
the chip. 
b
Genes included Methyl-CpG binding domain protein 4 (Mbd4), Proliferating cell nuclear antigen (Pcna), 
Activating transcription factor 1 (Atf1), Major histocompatibility complex, class I, E (H2-T23), Mitogen-activated 
protein kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), N-acetyltransferase 1 (arylamine N-
acetyltransferase) (Nat1), and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2). 
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Table 15. Top canonical pathways resulting from Ingenuity Pathway Analysis (IPA) of 
trimester one long-term (T1-L) differentially-expressed genes (DEGs). 
Canonical Pathway Name
a
 p-value Genes
b
 
Pentose Phosphate Pathway (Non-
oxidative Branch) 
1.75E-02 
 
Rpe 
 
IL-1 Signaling 2.81E-02 Map3k1, Gng4 
Ketogenesis 2.9E-02 Hmgcs2 
Pentose Phosphate Pathway 2.9E-02 Rpe 
Mevalonate Pathway I 3.47E-02 Hmgcs2 
 
a
Canonical pathways were identified in Ingenuity Pathway Analysis using the Core Analysis feature. The list of 
DEGs was generated using Partek Genomics Suite, using a ± 1.2 fold change and p < 0.05. 
b
Genes included Ribulose-5-phosphate-3-epimerase (Rpe), Mitogen-activated protein kinase kinase kinase 1, E3 
ubiquitin protein ligase (Map3k1), Guanine nucleotide binding protein (G protein), gamma 4 (Gng4), and 3-
hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2). 
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c) First-trimester effects on ethanol on cellular networks 
The T1-L gene list was subjected to analysis by the publically available tool, 
GeneMANIA, to identify disrupted networks. T1-L GeneMANIA analysis resulted in two 
significant network functions including, “olfactory bulb development” (p = 0.012) and “olfactory 
lobe development” (p = 0.012), both with Eomes as the only DEG. The nominally significant 
function, “forebrain development” (p = 0.059) included Eomes and Setd2.  
Network analysis was also completed using IPA using the Core Analysis function to 
identify enriched networks of interest based on literature review. Only one network with a score 
> 3 was identified from T1-L analysis. This network was termed, Infectious Disease, Organismal 
Injury and Abnormalities, Cellular Development (score = 22), and was comprised of 11 focus 
molecules. Focus molecules included: Hmgcs2, Pcna, Atf1, Ceacam1, Eomes, Map3k1, Hla-e, 
Tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19), RAS p21 protein activator 2 
(Rasa2), CDGSH iron sulfur domain 1 (Cisd1), and Major urinary protein 5 (Mup5) (Figure 
19). Because there were no other significant networks, a merged analysis could not be 
performed. Instead, this network was analyzed for the presence of any hub molecules that had > 
10 interactions with other genes. Hub analysis resulted in three molecules with interactions. 
These included interferon-gamma (IFNG), peroxisome proliferator-activated receptor gamma 
(PPARG) and peroxisome proliferator-activated receptor alpha (PPARA). Involved in 
immunoregulation, IFNG has indirect relationships with HLA-E (H2-T23), MAP3K1 and 
CEACAM1, which are all downregulated (Figure 19).  
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Figure 19. Network resulting from Ingenuity Pathway Analysis (IPA) of trimester one long-
term (T1-L) differentially-expressed genes. Network name: Infectious Disease, Organismal 
Injury and Abnormalities, Cellular Development. Highlighting (red and green) represents input 
genes. Red indicates downregulation and green indicates upregulation in ethanol mice versus 
control mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p 
< 0.05. A single-headed arrow indicates the action of one gene on another. A double arrow-
headed line indicates that the two genes act on each other. Dashed lines indicate an indirect 
interaction, and solid lines indicate direct interactions. E = expression, LO = localization, PD = 
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PP = protein-
protein interaction, T = transcription, TR = translocation.  Refer to Appendix F for a full IPA 
legend on relationship types, molecular shapes, and relationships.  
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d) Candidate gene selection and confirmation of specific genes disrupted following first-
trimester ethanol exposure 
Based on the criteria given in the Methods and Materials section (Figure 1), T1-L 
candidate genes were selected for confirmation by qRT-PCR. The functional (NCBI, DAVID, 
GE, GeneMANIA), pathway (IPA, PE, Pathway Express), and network (GeneMANIA and IPA) 
characterizations of DEGs are summarized in Table 16. For T1-L, the downregulation of 
Tnfrsf19, Eomes, Map3k1, and Synaptoporin (Synpr) was confirmed in six control and six 
ethanol samples. While the difference between ethanol and control subjects was significant for 
each of these genes, their degree of fold change was not identical between qRT-PCR are array 
results (Table 17). A series of box plots illustrating the variability across biological replicates in 
qRT-PCR demonstrates the similarity in ∆CT  values across replicates for Atf1, Ceacam1, Htr5a, 
and Stxbp6 (Figure 20). Also, given the number of biological replicate outliers present in various 
samples (eg. Htr5a), this may add to properly confirm genes by qRT-PCR. 
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Table 16. Candidate gene selection criteria for confirmation of specific trimester one long-
term (T1-L) differentially-expressed genes (DEGs).  
Genes
a
 Neurodevelopment and/or behaviour Tool
b
 
Network 
(IPA)
c
 
Atf1 TNF/Stress related signaling 
miRNA:gene (miR-1192 and miR-532-5p) 
DAVID 
IPA 
1 
Ceacam1 regulation of MAP kinase activity 
inflammatory response 
Partek GE 
IPA 
1 
Eomes olfactory bulb development; forebrain 
development 
embryonic placenta morphogenesis and 
development 
GeneMANIA 
 
Partek GE 
1 
Htr5a serotonin signaling  
suicide attempts and mood disorders
227
 
Partek GE 
 
PubMed 
None 
Map3k1 TNF/Stress related signaling 
visual system development and function 
loss enhances proliferation and apoptosis during 
retinal development
228
 
DAVID 
IPA 
PubMed 
1 
Stxbp6 linked to ADHD
229
 
implicated in bipolar disorder
230
 
miRNA:gene (miR-532-5p) 
PubMed  
PubMed 
IPA 
None 
Synpr intrinsic to small synaptic vesicles 
major depressive disorder link
231
 
PubMed 
PubMed 
None 
Tnfrsf19 Regulates differentiation of stromal stem cells
232
 PubMed 1 
 
 
a
Genes are listed alphabetically. Genes included Activating transcription factor 1 (Atf1), Carcinoembryonic antigen-
related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), Eomesodermin (Eomes), 5-hydroxytryptamine 
(serotonin) receptor 5A, G protein-coupled (Htr5a), Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin 
protein ligase (Map3k1), Syntaxin binding protein 6 (amisyn) (Stxbp6), Synaptoporin (Synpr), and Tumor necrosis 
factor receptor superfamily, member 19 (Tnfrsf19). 
b
Tools used to analyse candidate genes (by neurodevelopment and behaviour) include PubMed, Ingenuity Pathway 
Analysis (IPA), Partek Gene Ontology Enrichment, GeneMANIA (www.genemania.org) and The Database for 
Annotation, Visualization and Integrated Discovery (DAVID). 
c
IPA network shown in Figure 19. 
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Figure 20. Box plot analysis of qRT-PCR results 
for trimester one long-term genes (T1-L) using 
Statistical Package for the Social Sciences v.16.6. 
All control and ethanol replicates were included in 
the analysis. Data are represented by average ∆CT 
per treatment, generated using StepOne Real-time 
PCR software. An “o” represents a minor outlier (± 
1.5 interquartile range). A * represents a major 
outlier (± 3.0 interquartile range). 
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Table 17. A comparison between trimester one long-term (T1-L) qRT-PCR and microarray 
results for candidate genes. 
Genes
a
 
Array  
Fold change 
Array  
p-value 
qRT-PCR  
Fold change 
qRT-PCR  
p-value 
Atf1 -1.32 0.012 -0.93 0.655 
Ceacam1 -1.21 0.038 -0.80 0.481 
Eomes -1.20 0.039 -2.21 0.013 
Htr5a -1.24 0.022 -1.42 0.374 
Map3k1 -1.25 0.043 -1.36 0.010 
Stxbp6 -1.22 0.028 -0.67 0.592 
Synpr -1.25 0.038 -1.29 0.004 
Tnfrsf19 -1.20 0.024 -1.19 0.024 
      
a
Genes are listed alphabetically. Genes in bold font are those that showed differential expression between ethanol 
and control samples on the array and by qRT-PCR. Genes included Activating transcription factor 1 (Atf1), 
Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), Eomesodermin 
(Eomes), 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled (Htr5a), Mitogen-activated protein 
kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), Syntaxin binding protein 6 (amisyn) (Stxbp6), 
Synaptoporin (Synpr), and Tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19).  
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e) MiRNAs altered in the adult brain following first-trimester ethanol exposure 
 
The results from the mouse miRNA arrays were assessed using Partek. In the global 
analysis of T1-L, fold change ranged from -12.07-fold (miR-429) to +2.51-fold (miR-21). Of the 
1411 miRNAs that were specific to Mus Musculus, the ANOVA resulted in 671 miRNAs that 
were < 1 (47.6%), eight that were unchanged (0.6%) and 732 that were > 1 (51.9%). For 
consistency with gene expression data, miRNA arrays were assessed using a ± 1.2-fold change 
cut-off and p < 0.05. Table 18 shows a list of differentially-expressed miRNAs at PD 70, as a 
result of prenatal ethanol exposure during the first trimester equivalent. Using the established 
criteria for significance, these results show a total of eight miRNAs that were differentially 
expressed between control and ethanol samples. These miRNAs include: miR-1192, miR-202, 
miR-339, miR-532, miR-680, miR-695, miR-743 and miR-764. Their fold changes ranged from 
-1.46-fold to +1.73-fold. Six of the eight miRNAs (75%) were upregulated in ethanol mice 
compared to control mice. Detecting upregulation of miRNAs is reasonable given that miRNAs 
are involved in degradation of messenger RNAs (mRNAs) and are likely to be disrupted in the 
opposite manner of mRNAs.  
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Table 18. A list of differentially-expressed microRNAs in trimester one long-term (T1-L) 
array analysis. 
MicroRNA
a
 Fold change p-value 
miR-1192 
miR-202 
miR-339 
miR-532 
miR-680 
miR-695 
miR-743a 
miR-764 
 1.43 
-1.46 
-1.30 
 1.26 
 1.38 
 1.24 
 1.26 
 1.73 
0.028 
0.033 
0.019 
0.040 
0.049 
0.017 
0.044 
0.016 
 
a
MicroRNAs are listed by numerical ordering. Data generated using a ± 1.2-fold change and p < 0.05 in Partek 
Genomics Suite. 
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f) Identification and confirmation of specific miRNAs in T1-L and their gene targets 
The lists of DEGs from gene expression array analysis (n = 63) and differentially-
expressed miRNAs (n = 8) from T1-L were subjected to IPA miRNA and gene interaction 
analysis using the Target Filter function. Results for T1-L analysis of gene and miRNA 
interactions are shown in Table 19. Genes and miRNA fold changes are shown with their 
respective expressions. The results demonstrated that only two microRNAs, miR-1191 and miR-
532-5p, were implicated in inverse relationships with specific gene targets. Out of the 11 genes 
implicated in this analysis, Atf1, Syntaxin binding protein 6 (amisyn) (Stxbp6), and Centrosome 
and spindle pole associated protein 1 (Cspp1) were inversely expressed with both miRNAs. The 
relationship between an upregulated miRNA and a downregulated target mRNA is of interest in 
this study (Figure 1). The microRNAs that were in opposing expression to their target genes 
were used for confirmation by qRT-PCR. This included miR-1192 and miR-532-5p (Table 19). 
The upregulation of miR-532-5p was confirmed using qRT-PCR (-0.45-fold change, p = 7.97e-5; 
Figure 21). 
 
 
 
 
 
 
 
105 
 
 
 
 
 
 
 
 
Table 19. Ingenuity Pathway Analysis (IPA) target filtering of differentially-expressed 
genes (DEGs) and microRNAs from the trimester one long-term (T1-L) group. 
Genes
a
  MicroRNAs
b
    
Symbol Fold change Symbol Fold change Expression
c
 
(gene:miRNA) 
Confidence
d
 
(predicted) 
Atf1 -1.319 miR-1192 1.432 ↓↑ High 
Cspp1  1.217 miR-1192 1.432 ↑↑ High 
Gng4 -1.344 miR-1192 1.432 ↓↑ Moderate 
Map3k1 -1.247 miR-1192 1.432 ↓↑ High 
Rpe -1.206 miR-1192 1.432 ↓↑ High 
Setd2 -1.202 miR-1192 1.432 ↓↑ Moderate 
Stxbp6 -1.225 miR-1192 1.432 ↓↑ Moderate 
Trdn  1.308 miR-1192 1.432 ↑↑ High 
Zc3h6 -1.232 miR-1192 1.432 ↓↑ High 
Atf1 -1.319 miR-532-5p 1.263 ↓↑ Moderate 
Cspp1  1.217 miR-532-5p 1.263 ↑↑ Moderate 
Itpripl2 -1.211 miR-532-5p 1.263 ↓↑ Moderate 
Nat2  1.307 miR-532-5p 1.263 ↑↑ Moderate 
Stxbp6 -1.225 miR-532-5p 1.263 ↓↑ Moderate 
 
a
Genes included Activating transcription factor 1 (Atf1), Centrosome and spindle pole associated protein 1 (Cspp1), 
Guanine nucleotide binding protein (G protein), gamma 4 (Gng4), Mitogen-activated protein kinase kinase kinase 1, 
E3 ubiquitin protein ligase (Map3k1), Ribulose-5-phosphate-3-epimerase (Rpe), SET domain containing 2 (Setd2), 
Syntaxin binding protein 6 (amisyn) (Stxbp6), Triadin (Trdn), Zinc finger CCCH-type containing 6 (Zc3h6), Inositol 
1,4,5-trisphosphate receptor interacting protein-like 2 (Itpripl2), and N-acetyltransferase 2 (arylamine N-
acetyltransferase) (Nat2). DEGs are based on Partek Genomics Suite analysis with ± 1.2-fold change and p < 0.05 
b
MicroRNAs are listed by numerical order. MicroRNAs were differentially expressed based on Partek analysis with 
± 1.2-fold change and p < 0.05. 
c
Expression (gene:miRNA) is highlighted in red if an inverse relationship between gene:miRNA was identified.  
dConfidence is predicted based on IPA’s Target Filter function.  
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Figure 21. Bar graph of relative expression of microRNA 532-5p (miR-532-5p) between 
ethanol and control samples. Relative expression is shown. Error bars represent relative 
expression ± SEM. Statistical significance assessed using a two-tailed t-test with ***p < 0.001. 
Biological replicates n = 6 control, n = 6 ethanol. Technical replicates: n = 3. 
 
 
 
 
 
107 
 
 
 
3.3.4 Molecular analysis of second-trimester long-term (T2-L) DEGs 
a) Second-trimester effects of ethanol on cellular functions  
Functional analysis of T2-L DEGs was completed by inputting the gene list into three 
databases: DAVID, GE, and IPA. The top ten DAVID clusters from T2-L are shown in Table 
20. Three of the top 10 annotations were involved in endoplasmic reticulum (ER)-related 
functions. Several genes were also implicated in two top functions: “melanosome” and “pigment 
granule”. Two of the top 10 functions also included cellular reduction-oxidation (redox) reaction 
processes. Another two of the top 10 functions involved chromatin-related processes. 
T2-L GE analysis returned a list of 132 significant functions, with the top 10 listed in 
Table 21. Notably, Protein disulfide isomerase family A, member 4 (Pdia4) and 6 (Pdia6) were 
present in four of the top 10 pathways, which included ER-related isomerase activity. In fact, 
five of the ten categories were involved in ER-related activity, as identified in DAVID functional 
analysis (Table 20). Three of the 10 processes were involved in cellular redox reactions and 
metabolic processes, which were, again, consistent with DAVID analysis. Together, Heat shock 
70kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5) and Heat shock protein 90kDa 
alpha (cytosolic), class A member 1 (Hsp90aa1) were identified in six of the top 10 GE 
processes. Such processes were involved in ER-related functions including unfolded protein 
response (UPR), protein folding, and ion channel binding.  
Lastly, in T2-L IPA functional analysis, the top affected process in Diseases and 
Disorders, Molecular and Cellular Functions, and Physiological System Development and 
Function are given in Table 22. “Systemic lupus erythematosus” (SLE) has been previously 
identified as a top function in DAVID annotation clustering (Table 20). In the top three 
108 
 
 
 
significant Diseases and Disorders, the genes, Hspa5, X-box binding protein 1 (Xbp1), Early 
growth response 3 (Egr3), DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), Protein 
tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), and Integrin, alpha 4 (antigen 
CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4) appeared in each of these categories. Egr3 
seemed to be a key player in the Diseases and Disorders category, and along with its role in 
muscle spindle development, it serves as an important regulator of transcription. The term, SLE, 
included Ptpn22, which was also identified in a KEGG pathway in DAVID analysis (Table 20). 
Of all the implicated genes, Hspa5 was the only gene appearing in all five significant Diseases 
and Disorders, which complemented the results of DAVID analysis that implicated Hspa5 in the 
top five annotations (Table 20). Because Hspa5 was identified using three different methods of 
analysis, this signifies the importance of Hspa5 in ER-related processes including folding and 
assembly of proteins. The top T2-L process under Molecular and Cellular Functions included the 
genes: Ptpn22, Xbp1, and Cyclin-dependent kinase inhibitor 1a (Cdkn1a) (Table 22). Given 
their roles in cell cycle response, unfolded protein response, and T cell signaling, respectively, 
these genes are key factors responsible for the development and maintenance of critical cell 
processes. The top T2-L Physiological System Development and Functions implicated Cdkn1a, 
Ptpn22, Xbp1, Thromboxane A2 receptor (Tbxa2r), Peroxiredoxin 1 (Prdx1), Sprouty-related, 
EVH1 domain containing 2 (Spred2), and Core-binding factor, runt domain, alpha subunit 2; 
translocated to, 3 (Cbfa2t3) in the top three functional categories (Table 22). 
 
 
 
 
109 
 
 
 
 
 
Table 20. Top ten significant annotation clusters resulting from the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) functional analysis of 
trimester two long-term (T2-L) differentially-expressed genes (DEGs). 
Category
a
 Term p-value Genes
b
 
GO CC 
Endoplasmic 
reticulum lumen 
1.3e-6 
Dnajb11, Hspa5, Pdia4, 
P4ha1, Pdia6, Sdf2l1 
GO CC Melanosome 2.9e-5 
Hsp90aa1, Gchfr, Hspa5, 
Prdx1, Pdia4, Pdia6 
GO CC Pigment granule 7.9e-5 
Hsp90aa1, Gchfr, Hspa5, 
Prdx1, Pdia4, Pdia6 
INTERPRO 
Endoplasmic 
reticulum, targeting 
sequence 
7.9e-5 Sdf2l1, Hspa5, Pdia4, Pdia6 
GO CC 
Endoplasmic 
reticulum part 
1.9e-4 
Dnajb11, Hspa5, Pdia4, 
P4ha1, Pdia6, Serinc2, Sdf2l1 
KEGG PATHWAY 
Systemic lupus 
erythematosus 
3.7e-4 
Hist1h2bm, Hist1h3a, 
Hist1h3g, Hist1h3f, Hist1h3d, 
Hist2h3b, Ighg, Ptpn22 
INTERPRO Thioredoxin-like 2.7e-3 Pdia6, Prdx1, Pdia4 
GO BP 
Chromatin assembly 
or disassembly 
3.9e-3 
Hist1h3g, Hist1h3f, Hist1h2bm, 
Hist1h3a, Smarca5, Hist1h3d, 
Hist2h3b 
SP PIR keyword Redox-active center 4.3e-3 Pdia6, Prdx1, Pdia4 
INTERPRO Histone core 5.1e-3 
Hist1h3a, Hist1h3g, 
Hist1h2bm, Hist1h3f, Hist1h3d, 
Hist2h3b 
 
a
Category includes information from the Swiss-Prot and Protein Information Resource (SP PIR keyword), Gene 
Ontology’s (GO) cellular component (CC) and biological process (BP), InterPro keywords 
(www.ebi.ac.uk/interpro/), and Kyoto Encyclopedia of Genes and Genomes (KEGG) database. 
b
Genes included DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), Heat shock 90kDa protein 5 (glucose-
regulated protein, 78kDa) (Hspa5), Protein disulfide isomerase family A, member 4 (Pdia4), Prolyl 4-hydroxylase, 
alpha polypeptide I (P4ha1), Protein disulfide isomerase family A, member 6 (Pdia6), Stromal cell-derived factor 2-
like 1 (Sdf2l1), Heat shock protein 90kDa (cytosolic), class A member 1 (Hsp90aa1), GTP cyclohydrolase I 
feedback regulator (Gchfr), Peroxiredoxin 1 (Prdx1), Serine incorporator 2 (Serinc2), Histone cluster 1, H2bm 
(Hist1h2bm), Histone cluster 1, H3a (Hist1h3a), Histone cluster 1, H3g  (Hist1h3g), Histone cluster 1, H3f  
(Hist1h3f), Histone cluster 1, H3d (Hist1h3d), Histone cluster 2, H3b (Hist2h3b), Immunoglobulin heavy chain 
(gamma polypeptide) (Ighg), Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), and SWI/SNF 
related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 (Smarca5). 
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Table 21. Top ten significant functions of trimester two long-term (T2-L) differentially-
expressed genes (DEGs) from Gene Ontology Enrichment (GE). 
Gene Ontology Function Type
a
 Enrichment 
Score
b
 
p-value Genes
c
 
Endoplasmic reticulum lumen CC 8.49 0.0002 Hspa5, Pdia4, 
Pdia6 
Protein disulfide isomerase activity MF 8.05 0.0003 Pdia4, Pdia6 
Glycerol ether metabolic process BP 7.28 0.0007 Pdia4, Pdia6 
Unfolded protein binding MF 6.19 0.002 Dnajb11, Hspa5, 
Hsp90aa1 
Protein disulfide oxidoreductase 
activity 
MF 6.12 0.002 Pdia4, Pdia6 
Isomerase activity MF 5.37 0.005 Dnajb11, 
Hsp90aa1, Fkbp2 
Endoplasmic reticulum-Golgi 
intermediate compartment  
CC 5.35 0.005 Hspa5, Pdia6 
Protein folding BP 5.23 0.007 Dnajb11, 
Hsp90aa1, Fkbp2 
Positive regulation of fibroblast 
proliferation 
BP 4.94 0.009 Cdkn1a, Fosl2 
Ion channel binding MF 4.76 0.009 Homer1, 
Hsp90aa1 
 
a
Type indicates a biological process (BP), cellular component (CC), or molecular function (MF).  
b
Enrichment score = Significant genes in a category/All significant genes, vs All genes in the category/All genes on 
the chip.  
c
Genes included Heat shock 90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Protein disulfide 
isomerase family A, member 4 (Pdia4), Protein disulfide isomerase family A, member 6 (Pdia6), DnaJ (Hsp40) 
homolog, subfamily B, member 11 (Dnajb11), Heat shock protein 90kDa (cytosolic), class A member 1 (Hsp90aa1), 
FK506 binding protein 2, 13kDa (Fkbp2), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), FOS-like 
antigen 2 (Fosl2), and Homer homolog 1 (Drosophila) (Homer1). 
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Table 22. Functional characterization of trimester two long-term (T2-L) differentially-expressed genes (DEGs) using Ingenuity 
Pathway Analysis (IPA). 
Diseases and Disorders    
Name p-value # genes Genes
a
 Function Annotation
b
 
Inflammatory Disease 8.78E-05 – 3.11E-02 9 Dnajb11, Hspa5, Itga4, Ptpn22, Xbp1, Prdx1, 
Fosl2, Egr3, mir-342 
SLE; Multiple sclerosis 
Neurological Disease 8.78E-05 – 2.20E-02 13 Egr3, Galnt7, Hist1h2bm, Homer1, Xbp1, 
Dnajb11, Hspa5, Itga4,  
Ptpn22, Dynlt1, Hsp90aa1, Tufm, P4ha1 
Neuromuscular disease; 
Schizophrenia 
Skeletal and Muscular 
Disorders 
8.78E-05 – 4.33E-02 14 Egr3, mir-342, Ptpn22, Hsp90aa1, Prdx1, 
Cdkn1a, Fosl2, Tbxa2r,  
Dnajb11, Hspa5, Itga4, Xbp1, Dynlt1, 
Homer1, P4ha1 
SLE; osteosarcoma 
Cancer 8.78E-05 – 4.93E-02 8 Cdkn1a, Prdx1, Itga4, mir-342, Hsp90aa1, 
Hist1h3a, Hspa5, Ccdc6 
Incidence of lymphoma 
Hematological Disease 2.78E-03 – 4.93E-02 6 Cdkn1a, Itga4, Prdx1, Hspa5, Xbp1, Tbxa2r Chronic B-cell leukemia 
Molecular and Cellular Functions  
Name p-value # genes Genes
a
 Function Annotation
b
 
Cellular Development 5.24E-04 – 4.93E-02 12 Cdkn1a, Ccdc6, Xbp1, Tbxa2r, Egr3, 
Smarca5, Klk1b11, Hsp90aa1,  
Itga4, Ptpn22, Fosl2, Cbfa2t3 
Plasmacytoid dendritic 
cell development 
Cellular Function and 
Maintenance 
5.24E-04 – 4.63E-02 10 Egr3, Cdkn1a, Hsp90aa1, Itga4, Ptpn22, 
Hspa5, Tbxa2r, Slc9a3r2,  
Xbp1, Prdx1 
ER-stress response 
Cell Cycle 6.28E-04 – 4.33E-02 3 Cdkn1a, Ptpn22, Xbp1 Polyploidization of 
hepatocytes 
Cell Death 8.15E-04 – 4.93E-02 14 Smarca5, Cdkn1a, Hspa5, Xbp1, Egr3, 
Tbxa2r, Ptpn22, Ccdc6, Itga4, Prdx1, 
Slc9a3r2, Camk1g, Manf, Hsp90aa1 
Cell death of immune 
cells 
Cellular Compromise 1.44E-03 – 4.33E-02 5 Hspa5, Cdkn1a, Prdx1, Hsp90aa1, Xbp1 Stress response of cells 
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Physiological System Development and Function 
Name p-value # genes Genes
a
 Function Annotation 
Lymphoid Tissue 
Structure/Development 
4.30E-04 – 3.84E-02 10 Egr3, Cdkn1a, Hsp90aa1, Itga4, Ptpn22, 
Xbp1, Tbxa2r, Spred2, Cbfa2t3, Prdx1 
Development of 
plasmacytoid dendritic 
cells 
Organ Morphology 4.30E-04 – 4.93E-02 13 Cbfa2t3, Cdkn1a, Prdx1, Ptpn22, Tbxa2r, 
Fosl2, Tnnc1, Hspa5, Spred2, Homer1, 
Xbp1, Klk1b11, Itga4 
Organization of 
cerebellum 
Tissue Morphology 4.30E-04 – 4.93E-02 12 Itga4, Xbp1, Tbxa2r, Smarca5, Cdkn1a, 
Fosl2, Klk1b11, Ptpn22, Spred2, Cbfa2t3, 
Prdx1, Egr3 
Abnormal morphology 
of cholinergic neurons 
Cell-mediated Immune 
Response 
5.24E-04 – 2.19E-02 5 Cdkn1a, Egr3, Hsp90aa1, Itga4, Ptpn22 Metabolism of 
thymocytes 
Embryonic 
Development 
5.24E-04 – 4.93E-02 10 Cdkn1a, Spred2, Smarca5, Itga4, Egr3, 
Ptpn22, Fosl2, Xbp1, Hspa5, Otub2 
Cell death of embryonic 
tissue 
 
a
Genes from Partek Genomics Suite (± 1.2 fold change, p < 0.05). Genes included DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), Heat shock 
90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4), Protein tyrosine 
phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), X-box binding protein 1 (Xbp1), Peroxiredoxin 1 (Prdx1), FOS-like antigen 2 (Fosl2), Early growth 
response 3 (Egr3), microRNA 342 (mir-342), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GaINAc-T7) (Galnt7), 
Histone cluster 1, H2bm (Hist1h2bm), Homer homolog 1 (Drosophila) (Homer1), Dynein, light chain, Tctex-type 1 (Dynlt1), Heat shock protein 90kDa 
(cytosolic), class A member 1 (Hsp90aa1), Tu translation elongation factor, mitochondrial (Tufm), Prolyl 4-hydroxylase, alpha polypeptide I (P4ha1), Cyclin-
dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Thromboxane A2 receptor (Tbxa2r), Histone cluster 1, H3a (Hist1h3a), Coiled-coil domain containing 6 
(Ccdc6), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 (Smarca5), Kallikrein 1-related peptidase b11 
(Klk1b11), Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (Cbfa2t3), Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 
3), member 3 regulator 2 (Slc9a3r2), Calcium/calmodulin-dependent protein kinase IG (Camk1g), Mesencephalic astrocyte-derived neurotrophic factor (Manf), 
Sprouty-related, EVH1 domain containing 2 (Spred2), Troponin C type 1 (slow) (Tnnc1), and OTU domain, ubiquitin aldehyde binding 2 (Otub2). 
b
Functional annotation s: SLE = Systemic Lupus Erythematosus; ER = endoplasmic reticulum. 
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b) Second-trimester effects of ethanol on cellular pathways 
As in the previous pathway analyses for T2-S and T1-l, Pathway Express, PE, and IPA’s 
canonical pathway tool were used to identify T2-L pathways. T2-L DEGs were inputted into the 
freely available tool, Pathway Express. The top significant KEGG pathway was “systemic lupus 
erythematosus” (Table 23), which agreed with the T2-L functional analysis results. This 
pathway included six histone genes, along with Immunoglobulin heavy chain (gamma 
polypeptide) (Ighg). The other four disrupted processes were involved in cellular signaling and 
maintenance.  
Partek was used to identify relevant pathways using Pathway Enrichment. PE data for 
T2-L analysis are shown in Table 24. This analysis resulted in six pathways, the top being 
“systemic lupus erythematosus”, with nine histones. Finding SLE using PE complements the 
Pathway Express results (Table 23). The next two pathways also involved all histones (Table 
24). “Transcriptional regulation of cancer” included the cell cycle regulator, Cdkn1a. As with 
functional analysis, two of the five significant pathways from PE implicated ER-related 
functions that were disrupted in the adult brain following prenatal ethanol exposure during the 
second trimester equivalent. Hspa5 is present in three of the five top functions, which mostly 
include ER-related processes. 
IPA using the canonical pathway tool was used to identify relevant pathways in T2-L 
(Table 25). Canoonical pathways are consistent with GE and PE results, and support the finding 
that second trimester ethanol exposure was most significantly associated with ER-related damage 
(Tables 21, 24). Hspa5, Hsp90aa1, and Cdkn1a each appeared in more than one of the five 
canonical pathways. Xbp1 was present in the top disrupted pathway, Endoplasmic Reticulum 
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Stress Response. The previously unmentioned genes, UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GaINAc-T7) (Galnt7) and 9 
(Galnt9) comprised the second significant pathway, O-glycan Biosynthesis. These results reveal 
the importance of altered ER-related stress response following trimester two long-term ethanol 
exposure. Cdkn1a was also an important factor, present in two of the five canonical pathways 
involved in cell signaling. Previously, Cdkn1a was identified in IPA functional analysis as one of 
the three genes that implicated “Cell Cycle” as a significant Molecular and Cellular Function 
upon trimester two long-term alcohol exposure (Table 22). 
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Table 23. Top five pathways resulting from Pathway Express analysis of trimester two 
long-term (T2-L) differentially-expressed genes (DEGs). 
Pathway Name Impact  
Factor
a
 
Corrected  
p-value
b
 
Genes
c
 
Systemic lupus erythematosus 17.06 3.89e-8 Hist2h3b, Hist1h2bm, Ighg, Hist1h3g, 
Hist1h3f, Hist1h2d, Hist1h3a  
Calcium signaling pathway 4.14 0.016 Ighg, Tbxa2r, Tnnc1 
Hematopoietic cell lineage 3.71 0.025 Itga4, Ighg 
Antigen processing and 
presentation 
3.69 0.025 Hsp90aa1, Hspa5 
Prostate cancer 3.58 0.028 Hsp90aa1, Cdkn1a 
 
a
Impact factor = a probabilistic term that takes into consideration the proportion of DEGs on the pathway and gene 
perturbation factors of all genes in the pathway. 
b
Corrected p-value is based on a False-Discover-Rate correction. 
c
Genes were differentially expressed based on Partek Genomics Suite (± 1.2-fold change, p < 0.05). Genes included 
Histone cluster 2, H3b (Hist2h3b), Histone cluster 1, H2bm (Hist1h2bm), Immunoglobulin heavy chain (gamma 
polypeptide) (Ighg), Histone cluster 2, H3g (Hist1h3g), Histone cluster 2, H3f (Hist1h3f), Histone cluster 2, H3d 
(Hist1h3d), Histone cluster 2, H3a (Hist1h3a), Thromboxane A2 receptor (Tbxa2r), Troponin C type 1 (slow) 
(Tnnc1), Integrin, alpha 4 (antigen CD49D, alpha subunit of VLA-4 receptor) (Itga4), Heat shock protein 90kDa 
alpha (cytosolic), class A member 1 (Hsp90aa1), Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) 
(Hspa5), and Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a). 
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Table 24. Significant pathways resulting from Pathway Enrichment (PE) analysis of 
trimester two long-term (T2-L) differentially-expressed genes (DEGs). 
Pathway Name Enrichment 
Score
a
 
p-value Genes
b
 
Systemic lupus 
erythematosus 
18.63 8.08E-9 Hist1h2bm, Hist1h3a, Hist1h3b, 
Hist1h3c, Hist1h3d, Hist1h3e, 
Hist1h3g, Hist1h3h, Hist1h3i 
Transcriptional 
misregulation in cancer 
16.56 6.44E-8 Cdkn1a,  Hist1h3a, Hist1h3b, 
Hist1h3c, Hist1h3d, Hist1h3e, 
Hist1h3g, Hist1h3h, Hist1h3i 
Alcoholism 16.00 1.12E-7 Hist1h2bm, Hist1h3a, Hist1h3b, 
Hist1h3c, Hist1h3d, Hist1h3e, 
Hist1h3g, Hist1h3h, Hist1h3i 
Protein processing in 
endoplasmic reticulum 
9.24 9.74E-5 Dnajb11, Hsp90aa1, Hspa5, Pdia4, 
Pdia6, Xbp1 
Protein export 4.89 0.008 Hspa5, Immp1l 
Antigen processing and 
presentation 
3.15 0.043 Hsp90aa1, Hspa5 
 
a
Enrichment score = Significant genes in a category/All significant genes vs All genes in the category/All genes on 
the chip. 
b
Genes included Histone cluster 1, H2bm (Hist1h2bm), Histone cluster 2, H3a (Hist1h3a), Histone cluster 2, H3b 
(Hist1h3b), Histone cluster 2, H3c (Hist1h3c), Histone cluster 2, H3d (Hist1h3d), Histone cluster 2, H3e (Hist1h3e), 
Histone cluster 2, H3g (Hist1h3g), Histone cluster 2, H3h (Hist1h3h), Histone cluster 2, H3i (Hist1h3i), Cyclin-
dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), 
Heat shock protein 90kDa alpha (cytosolic), class A member 1 (Hsp90aa1), Heat shock 70kDa protein 5 (glucose-
regulated protein, 78kDa) (Hspa5), Protein disulfide isomerase family A, member 4 (Pdia4), Protein disulfide 
isomerase family A, member 6 (Pdia6), X-box binding protein 1 (Xbp1), and IMP1 inner membrane peptidase-like 
(S. cerevisiae) (Immp1l). 
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Table 25. Top canonical pathways resulting from Ingenuity Pathway Analysis (IPA) of 
trimester two long-term (T2-L) differentially-expressed genes (DEGs ). 
Canonical Pathway Name
a
 p-value Genes
b
 
Endoplasmic reticulum stress pathway 1.44E-03 Xbp1, Hspa5 
O-glycan biosynthesis 4.26E-03 Galnt7, Galnt9 
PI3K/AKT Signaling 4.98E-03 Cdkn1a, Hsp90aa1, Itga4 
Aldosterone Signaling in Epithelial Cells 0.0115 Dnajb11, Hspa90aa1, Hspa5 
Prostate Cancer Signaling 0.0245 Cdkn1a, Hsp90aa1 
 
a
Canonical pathways were identified in Ingenuity Pathway Analysis® using the Core Analysis feature. The list of 
DEGs was generated using Partek Genomics Suite using a ± 1.2 fold change and p < 0.05. 
b
Genes included X-box binding protein 1 (Xbp1), Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) 
(Hspa5), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GaINAc-T7) 
(Galnt7), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GaINAc-T9) 
(Galnt9), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Heat shock protein 90kDa alpha (cytosolic), 
class A member 1 (Hsp90aa1), Integrin, alpha 4 (antigen CD49D, alpha subunit of VLA-4 receptor) (Itga4), and 
DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11). 
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c) Second-trimester effects of ethanol on cellular networks  
The DEG list from T2-L was subjected to network analysis using GeneMANIA and IPA. 
The results from GeneMANIA are shown in Table 26. All six significant functions were 
involved in ER-related processes, which further indicate the importance of ER-related cellular 
responses that are altered following second trimester ethanol exposure. The results of 
GeneMANIA are comparable to DAVID analysis that identified the GO CCs “endoplasmic 
reticulum lumen” and “endoplasmic reticulum part” (Table 20). Hspa5, Hsp90aa1, and Dynein, 
axonemal, heavy chain 3 (Dnahc3) are present in all five GeneMANIA functions. Additionally, 
Pdia6 and Xbp1 are each present in two of the five functions. 
Network analysis of DEGs in T2-L was performed using the Core Analysis function in 
IPA. Only those networks with score > 3 are presented (Table 27). The T2-L top network was 
termed: Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders. This 
network included 11 downreguated genes and two upregulated genes out of a total of 35 network 
genes (Figure 22). The second network was termed, Cardiovascular System Development and 
Function, Cellular Movement, Cell-To-Cell Signaling Interaction. This network included 11 
differentially-expressed genes out of 36 network genes, nine of which were downregulated and 
two of which were upregulated (Figure 23). The third network was termed, Amino Acid 
Metabolism, Lipid Metabolism, Molecular Transport. This network included nine DEGs out of 
35 network genes, seven of which were downregulated and two of which were upregulated 
(Figure 24). Similar to their implication in two of the six ER-related GeneMANIA functions, 
Hspa5 and Pdia6 were implicated in the first IPA network. As part of the first IPA network, 
Xbp1 was also identified in two of the six GeneMANIA functions that involved “response to 
unfolded protein” and “response to topologically incorrect protein” (Table 27). As part of the 
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second IPA network, Hsp90aa1 and Dnahc3 were also implicated in all six GeneMANIA 
functions involved in UPR and other ER functions (Table 27). The three significant T2-L 
networks were merged in order to identify relevant hub molecules associated with T2-L ethanol 
exposure. The merged analysis resulted in one hub molecule in common with trimester one: 
IFNG. In total, there were 17 hubs with > 10 gene interactions (Figure 25). Of the differentially-
expressed gene list, XBP1 and CDKN1A were hubs in the merged T2-L network. Hubs common 
to trimester two ethanol exposure (T2-S and T2-L) included: huntingtin (HTT), FBJ murine 
osteosarcoma viral oncogene homolog (FOS), and nuclear factor-kappaB (NFkB).  
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Table 26. Significant network functions resulting from GeneMANIA analysis of trimester 
two long-term (T2-L) differentially-expressed genes (DEGs). 
Network Functions
a
 p-value 
(FDR- 
corrected) 
Genes
a
 
Endoplasmic reticulum lumen 1.12e-5 Erp44, Dnahc3, Hspa5, Hsp90aa1, 
Pdia6, Calr 
Response to unfolded protein 1.36e-3 Erp44, Dnahc3, Hspa5, Hsp90aa1, 
Xbp1 
Response to topologically incorrect 
protein 
1.75e-3 Erp44, Dnahc3, Hspa5, Hsp90aa1, 
Xbp1 
Endoplasmic reticulum part 2.67e-3 Erp44, Dnahc3, Hspa5, Hsp90aa1, 
Ostc, Magt1, Calr, Pdia6 
Endoplasmic reticulum membrane 8.51e-3 Erp44, Dnahc3, Hspa5, Hsp90aa1, 
Ostc, Magt1, Calr 
Nuclear outer membrane-endoplasmic 
reticulum membrane network 
0.012 Erp44, Dnahc3, Hspa5, Hsp90aa1, 
Ostc, Magt1, Calr 
 
a
Network functions were identified by inputting the T2-L DEG list generated from Partek Genomics Suite (± 1.2-
fold change and p < 0.05).  
b
Genes in bold font indicate those present in the inputted gene list (DEGs). DEGs included Dynein, axonemal, heavy 
chain 3 (Dnahc3), Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Heat shock protein 
90kDa alpha (cytosolic), class A member 1 (Hsp90aa1), Protein disulfide isomerase family A, member 6 (Pdia6), 
and X-box binding protein 1 (Xbp1). 
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Table 27. Top Ingenuity Pathway Analysis (IPA) networks identified in trimester two long-
term (T2-L) analysis of differentially-expressed genes (DEGs). 
Network No. Focus 
Molecules
a
 
Top Network Function
b
 Input Genes
c
 Score
d
 
1 13 Inflammatory Disease, 
Neurological Disease, 
Skeletal and Muscular 
Disorders 
Cdkn1a, Dnajb11, Hist1h3a, 
Hspa5, Itga4, Pdia4, Pdia6, 
Ptpn22, Sdf2l1, Smarca5, 
Spred2, Xbp1, Fkbp2 
24 
2 11 Cardiovascular System 
Development and Function, 
Cellular Movement, Cell-
To-Cell Signaling and 
Interaction 
Hsp90aa1, Dynlt1, Cbfa2t3, 
Prdx1, Dnahc3, P4ha1, 
Manf, Tbxa2r, Gchfr, 
Hist3h3, Slc9a3r2 
20 
3 9 Amino Acid Metabolism, 
Lipid Metabolism, 
Molecular Transport 
Zhx2, Fosl2, Tufm, Homer1, 
Klk1b11, Vps13b, Camk1g, 
Egr3, Tnnc1 
15 
 
a
Number (No.) Focus Molecules indicates the number of genes that were differentially expressed (Partek Genomics 
Suite: ± 1.2 fold change, p < 0.05) in adult brain (GD 14 and 16) as a result of ethanol exposure in the second 
trimester equivalent. 
b
Top Function represent the name of the network in IPA. 
c
Input genes included Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), DnaJ (Hsp40) homolog, 
subfamily B, member 11 (Dnajb11), Histone cluster 1, H3a (Hist1h3a), Heat shock 90kDa protein 5 (glucose-
regulated protein, 78kDa) (Hspa5), Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4), 
Protein disulfide isomerase family A, member 4 (Pdia4), Protein disulfide isomerase family A, member 6 (Pdia6), 
Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), Stromal cell-derived factor 2-like 1 
(Sdf2l1), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 
(Smarca5), Sprouty-related, EVH1 domain containing 2 (Spred2), X-box binding protein 1 (Xbp1), FK506 binding 
protein 2, 13kDa (Fkbp2), Heat shock protein 90kDa (cytosolic), class A member 1 (Hsp90aa1), Dynein, light 
chain, Tctex-type 1 (Dynlt1), Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (Cbfa2t3), 
Peroxiredoxin 1 (Prdx1), Dynein, axonemal, heavy chain 3 (Dnahc3), Prolyl 4-hydroxylase, alpha polypeptide I 
(P4ha1), Mesencephalic astrocyte-derived neurotrophic factor (Manf), Thromboxane A2 receptor (Tbxa2r), GTP 
cyclohydrolase I feedback regulator (Gchfr), Histone cluster 3, H3 (Hist3h3), Solute carrier family 9, subfamily A 
(NHE3, cation proton antiporter 3), member 3 regulator 2 (Slc9a3r2), Zinc fingers and homeboxes 2 (Zhx2), FOS-
like antigen 2 (Fosl2), Tu translation elongation factor, mitochondrial (Tufm), Homer homolog 1 (Drosophila) 
(Homer1), Kallikrein 1-related peptidase b11 (Klk1b11), Vacuolar protein sorting 13 homolog B (yeast) (Vps13b), 
Calcium/calmodulin-dependent protein kinase IG (Camk1g), Early growth response 3 (Egr3), and Troponin C type 
1 (slow) (Tnnc1). 
d
Score is equal to the negative exponent of the respective p-value such that a score of 3 corresponds to a p-value of 
10E-3. Network 1 score of 24 is equivalent to p = 10E-24. Network 2 score of 20 is equivalent to p = 10E-20. 
Network 3 score of 15 is equivalent to p = 10E-15. 
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Figure 22. First network resulting from Ingenuity Pathway Analysis of trimester two long-
term (T2-L) differentially-expressed genes (DEGs). Network name: Inflammatory Disease, 
Neurological Disease, Skeletal and Muscular Disorders. Highlighting (red and green) represents 
input genes. Red indicates downregulation and green indicates upregulation in ethanol mice 
versus control mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change 
and p < 0.05. A single-headed arrow indicates the action of one gene on another. A double 
arrow-headed line indicates that the two genes act on each other. Dashed lines indicate an 
indirect interaction, and solid lines indicate direct interactions. E = expression, L = proteolysis, 
LO = localization, PD = protein-DNA binding, A = activation, P = 
phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-protein 
interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T = 
transcription, TR = translocation.  Refer to Appendix F for a full IPA legend on relationship 
types, molecular shapes, and relationships. 
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Figure 23. Second network resulting from Ingenuity Pathway Analysis of trimester two 
long-term (T2-L) differentially-expressed genes (DEGs). Network name: Cardiovascular 
System Development and Function, Cellular Movement, Cell-To-Cell Signaling and Interaction. 
Highlighting (red and green) represents input genes. Red indicates downregulation and green 
indicates upregulation in ethanol mice versus control mice. DEGs were identified using Partek 
Genomics Suite with a ± 1.2 fold change and p < 0.05. A single-headed arrow indicates the 
action of one gene on another. A double arrow-headed line indicates that the two genes act on 
each other. Dashed lines indicate an indirect interaction, and solid lines indicate direct 
interactions. E = expression, L = proteolysis, LO = localization, PD = protein-DNA binding, A = 
activation, P = phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-
protein interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T 
= transcription, TR = translocation.  Refer to Appendix F for a full IPA legend on relationship 
types, molecular shapes, and relationships. 
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Figure 24. Third network resulting from Ingenuity Pathway Analysis of trimester two long-
term (T2-L) differentially-expressed genes (DEGs). Network name: Amino Acid Metabolism, 
Lipid Metabolism, Molecular Transport. Highlighting (red and green) represents input genes. 
Red indicates downregulation and green indicates upregulation in ethanol mice versus control 
mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p < 0.05. 
A single-headed arrow indicates the action of one gene on another. A double arrow-headed line 
indicates that the two genes act on each other. Dashed lines indicate an indirect interaction, and 
solid lines indicate direct interactions. E = expression, L = proteolysis, LO = localization, PD = 
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PR = protein-
RNA binding, PP = protein-protein interaction, I = inhibition, M = biochemical modification, RB 
= regulation of binding, T = transcription, TR = translocation.  Refer to Appendix F for a full 
IPA legend on relationship types, molecular shapes, and relationships. 
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Figure 25. A merged network from Ingenuity Pathway Analysis (IPA) of trimester two 
long-term (T2-L) differentially-expressed genes (DEGs). Highlighting (red and green) 
represents input genes. Red indicates downregulation and green indicates upregulation in ethanol 
mice versus control mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold 
change and p < 0.05. A single-headed arrow indicates the action of one gene on another. A 
double arrow-headed line indicates that the two genes act on each other. Dashed lines indicate an 
indirect interaction, and solid lines indicate direct interactions. E = expression, L = proteolysis, 
LO = localization, PD = protein-DNA binding, A = activation, P = 
phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-protein 
interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T = 
transcription, TR = translocation.  Refer to Appendix F for a full IPA legend on relationship 
types, molecular shapes, and relationships. 
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d) Candidate gene selection and confirmation of specific genes disrupted following 
second-trimester ethanol exposure 
The selected T2-L gene candidates are shown in Table 28, which specifies the criteria 
used for qRT-PCR confirmation experiments. The criteria were based on functional analysis 
(DAVID, GE, IPA), pathway analysis (Pathway Express, PE, canonical pathways), and network 
analysis (GeneMANIA, IPA). Selected genes were subjected to qRT-PCR for confirmation, and 
the results are shown in Table 29. The downregulation of T2-L genes including, 
Calcium/calmodulin-dependent protein kinase IG (Camk1g), Coiled-coil domain containing 6 
(Ccdc6), Mesencephalic astrocyte-derived neurotrophic factor (Manf), Cdkn1a, Egr3, Hspa5, 
and Xbp1 was confirmed. Homer homolog 1 (Drosophila) (Homer1) and Hspa90aa1 qRT-PCR 
fold-changes, albeit statistically significant, were opposite to the array fold-changes. A series of 
box plots illustrating the variability across biological replicates in qRT-PCR demonstrates the 
similarity in ∆CT  values across replicates, and the presence of major and minor outliers, for 
Tbxa2r samples (Figure 26). Comparing the Tbxa2r box plot to those of other genes, the data 
suggest that all other genes from this group show between-group variability in order to reach 
statistical significance. 
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Table 28. Candidate gene selection criteria for confirmation of specific trimester two long-
term (T2-L) differentially-expressed genes (DEGs).  
Genes
a
 Neurodevelopment and/or behaviour Tool
b
 
Network 
(IPA)
c
 
Camk1g pathophysiology of sleep disorders
233
 PubMed 3 
Ccdc6 responsive to genotoxic stress (DNA damage)
234
 
miRNA:gene (miR-302c) 
PubMed 
IPA 
None 
 
Cdkn1a PI3K/AKT signaling; prostate cancer signaling 
misregulation in cancer 
IPA 
GE 
1 
(hub) 
Egr3 attack behaviour
235
 
neuromuscular synaptic transmission 
association with schizophrenia
236
 
IPA, PubMed 
GE 
PubMed 
3 
Homer1 working memory; navigation 
skeletal muscle contraction 
enhanced behavioural despair and anxiety
237
 
IPA 
GE 
NCBI 
3 
Hsp90aa1 protein refolding; nitric-oxide synthase regulator 
altered expression in autism post-mortem brains
238
 
P.Express  
PubMed 
2 
Hspa5 ER response (to unfolded proteins) 
pathogenesis of spinocerebellar ataxis
239
 
DAVID 
PubMed 
1 
Manf reduces ER stress (neuroprotective); recovery of 
motor functions
240
 
PubMed 
 
2 
Tbxa2r contraction of skeletal muscle 
asthma-related symptoms
241
 
IPA 
PubMed 
2 
Xbp1 ER stress response 
 
UPR in neurites
242
 
association with schizophrenia
243
 
IPA, 
GeneMANIA 
PubMed 
1 
(hub) 
 
a
Genes listed alphabetically; DEGs: Calcium/calmodulin-dependent protein kinase IG (Camk1g), Coiled-coil 
domain containing 6 (Ccdc6), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Early growth response 3 
(Egr3), Homer homolog 1 (Drosophila) (Homer1), Heat shock protein 90kDa (cytosolic), class A member 1 
(Hsp90aa1), Heat shock 90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Mesencephalic astrocyte-
derived neurotrophic factor (Manf), Thromboxane A2 receptor (Tbxa2r), and X-box binding protein 1 (Xbp1). 
b
Tools used to analyse candidate genes (by neurodevelopment and behaviour) include PubMed, Ingenuity Pathway 
Analysis, Partek Gene Ontology Enrichment (GE), National Center for Biotechnology Information (NCBI), 
GeneMANIA (www.genemania.org), The Database for Annotation, Visualization and Integrated Discovery 
(DAVID), and Pathway Express (P. Express). 
c
IPA networks listed are shown in Figure 22-24. “Hub” =  molecule that appears in a top IPA network with strong 
intramodule connectivity to all other genes in the same network. Connectivity of a hub > 10 interaction.    
 
 
128 
 
 
 
 
 
 
 
 
 
 
Table 29. A comparison of trimester two long-term (T2-L) qRT-PCR and microarray 
results for candidate genes. 
Genes
a
 
Array  
Fold change 
Array  
p-value 
qRT-PCR  
Fold change 
qRT-PCR  
p-value 
Camk1g -1.27 0.023 -1.66 3.0e-4 
Ccdc6 -1.25 0.019 -1.19 0.049 
Cdkn1a -1.43 0.021 -2.23 0.003 
Egr3 -1.21 0.040 -1.29 0.026 
Homer1 -1.20 0.021 -0.74 0.005  
Hsp90aa1 -1.21 0.041 -0.89 0.025 
Hspa5 -1.36 0.005 -1.61 0.029 
Manf -1.35 0.009 -1.70 0.006 
Tbxa2r 1.21 0.033 -1.18 0.079 
Xbp1 -1.37 0.028 -1.54 0.018 
      
a
Genes are listed alphabetically. Genes included Calcium/calmodulin-dependent protein kinase IG (Camk1g), 
Coiled-coil domain containing 6 (Ccdc6), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Early growth 
response 3 (Egr3), Homer homolog 1 (Drosophila) (Homer1), Heat shock protein 90kDa (cytosolic), class A 
member 1 (Hsp90aa1), Heat shock 90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Mesencephalic 
astrocyte-derived neurotrophic factor (Manf), Thromboxane A2 receptor (Tbxa2r), and X-box binding protein 1 
(Xbp1). Genes with bold font represent those that were differentially expressed in array and qRT-PCR results. An 
underline indicates opposing results between array and qRT-PCR results.  
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Figure 26. Box plot analysis 
of qRT-PCR results for 
trimester two long-term 
genes (T2-L) using 
Statistical Package for the 
Social Sciences v.16.6. All 
control and ethanol replicates 
were included in the analysis. 
Data are represented by 
average ∆CT per treatment, 
generated using StepOne 
Real-time PCR software. An 
“o” represents a minor outlier 
(± 1.5 interquartile range). A 
* represents a major outlier 
(± 3.0 interquartile range). 
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e) MiRNAs altered in the adult brain following second-trimester ethanol exposure  
In the global analysis of T2-L miRNAs, fold change ranged from -476-fold (miR-704) to 
+1.96-fold (miR-467e). Of the 1407 miRNAs on the T2-L arrays that were specific to Mus 
Musculus, the ANOVA resulted in 790 that were < 1 (56.2%), four that were unchanged (0.3%) 
and 613 that were < 1 (43.6%). T2-L analysis resulted in 20 differentially-expressed miRNAs (± 
1.2-fold change, p < 0.05) listed in Table 30. Only seven of 20 (35%) were found to be 
upregulated in ethanol mice compared to control mice. None of the miRNAs found in T2-L were 
in common with those in T1-L. However, miR-342-5p, identified in miRNA T2-L analysis (± 
1.2-fold change, p < 0.05), was also found in the T2-L long-term gene list (Appendix D).  
f) Identification and Confirmation of Specific MiRNAs in T2-L and their Gene Targets 
For T2-L analysis of miRNA and gene expression levels, the target filtering results are 
shown in Table 31. Six miRNAs were implicated in the results including: miR-146b, miR-208b, 
miR-302c, miR-335, miR-449 and miR-455. Contrary to T1-L, all miRNAs except for miR-302c 
were downregulated, which was surprising since it opposes the notion that an upregulated 
miRNA(s) leads to decreased expression of mRNAs. There were 10 genes identified in target 
filtering analysis, which were all downregulated. The only miRNA:gene inverse relationship 
included miR-302c and Ccdc6. Mir-302c was subjected to confirmation by qRT-PCR. The 
upregulation of miR-302c ― along with the previously mentioned corresponding 
downregulation of its target gene, Ccdc6 ― was confirmed (Figure 27).  
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Table 30. A list of differentially-expressed microRNAs in trimester two long-term (T2-L) 
array analysis. 
MicroRNA
a
 Fold change p-value 
miR-10b -1.47 0.002 
miR-1194 -1.30 0.006 
miR-146b -1.24 0.049 
miR-184 -1.44 0.001 
miR-1942  1.38 0.029 
miR-1952  1.25 0.018 
miR-1964  1.26 0.032 
miR-208b -1.37 0.040 
miR-2145  1.39 0.029 
miR-302c  1.27 0.011 
miR-335-5p -1.35 0.038 
miR-342-5p -1.27 0.025 
miR-343  1.27 0.018 
miR-369-5p  1.29 0.003 
miR-449b -1.27 0.043 
miR-455 -1.48 0.037 
miR-466b-3p -1.35 0.038 
miR-466c-3p -1.90 0.030 
miR-466e-3p -1.49 2.5e-4 
miR-684 -1.28 0.021 
 
a
MicroRNAs are listed by numerical ordering. Data generated using a ± 1.2-fold change and p < 0.05 in Partek 
Genomics Suite. 
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Table 31.  Ingenuity Pathway Analysis (IPA) target filtering of differentially-expressed 
genes (DEGs) and microRNAs from the trimester two long-term (T2-L) group. 
Genes
a
  MicroRNA
b
    
Symbol Fold change Symbol Fold change Expression
c
 
(gene:miRNA) 
Confidence
d
 
(predicted) 
Ccdc6 -1.254 miR-146b -1.243 ↓↓ High  
Cdkn1a -1.425 miR-208b -1.373 ↓↓ Moderate 
Dynlt1 -1.208 miR-208b -1.373 ↓↓ High 
Ccdc6 -1.254 miR-302c  1.265 ↓↑ Moderate 
Fam107b -1.245 miR-335-5p -1.349 ↓↓ High 
Ptpn22 -1.216 miR-335-5p -1.349 ↓↓ Moderate 
Cbfa2t3 -1.203 miR-449b -1.268 ↓↓ High 
Galnt7 -1.212 miR-449b -1.268 ↓↓ High 
Xbp1 -1.367 miR-449b -1.268 ↓↓ Moderate 
Zhx2 -1.221 miR-449b -1.268 ↓↓ High 
Cdkn1a -1.425 miR-455 -1.477 ↓↓ Moderate 
Otub2 -1.314 miR-455 -1.477 ↓↓ Moderate 
 
a
Genes included Coiled-coil domain containing 6 (Ccdc6), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) 
(Cdkn1a), Dynein, light chain, Tctex-type 1 (Dynlt1), Family with sequence similarity 107, member B (Fam107b), 
Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), Core-binding factor, runt domain, alpha 
subunit 2; translocated to, 3 (Cbfa2t3), UDP-N-acetyl-alpha-D-galactosamine:polypeptide-N-
acetylgalactosaminyltransferase 7 (GaINAc-T7) (Galnt7), X-box binding protein 1 (Xbp1), Zinc fingers and 
homeboxes 2 (Zhx2), and OUT domain, ubiquitin aldehyde binding 2 (Otub2). DEGs are based on Partek Genomics 
Suite analysis with ± 1.2-fold change and p < 0.05 
b
MicroRNAs are listed by numerical order. MicroRNAs were differentially expressed based on Partek analysis with 
± 1.2-fold change and p < 0.05. 
c
Expression (gene:miRNA) is highlighted in red if an inverse relationship between gene:miRNA was identified.  
dConfidence predicted based on IPA’s Target Filter function. 
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Figure 27. Bar graph of relative expression of miR-302c between ethanol and control 
samples. Error bars represent relative expression ± SEM. Statistical significance assessed using a 
two-tailed t-test with *p < 0.05. Biological replicates: n = 5 control, n = 6 ethanol. Technical 
replicates: n = 3. 
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4.  Discussion 
 My central hypothesis stated that, prenatal alcohol exposure during the first and second 
term of gestation causes FASD-related behavioural abnormalities and may involve immediate 
and lifelong changes in brain gene expression, affecting specific pathways. The results presented 
in this thesis show that B6 mice exhibit behavioural delays and alterations to the brain 
transcriptome, both immediately following ethanol treatment and into adulthood, regardless of 
neurodevelopmental timing. More specifically, I established that prenatal ethanol exposure alters 
developmental milestones, particularly those associated with motor skill, and leads to learning 
abnormalities associated with FASD. Immediate (fetal) and long-term (adult) effect of binge-like 
exposure in B6 mice involves genome-wide gene expression in the brain. Such changes are 
specific to cellular pathways and networks related to neurodevelopment and FASD-relevant 
behaviours. I also investigated a role for miRNAs in the long-term maintenance of gene 
expression changes in response to prenatal ethanol exposure. 
The discussion interprets the behavioural and transcriptomic results in the context of 
neurodevelopment and FASD. In the behaviour section of the discussion, long-term effects 
(treated during trimester one or two) phenotypic explanations are organized by specific 
behaviours analysed comparatively to the results. In the molecular section of the discussion, an 
interpretation of the immediate effects of prenatal alcohol exposure (T2-S) is presented. Next, 
the long-term effects (T1-L and T2-L) on mRNA and miRNA changes resulting from prenatal 
ethanol exposure are reported. For each of the groups in the molecular section (T2-S, T1-L, and 
T2-L), the discussion includes the interpretation of functions, pathways, and networks, and their 
importance to specific cellular processes.  
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4.1 Binge-like prenatal ethanol exposure leads to behavioural alterations in exposed 
offspring 
 4.1.1 Gestational ethanol exposure leads to motor skill deficits 
 The results from behavioural analysis demonstrate that ethanol exposure during the first 
and second trimester equivalent may cause delays in specific developmental milestones. When 
pups are exposed during the first trimester equivalent, the effects appear to be subtle, with four of 
the nine milestones affected. Trimester-one-exposed males and females show significant deficits 
in surface righting, forelimb grasping, open-field traversal, and air righting, which follows the 
literature
8
. Such phenotypes are early indicators of the rostro-caudal gradient of limb 
coordination maturation
244
. Limb and musculoskeletal defects have been reported in children 
with FASD, at early infancy
245
. Poor limb coordination has been observed in ethanol-affected 
animals, including mice
91,246
. Ethanol exposure during the second trimester equivalent produces 
delays in six of nine developmental milestones in males and females including: surface righting, 
negative geotaxis, cliff aversion, open-field traversal, eye opening, and air righting. Trimester 
two ethanol mice are delayed in reflex (eg. negative geotaxis) and sensory coordination (eg. cliff 
aversion). Similar to trimester one results, motor skill and coordination deficits are persistent in 
trimester two ethanol mice compared to control mice. Trimester two ethanol mice were 
significantly delayed in forelimb grasping (which measures balance, coordination, and motoric 
strength) compared to trimester one ethanol mice.  
The reported motor strength, reflex, and coordination deficits have been observed in other 
studies assessing developmental milestones in FASD
247,248
. These patterns may suggest that the 
brain regions responsible for the development of these neuro-motor skills may be sensitive to 
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ethanol at early stages of development, at which time neurulation and cell proliferation occur
2
. 
Motor activity behaviours have been closely correlated with serotonin function
249
. Serotonin 
function is important for neurogenesis; and, its levels are altered by alcohol exposure
250
. 
Serotonin may be important in the disrupted development of motor skills. Fetal ethanol exposure 
can cause cell death and neuronal reduction, which may lead to motor impairments
61,93,251,252
. 
The impairments caused by late gestation ethanol exposure may be attributed to interference 
during specific brain region development including synapse formation in the cerebellum and 
prefrontal cortex
93,253–256
. Such results are relevant to FASD, as young children with FASD show 
delayed motor development and fine-motor dysfunction including weak grasp, poor hand-eye 
coordination, and poor balance
19,257,258
. Deficits in fine-motor skills are thought to result from 
damage to the cerebellum, due to its involvement in motor learning
259
. The cerebellum is also 
sensitive to the apoptotic effects of ethanol, particularly during later neurodevelopmental 
stages
53
. My results support these findings, and suggest that ethanol exposure, particularly when 
given at late gestation, may be detrimental to the development of motor skills, reflexes, and 
coordination.  
 4.1.2 Prenatal ethanol exposure leads to increased activity 
The literature is divided on the impact of prenatal alcohol exposure on activity 
levels
1,78,260,261
. In my study, novelty-based activity levels (movements) are increased in 
trimesters one and two ethanol mice compared to control mice, which follows the 
literature
1,68,262
. Trimester two ethanol mice were significantly more active than trimester one 
ethanol mice (Figure 6), suggesting that second trimester ethanol exposure may lead to more 
severe deficits in activity levels in offspring than early ethanol exposure. Increased activity are 
common in children with FASD, and in animal models of FASD
1,14,263,264
.  
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In the open-field activity analysis, I sought to differentiate the effects of alcohol on 
activity versus novelty-induced stress by measuring overnight activity of the mouse. Overnight 
activity levels, plotted hour-by-hour, were not consistent between males and females from 
trimesters one and two. Results suggest that alterations to activity levels in a familiar 
environment may be due, at least in part, to the timing of exposure during neurodevelopment. 
Trimester one ethanol females were significantly less active than control females at three time-
points during the night; whereas, at one time-point, ethanol females were more active than 
control females (Figure 7A). Trimester one ethanol males were significantly more active than 
control males at the beginning and ending time-points of overnight testing; ethanol males were 
significantly less active than control males for one hour during the night (Figure 7B). The results 
suggest that prenatal ethanol exposure during the first trimester equivalent results in generally 
altered (whether increased or decreased) levels of activity in ethanol mice. The results also point 
to the complexity of locomotor behaviours associated with FASD. These findings are consistent 
with studies that have observed differences in activity in animals following ethanol 
administration during early stages of fetal development
1,68,262,263
. Trimester two ethanol females 
were hyper-active for two hours during the nocturnal phase, and hypo-active for one hour 
(Figure 8B). Ethanol males showed altered activity levels compared to their control counterparts 
at certain peaks throughout the night. Trimester two ethanol males displayed increased activity 
for four hours, and significantly decreased activity for two hours (Figure 8A). Such disturbances 
in activity levels follow the results from trimester one. Ultimately, both early- and mid-gestation 
ethanol exposures led to changes in nocturnal behaviour in ethanol-exposed adolescent mice. 
These abnormalities may represent sporadic alterations in activity following prenatal ethanol 
exposure. 
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Researchers have reported on altered locomotor activity of mice, and its association with 
5-hydroxytryptophan (5-HT) transporter mRNA levels in neurons
266
. Serotonin, a 
neurotransmitter involved in behaviour and CNS development, is decreased in the forebrains of 
ethanol mice compared to control counterparts
267
. Prenatal ethanol exposure leads to differential 
long-term effects on 5-HT-mediated neuroendocrine function in males and females
268
. Timester 
one is important for neural progenitor development and forebrain development
64,65
. Altered 
activity levels in ethanol mice could be maintained into adulthood due to altered serotonin 
signaling in the brain. Trimester two is a critical period for neuroepithelial cell proliferation, 
differentiation, and migration
69
. Ethanol exposure during this stage alters neuronal migration 
and, similar to first trimester exposure, reduces the number of neurons and glial cells in the 
neocortex, hippocampus, and sensory nucleus
64,70
; these reductions are associated with 
alterations in locomotor activity
269
. A correlation between neuronal reduction and disturbed 
locomtor activity is logical, given that the hippocampus ― one of the prominent limbic system 
structures ― contributes to exploratory locomotion behaviour270. Prenatal ethanol exposure has 
been reported to lead to a 25-30% decline in the number of hippocampal cornu ammonis area 1 
(CA1) pyramidal cells, which corresponded to a significant increase in activity levels in ethanol 
subjects
269
. Long-term abnormalities in the cerebral cortex, a region important for the control of 
voluntary movement, have been noted in motor-impaired individuals with FAS and FASD
48,271
.  
4.1.3 Ethanol leads to changes in anxiety-related traits when offspring are exposed 
during the second trimester  
The results from anxiety testing indicate that anxiety-related traits may confound analysis 
of locomotor behaviours in FASD models, particularly when assessed in novel environments. In 
my study, three measures of anxiety-related traits were used including an open field test, a LDB, 
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and an EPM. Thigmotaxis is an index of anxiety in mice, and is observed when a mouse has a 
tendency to remain close to walls or in the dark, i.e., away from open and light areas
272
. 
Trimester one ethanol mice and control mice were not significantly different, which suggests that 
mice exposed to ethanol during the beginning of gestation have no observable anxiety-related 
deficits. Although others have agreed that there may be no changes in anxiety-related traits 
following prenatal alcohol exposure
102
, they have not focussed on the first trimester, leading to 
the novelty of the findings in this thesis.  
Trimester two ethanol mice showed significantly lower levels of thigmotaxis, indicated 
by significantly increased time, compared to control mice, in the center zone and light arena of 
the open-field test and LDB, respectively (Figures 9-10). Additionally, trimester two ethanol 
mice show lower levels of thigmotaxis in the open field than trimester one ethanol mice. No 
changes in activity between trimester two ethanol and control mice were observed in the EPM. It 
is possible that using multiple anxiety tests may lead to unreliable estimates of the similarities 
between the tests; a physical integration of these tests into one apparatus may prove to be more 
useful in the assessment of anxiety-related traits
115
. From the open field and LDB results, one 
can infer that second-trimester ethanol mice show significantly lower levels of anxiety-related 
traits than control mice. A decrease in anxiety-related behaviour does not follow previous reports 
in the literature. However, it is possible that trimester two exposure may not reduce anxiety in 
offspring, per se, but may instead increase the risk of other FASD-related phenotypes, such as 
impulsivity
273
. In such a way, the lowered anxiety-related phenotype may actually represent high 
impulsivity or risk-taking behaviour, which have been reported in animal models of FASD
274,275
. 
Children with FASD are known to be impulsive and to take risks
11,276–278
. Risky behaviour and 
low impulse control is associated with damage to the ventromedial prefrontal cortex (VPC)
279,280
. 
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The VPC undergoes massive neuronal migration of cells, which may contribute to this 
phenotype
281
. The second possibility to observing lowered anxiety-like behaviours is an 
anxiolytic effect of alcohol during the second trimester. Previous studies have identified a similar 
phenomenon resulting in anxiolytic effects in prenatally ethanol mice
282
. Such findings give 
evidence to the sedative effects of ethanol
283
. Further behavioural testing ― that deciphers 
between anxiety-related behaviours and impulsivity or risky behaviour ― would allow for more 
comprehensive conclusions regarding the results of anxiety-related behaviours during second 
trimester ethanol exposure. 
4.1.4 Deficits in spatial learning and memory result from prenatal ethanol exposure 
 Ethanol mice from trimester one and two showed impairments in spatial learning and 
memory, albeit not to the same degree. Trimester one ethanol mice did not learn the location of a 
target hole by the final learning day (Figure 11A). During short-term recall trials, ethanol mice 
made the same number of explorations around the target hole than control mice (Figure 12A). 
No changes in exploration indicates the adsence of short-term memory deficits in trimester one 
ethanol mice. Control mice displayed an increased number of explorations to a position near the 
target hole in long-term recall trials (Figure 12B). Although there was a general trend of 
increased explorations to the target hole by control mice versus ethanol mice, the findings were 
not significant. These results indicate the presence of learning deficits in ethanol mice; however, 
trimester one exposed mice do not have severe memory delays. My results on learning trials 
support those from other studies, which have demonstrated that ethanol mice show significant 
impairments in spatial learning
78,91,284
. Observing no memory deficits following early-gestational 
alcohol exposure is novel in the literature. However, the results should be interpreted with 
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caution. A general trend of increased latency to the target hole was observed in ethanol mice, and 
these results may be significant with increased sample size.  
Young adults with FASD often have cognitive functioning abnormalities in the following 
areas: intellectual ability, attention and speed of information processing, executive functioning, 
language, visual perception and visual construction, number processing, and learning
9,285–288
. 
Akin to mice that did not learn the spatial orientation of the target in the Barnes Maze, 
individuals with FASD may have difficulty in developing spatial navigation and require 
consistent repetition to reinforce learning
15
. Ethanol decreases the spatial specificity of 
hippocampal place cells, suggesting that ethanol affects learning and memory by altering, 
directly or indirectly, neuronal activity in the hippocampus and related structures
289
. The 
hippocampus is critical for spatial information in guiding and organizing behaviours
290
. Given 
that the hippocampus becomes visible during the first trimester and is vulnerable to external cues 
(eg. ethanol), hippocampal abnormalities may lead to the observed spatial learning deficits
291
. 
Although second trimester ethanol mice took longer than control mice to reach the target 
on the first learning day, they were able to “catch up” by the end of the trials (Figure 11B). On 
learning days three and four, trimester two ethanol mice spent signifcnatly less time searching 
for the target hole than trimester one ethanol mice. The difference between early- and late-
gestational alcohol exposures suggests that reinforced learning in the Barnes Maze allowed 
trimester-two-exposed mice to catch up to control mice by the final trial day. On the other hand, 
early-gestational alcohol exposure impairs learning in offspring into adulthood, even with 
repeated trials. Others have agreed that repeated learning can result in ethanol animals reaching a 
similar performance level to that of control animals
292
. Repeated learning in children with FASD 
may help to improve spatial learning when children are given an implicit learning strategy
15,293
. 
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The late second trimester is the beginning of rapid brain growth, a time when neuroteratogens 
can exert adverse effects
294
. Ethanol exposure during the second trimester leads to reductions in 
the number of neurons and glial cells in the hippocampus
2,70,295
. Any spatial deficits resulting 
from ethanol exposure during this time may result from hippocampal neuronal damage. In the 
Barnes Maze, short-term recall trials resulted in lower numbers of explorations to the target area 
by trimester two ethanol mice than control mice. Ethanol mice also made more explorations to 
the opposite side of the maze than control mice (Figure 12A). Long-term recall trials resulted in 
lower numbers of explorations in the target area by ethanol mice compared to control mice 
(Figure 12B). These findings are contradictory, since repeated learning led to an improvement in 
learning performance in ethanol mice. However, the results suggest that even repeated learning 
trials may not necessarily lead to improved short-term or long-term memory following mid-
gestational ethanol exposure.  
4.1.5 Caveats to behaviour modeling of complex disorders 
a) General use of mice as a model 
Modeling complex disorders using the mouse is not without limitations. The first caveat 
to mouse behavioural phenotyping is the resulting comparison to human subjects. This limitation 
represents an issue pertaining to face validity in animal models, which addresses the extent to 
which a test is subjectively viewed as covering the concept it purports to measure
186
. Essentially, 
there must be similarity between the behaviour exhibited by the animal model, and the specific 
symptom of the human condition. Establishing face validity of a model is impossible, because 
claims for face validity of a model almost invariably involve subjective arbitrary arguments that 
are not necessarily accepted by all investigators in the field
186
. As proper characterization of 
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many complex disorders still remains to be properly elucidated in human studies, the validity of 
specific behavioural tests to measure animal behaviour will also require revision. Another aspect 
of animal model validity includes predictive validity. Predictive validity involves the 
identification of potential treatments or pharmacotherapies for reducing physical or behavioural 
abnormalities
186
. This feature of animal model validity was not addresses in my thesis, and 
remains to be observed in future studies. Lastly, construct validity must be established in an 
animal model of human complex disorders in order to remain valid. Construct validity refers to 
whether a test measures that which it is intended to measure
186
. Although a necessary component 
in establishing the reliability and validity of animal models, it is rarely established. For instance, 
I measured anxiety-related traits using three testing apparatuses for mice, with inconsistent 
results. Given this, complex behaviours may not be properly characterized using available testing 
apparatuses, and the results could be misrepresented.  
Other than addressing the validity of mouse models of complex disorders, there are other 
limitations to behavioural research on animals. These may include: 1. varying results across 
different labs using the same behavioural test, 2. experimenter’s influence (eg. odour cues) on 
animal performance, 3. early-life environment of the mouse (eg. stress, maternal care), 4. 
variation across mouse strains, 5. influences from previous behaviour tests . Each of these factors 
may alter the outcome of behavioural analysis. However, although these issues may confound 
behavioural testing, the mouse was chosen for this project based on the extensive availability of 
behavioural and analytical tools.    
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b) Technical considerations in the FASD project 
In my project, the first caveat was the use of cardboard material in the construction of the 
LDB (enclosure), EPM (closed arms), and Barnes Maze (hole covers). Cardboard has been used 
by other researchers in construction of behavior apparatuses
100
. However, odour cues are used as 
scent marks for communication between mice
296
. It is possible that olfactory cues could have 
remained on the testing apparatus and influenced the results. Another limitation to behaviour 
testing involves measurement of human traits in animal models. In my study, I found 
inconsistent results across three tests that apparently measure anxiety-related behaviours (open 
field, LDB, EPM). Such discrepancies may have been due to the mouse’s familiarization to 
anxiety-related experiments with time, or the inability of the apparatuses to reliably measure the 
same aspect of anxiety. A final source of concern in behaviour testing included reliance on 
previous BAC studies in B6 mice. Given the amount of ethanol injected, I can predict that BACs 
remained above a critical threshold of neurodegeneration, described by Ikonomidou and 
colleagues
21
. However, because the exact BACs were unknown, there may be inconsistencies in 
the treatments. Such caveats are intrinsic to behavioural testing, and the results from my studies 
should be interpreted with caution.           
4.1.6 Prenatal ethanol exposure leads to behavioural disabilities in mice  
Prenatal ethanol exposure in the first and second trimester equivalents in mice leads to 
delays in the achievement of developmental milestones, increased activity levels in a novel 
environment, altered activity in a home cage environment, and deficits in spatial learning and 
memory. However, abnormalities in anxiety-related behaviours are dependent on the timing of 
gestational alcohol exposure. Mice treated at the second trimester equivalent show decreased 
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anxiety-like traits compared to matched control mice. Whereas, mice treated at the first trimester 
equivalent are not statistically different from matched controls. Given the nature of the 
neurodevelopmental processes that occur during each stage, it is likely that behavioural 
abnormalities are resultant from differential timing of gestational ethanol exposure. However, the 
results also provide evidence that neither time is safe from the teratogenic effects of alcohol on 
the developing brain. Herein, the timing of gestational ethanol exposure is an important factor in 
the development of a spectrum of abnormalities associated with FASD. 
4.2 Molecular search for the mechanisms that may govern FASD 
4.2.1 Prenatal ethanol exposure leads to gene expression changes that are subtle, timing-
dependent, and developmental stage-specific 
The developing brain is highly susceptible to the teratogenic effects of ethanol
54,297
. 
Researchers have demonstrated that prenatal ethanol exposure can lead to long-term behavioural 
abnormalities that characterize FASD
7,17,91,217
. These long-term behavioural consequences are 
associated with changes in gene expression that are maintained into adulthood
158,217
. The 
mechanisms maintaining alterations in gene expression may be a result of epigenetic 
mechanisms, including “fine tuning” of the genome by miRNAs95,165. In my thesis, I took a novel 
approach by comparing the short-term (fetal) and long-term (adult) transcriptomic changes 
resulting from gestational ethanol exposure during the second trimester equivalent in the B6 
mouse. I also compared the long-term changes in gene expression between two time points: first 
trimester and second trimester. Furthermore, the role of miRNAs was explored in the 
maintenance of the observed long-term (T1-L and T2-L) gene expression changes. 
146 
 
 
 
The resulting list of T1-L and T2-L DEGs from microarray analysis provides evidence 
that ethanol exposure during neurodevelopment significantly alters the transcriptome of the adult 
brain, regardless of timing. In addition, prenatal ethanol exposure at T2-S also produces subtle, 
immediate changes in the transcriptome of the fetal brain. Researchers argue that subtle changes 
to the transcriptome are relevant to the idenitification of altered biological processes
298
. Because 
there was close to no gene overlap across groups, this may suggest that major contributors to the 
DEGs ― aside from ethanol itself ― are the timing and developmental stage of ethanol 
exposure. Gestational timing may result in different sets of genes being implicated due to 
changes that occur in the transcriptome as the brain develops. The resulting affected gene-sets 
are based on the biological processes occuring at the time of exposure. Depending on the timing 
(i.e. trimester), ethanol would likely disrupt different sets of biological pathways. Depending on 
the developmental stage (fetal brain versus adult brain), the genes and pathways corresponding to 
these stages will reflect differences in ethanol’s targets during brain development in the womb 
versus in adulthood. Changes in gene expression could result from ethanol-induced apoptosis of 
specific cell types, which may lead to an overall change in the cellular composition of the brain 
and, subsequently, the overall pattern of brain gene expression
21,53,54,297,299
. Ethanol may disrupt 
specific developmental processes that are sensitive to external cues, such as cell growth, 
proliferation, migration, or differentiation
10,300,301
. These mechanisms may represent immediate 
effects of ethanol. Ethanol may not directly alter gene expression, but rather, it may act indirectly 
by altering cellular identity or physiology of the brain such that the appropriate balance of neural 
gene expression is not maintained. If proper patterning is not maintained into adulthood, this may 
explain why gene expression changes are still persistent in adult mice, thereby leaving a 
molecular “footprint”158. Interestingly, even low blood alcohol levels can trigger apoptosis in the 
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developing brain
54
. Also, FASD-relevant behaviours are observed in individuals with no obvious 
brain abnormalities
27
. These observations suggest that a reduction in brain cell populations does 
not account for all of the variation in FASD. Epigenetic modification may be another mechanism 
responsible for altered gene expression following prenatal ethanol exposure.  
It is important to note that the overall patterns of gene expression in T1-L and T2-L have 
inverse numbers of upregulated versus downregulated genes from T2-S. More genes (~63%) 
from T2-S analyses were upregulated than downregulated. In agreement with this finding, others 
have shown that more transcripts are upregulated than downregulated as a result of inhibition of 
proteins related to cell growth, differentiation, and modification
302
. This is reasonable given that 
the second trimester is important for cell growth, proliferation, migration, and differentiation
2,69
. 
Also, the higher percentage of upregulated genes in T2-S may be a result of an immediate 
compensatory response to fetal teratogen (i.e. ethanol) exposure. More genes from T1-L (~82%) 
and T2-L (~60%) were downregulated than upregulated. These overall patterns represent 
developmental-stage-specific changes in the transcriptomes. Downregulation and upregulation of 
different sets of genes and pathways likely depends on which biological processes are affected 
by prenatal alcohol exposure at two developmental times. Ethanol has been shown to result in 
downregulation of neurotransmitter-related genes in the brain, even in adult mice
91,102
. The 
results suggest that certain genes remain dysregulated into adulthood, leading to long-term 
maintenance of FASD-related behavioural abnormalities.  
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4.2.2 The effects of second-trimester ethanol exposure on molecular processes in the fetal 
brain (T2-S) 
a) Short-term (T1-S) process 1: neuroinflammation 
Functional, pathway, and network characterization of T2-S genes resulted in 
neurinflammation as an affected process. The neutrophil-derived, Chemokine (C-C motif) ligand 
3 (CCL3), is essential for the rapid recruitment of dendritic cells to sites of microbial 
infection
303
. Given its role in inflammation of the nervous system, Ccl3 may have an integral and 
immediate reaction to ethanol. Another gene, Leukocyte-associated immunoglobulin-like 
receptor 1 (Lair1) was implicated in natural killer cell proliferation, and is involved in inhibitory 
regulation of the immune system to prevent cell lysis
304
. Studies show that in utero alcohol 
exposure can result in immune deficiencies, including impaired adaptive immune responses to 
influenza virus infection, in neonates and adults
305,306
. Immune system-related genes affected 
immediately following gestational ethanol exposure can lead to compromised immune system 
response into adulthood. An ongoing neuroinflammatory process in the cerebral cortex and 
cerebellum of post-mortem autistic brain samples
307
. Comorbidity of cognitive and behavioural 
deficits in autistic children and individuals with FASD is quickly becoming a new avenue of 
investigation. FASD and autism share similarities with regard to social and communicative 
functioning
308
. Researchers have also supported the position of compromised immunity and 
neuroinflammation in the autistic brain
309
. Of the two networks identified by IPA analysis, the 
top pathway included Lair1 and Ccl3 (Figure 15). Ccl3 and Lair1 may be upregulated 
immediately following prenatal ethanol exposure in an attempt to mediate the effects of 
neuroinflammation by alcohol on the sensitive brain. A loss of LAIR1 results in altered immune 
cell phenotypes
310
. CCL3 functions to traffic inflammatory cells across the blood brain barrier in 
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CNS inflammation
311
. As a result, Lair1 and Ccl3 expression may increase in order to facilitate 
proper immune function in an attempt to elicit a response following ethanol-induced 
inflammation. It is possible that neuroinflammation could be a potential cause of cognitive 
decline in individuals with neurodevelopmental disorders
194
. 
b) Short-term (T2-S) process 2: chromatin stability 
A second process that is disrupted in the fetal brain following acute ethanol 
administration in the second trimester is chromatin stability. GE analysis identified chromatin 
stability, specifically histone-related processes, with Tdg and RING1 and YY1 binding protein 
(Rybp) (Table 4). Given that Tdg’s main function is repairing DNA mismatches, the finding of 
“base excision repair” as the top pathway (albeit not statistically significant) from Pathway 
Express is reasonable. Base excision repair mechanisms must function correctly to enable 
efficient repair, and subsequent repackaging of DNA into nucleosomes
312
. Network analysis 
using IPA showed Tdg and Rybp involved in the top network (Figure 15). Given its association 
with TP53, Tdg may be upregulated immediately following fetal ethanol exposure in order to 
compensate for cell death. The upregulated Rybp, involved in degradation of TP53, may 
additionally compensate for the damaging effects of ethanol on the developing brain. Damage to 
DNA resulting from oxidation generates single stranded breaks that must be repaired
313
. 
Chromatin instability could be promoted if these breaks are left unrepaired. RYBP interacts with 
E2 transcription factors (E2fs). E2fs play a major role in the cell cycle as checkpoint regulators 
and DNA repair and replication proteins
314,315
. These factors also interact with histone 
acetyltransferases to facilitate proper gene expression in the cell cycle
316
. An alteration in 
transcript levels of Rybp, whether increased or decreased, may interrupt histone interaction and 
lead to improper chromatin regulation. Improper chromatin regulation may lead to a loss in 
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control of gene regulation and cell cycle response. Another gene, Jmy, was also identified in T2-
S functional and pathway analysis as a regulator of DNA-dependent transcription in response to 
stress (Tables 3-6). As a transcriptional cofactor, Jmy is a key player that can impact p53 
activity
317
. If disrupted, the DNA damage response may be altered, which could impact the 
regulation of a variety of genes involved in cell cycle control and apoptosis. Ethanol exposure 
can lead to DNA damage, specifically by disrupting chromatin remodeling
318
. Given that 
chromatin remodeling is important in the regulation, unfolding, and activity of genes, any 
deficiencies in this process may have severe implications on neural development and 
plasticity
319
.     
c) Short-term (T2-S) process 3: signal transduction 
Another disrupted process in the fetal brain immediately following second trimester 
ethanol administration is signal transduction. In the second trimester, neuroepithelial cell 
proliferation and migration occurs
2,69
. Hence, cell-to-cell communication via signalling pathways 
may be impacted as a result of ethanol exposure. Functional analysis using DAVID resulted in 
the keyword, Dual specificity phosphatase (catalytic domain) or “DSPc” (Table 3). DSPcs are 
key regulatory components in signal transduction pathways (eg. MAPK pathway) involved in 
cellular localisation, growth, proliferation, differentiation, and transformation
320
. In this DAVID 
category, Dusp19 and Ssh2 were implicated (Table 3). A knock down of SSH2 was found to 
induce apoptotic cell death through cell cycle arrest
321
. Apoptotic cell death may be mediated by 
changes in chromatin, resulting from damage to the DNA-histone interactions
322,323
. DSPcs, such 
as Dusp19, have been previously implicated in major depressive disorder (MDD)
324
. MDD and 
other depressive disorders often occur comorbid with anxiety
325
. These disorders may also share 
similar phenotypes with FASD. Of the canonical pathways identified in IPA, “p53 signaling”, 
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driven by Jmy, is associated with signal transduction pathways that mediate apoptosis. Jmy and 
Bcap31 are identified in the top network from IPA (Figure 15). The downregulation of Bcap31 
and Jmy may be a result of ethanol’s effect on signaling, leading to cellular compromise in the 
fetal brain. Signaling pathways, including MAPK, are involved in synaptic plasticity and 
learning
326,327
. Ethanol’s immediate effects may disrupt genes relevant to these processes. 
Differential regulation of cell signaling, specifically MAPK1/ERK2 signaling, may contribute to 
genetic susceptibility to FASD
328
. Other studies agree with my findings that signaling pathways 
are disrupted following prenatal ethanol exposure in the fetal brain. 
d) Short-term (T2-S) process 4: actin cytoskeleton development  
Another process disrupted immediately following second trimester ethanol exposure is 
actin cytoskeleton development. Specifically, Trdn was identified in the IPA function, 
hypertrophy of skeletal muscle; Crem (cAMP responsive element modulator) and Trdn were both 
involved in muscular hypertrophy (Table 5). Given that actin cytoskeleton development has 
been identified as a disrupted process in a mouse model of FAS
82
, these results are relevant to 
my model. Thyroid hormone and its receptor, TRDN, have been implicated in limb 
development
329
. Other factors involved in cytoskeleton development are miRNAs; miRNA 
importance in cytoskeleton development is supported in the literature
330
. In the top IPA network, 
Hpca is upregulated while Crem, miR-397 and miR-99 are downregulated (Figure 15). Although 
mature miRNAs are usually upregulated in order to downregulate their target mRNAs, they 
themselves can be downregulated following prenatal ethanol exposure
331
. Skeletal abnormalities 
are often observed in children with FAS
46,332–334
. Also, deformities of the joints, limbs, and 
fingers have been observed in individuals with FAS
257
. It is presumable that genes involved in 
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cytoskeleton development are altered immediately following prenatal ethanol exposure in this 
model. 
e) Inability to confirm short-term genes using qRT-PCR 
None of the selected genes from T2-S analysis were confirmed by qRT-PCR. The 
inability of qRT-PCR to detect low-fold changes is a possibility
335
. The likelihood that all eight 
genes may be false positives is questionable, especially given that four of the genes have a 
relatively high (±1.34) fold change. There was no bias in confirmation of upregulated versus 
downregulated genes. An important next step to determining the problem with confirmation 
would be to repeat the microarray experiment and confirm specific genes. Another step could be 
to use a newer technology such as RNA sequencing (RNAseq) to further investigate candidate 
genes. Another idea could be to use a more rigorous method to quantify mRNA transcript levels, 
particularly if some of the genes were false positives. This could be achieved using well-
established technology such as, Northern Blotting, ribonuclease protection assays, or droplet 
digital PCR, which can confirm low fold-changes
336
. Using a different algorithm to assess 
microarray data is another possibility. Dallas and colleagues reported a high correlation of 
microarray and qRT-PCR experiments using Partek’s RMA algorithm337. The RMA algorithm 
could be applied to my dataset, and the top DEGs could then be confirmed by qRT-PCR. 
4.2.3 Ethanol exposure during trimester one (T1-L) leads to long-term changes to the 
adult brain transcriptome 
a) Long-term (T1-L) process 1: tissue morphology 
Functional, pathway, and network characterization of T1-L ethanol-responsive genes 
resulted in the disruption of a variety of cellular processes. One of these processes included 
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tissue morphology. Gastrulation ― the early phase in embryonic development during which 
germ layers begin to form ― takes place during trimester one2. Herein, it is reasonable that the 
embryonic stage is disrupted following early prenatal alcohol exposure. Functional 
characterization of significant genes using GE resulted in “mesoderm morphogenesis” with 
Setd2 and Eomes implicated (Table 11). Eomes interacted with an interleukin in the only 
significant IPA network (Figure 19). Studies have shown that Eomes is required for trophoblast 
differentiation and mesoderm formation during gastrulation
338
. This lends credence to the 
likelihood that first trimester ethanol exposure interferes with tissue morphology in the fetus, 
which could be mediated by tissue-specific genes such as Eomes. Another gene, Map3k1, was 
implicated in IPA functional analysis, in “Tissue Morphology” (Table 12). Loss of MAP3K1, an 
enzyme involved in cellular responses to stimuli, enhances proliferation and apoptosis during 
retinal morphology
339
. A role in developmental eyelid closure during fetal development is among 
the most obvious functions of MAP3K1
340
. The only significant T1-L IPA network included nine 
downregulated genes (Figure 19), including RAS p21 protein activator 2 (Rasa2), which is part 
of several known Ras GTPase activating proteins involved in tissue distribution
341
. Spruce and 
colleagues have implicated Rasa2, along with Eomes, in mouse embryogenesis
342
. Children with 
FASD are often characterized with malformations of various organs, facial abnormalities, and 
malformations of the optic discs and retinal vessels
25
. Previous mouse models have consistently 
resulted in craniofacial malformations and anomalies of the face and eyes following trimester 
one ethanol exposure
334,343–345
. It is logical that biological processes involved in tissue 
morphology and organogenesis are disrupted following early gestational ethanol exposure in this 
model.   
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b) Long-term (T1-L) process 2: adaptive immunity 
Similar to T2-S, genes and pathways disrupted in T1-L were also involved in immune 
system response. Functional characterization of gene annotations using DAVID resulted in a 
significant term, “TNF/stress related signaling”, with Map3k1 and Atf1 implicated. Various 
Tumor necrosis factor (TNF) receptor family members are involved in lymphoid development 
and/or peripheral immune system response
346
. One of the essential roles of Map3k1 includes 
regulation of immune system development and function
347,348
. Given the diverse roles of 
Map3k1, its disruption in the brain following ethanol exposure in the first trimester leads to 
compromised immune system response. Eomes also plays a role in cell immunity, as per its 
interaction with interleukin 5 (IL5) in the IPA network (Figure 19). Interleukins are cytokines 
that regulate immune and inflammatory responses. Eomes controls IL5 production in memory T 
helper 2 cells; T helper 2 cells play an important role in the clearance of different pathogens, 
including toxins
349
. The downregulation of Eomes may directly impact immunity to infection by 
disrupting interleukins, such as IL5. GE analysis complemented DAVID analysis, with the 
identification of H2-T23 in T cell proliferation (Table 10). Given that B and T lymphocytes have 
central roles in cell-mediated immunity, their identification in T1-L is well-founded. H2-T23 is a 
homologue of Major histocompatibility complex, class I molecule human leukocyte antigen, E 
(HLA-E), which is involved in the innate and adaptive immune systems
350
. My findings are 
consistent with animal models of FASD that have identified deficits in adaptive immunity 
following prenatal ethanol exposure
351,352
. Individuals with FAS can exhibit immune 
deficiencies, specifically decreased lymphocytes, and diminished mitogen-induced stimulation 
responses to mitogens
353
. It is possible that defects in host defense to infection could be 
attributable to prenatal exposure to high levels of ethanol during early gestation. Tnfrsf19 also 
155 
 
 
 
plays a role in immunotoxicity. Tnfrsf19 is downregulated by Aryl hydrocarbon receptor (AhR) 
(Figure 19), which mediates biochemical and toxic effects of halogenated aromatic 
hydrocarbons
354
. AhR is also involved in cell cycle regulation and development and maturation 
of many tissues. The disruption of AhR by Tnfrsf19 may lead to compromised immune system 
following toxicity. Ceacam1, identified in functional analysis, is responsible for a variety of 
functions, one of which includes modulation of innate and adaptive immune responses. Given its 
disruption following ethanol exposure, Ceacam1 may lead to lifelong changes in dendritic and 
natural killer cells, which are part of the innate immune system. Adaptive immunity refers to the 
adaptability of cells to infectious agents, mediated by B or T lymphocytes. Both processes may 
be altered into adulthood following exposure to toxins, such as ethanol. 
c) Long-term (T1-L) process 3: fatty acid synthesis 
Lipid synthesis is another process that is disrupted in the adult brain following first 
trimester ethanol exposure. The top functional annotation from DAVID analysis was “coenzyme 
A”, with Hmgcs2 (Table 10). PE identified Hmgcs2 in the significant pathway, “synthesis and 
degradation of ketone bodies”. Meanwhile, three of five top IPA canonical pathways were 
relevant to fatty acid synthesis, with Rpe and Hmgcs2 included as key players. HMGCS2 is 
known to regulate mitochondrial fatty acid oxidation
355
. Hmgcs2’s downregulation in the T1-L 
network suggests that ethanol may inhibit lipid synthesis. Fatty acids contribute to regulation of 
hepatic acid oxidation and synthesis in adults; fatty acids also accumulate in fetal and infant liver 
in variable amounts depending on maternal diet fat composition
356
. My results suggest that 
disruption in fatty acid production during the first trimester may lead to lifelong impairments to 
similar processes in the adult. Furthermore, the role of fatty acids in FASD is recognized. 
Placental fatty acid ethyl esters (FAEEs) are well-known biomarkers of heavy prenatal ethanol 
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exposure
357
. FAEEs may be a useful screening tool for the identification of newborns at risk for 
FASD
358
. This screening tool would be a biological attempt to facilitate proper characterization 
of FASD. Results from my study are in-line with previous reports that have identified fatty acid 
biosynthesis as a disrupted process following in utero ethanol exposure, and may help to 
elucidate the key players involved in FASD. 
d) Long-term (T1-L) process 4: DNA repair  
An analysis of T1-L ethanol exposure has also implicated DNA repair as a disrupted 
process. DAVID clustering of functional annotations resulted in “base-excision repair” as a 
significantly affected process dependent on two genes: Mbd4 and Pcna (Table 10). “Base-
excision repair” was also the top pathway resulting from PE analysis, and also included Mbd4 
and Pcna (Table 13). It is well known that ethanol is a toxic substance. The most obvious line of 
evidence that ethanol produces DNA damage is the positive association between alcohol intake 
and an increased risk for cancer
359
. Brooks and colleagues were the first to provide direct 
evidence that neurons in the adult mammalian brain have the capacity to carry out DNA 
mismatch repair
360
. Formation of the neural plate begins on GD 7 in mice
345
, which allows for 
the compairons of these reports to my findings. Genes involved in DNA mismatch repair have 
decreased expression following hypoxic stress in mammalian cells
361
. Herein, one can speculate 
that perhaps mismatch repair proteins, i.e. PCNA are dysregulated upon gestational insults (i.e. 
ethanol) and remain decreased even into adulthood
362
. By doing so, such proteins maintain 
changes in the brain resulting from abnormalities in DNA repair.   
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e) Confirmation of T1-L-specific genes using qRT-PCR 
The qRT-PCR results for T1-L included the confirmation of four genes: Tnfrsf19, Eomes, 
Synpr, and Map3k1 (p < 0.05). The differential expressions of Atf1, Stxbp6, Ceacam1 and 5-
hydroxytryptamine (serotonin) receptor 5A, G-protein coupled (Htr5a) were not reproducible by 
qRT-PCR (Table 16). Given that the gene lists generated from microarray analysis did not 
correct for a FDR, there may be false positives in the results, particularly for genes at low-fold 
changes. 
f) Alteration of miRNAs following first-trimester ethanol exposure 
i. General trends in alteration of mouse-specific miRNAs  
Mouse miRNA arrays were completed on the long-term (T1-L and T2-L) samples. The 
results from T1-L mouse miRNA arrays demonstrate that ethanol exposure during early 
neurodevelopment affects miRNA expression in the adult brain. Since only eight mouse-specific 
miRNAs out of ~1000 were significantly affected (± 1.2-fold change, p < 0.05), the results are 
not stringent enough to make conclusions on array data. The findings from the miRNA arrays 
should be examined with caution. It is important to note that others have also observed low 
numbers of miRNAs disrupted using expression arrays
363,364
. Given that one miRNA has the 
potential to downregulate hundreds of target mRNAs
365
, my findings may be relevant. In fact, a 
miRNA:mRNA relationship may result in subtle, rather than drastic, changes to the 
transcriptome
366
. A disruption in miRNAs usually leads to low-fold changes in gene expression. 
Such an association is why miRNAs are often referred to as, “fine turners of gene expression”165. 
Although global miRNA profiling has not been widely-used in FASD research, recent studies 
report that ethanol does alter miRNA expression
175,176,182,367
. In my study, miRNA analysis was 
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undertaken at postnatal day 70, i.e. young adulthood; therefore, the disrupted miRNAs represent 
altered biological processes that are maintained into adulthood. These altered miRNAs and 
processes may have lasting effects on gene expression and behavioural phenotypes.  
ii. Candidate mouse-specific miRNAs in T1-L 
In general, if a miRNA is upregulated, its target gene(s) is likely to be post-
transcriptionally downregulated. IPA target filtering was performed on the eight T1-L 
differentially-expressed miRNAs, along with their respective DEGs to identify potential targets 
of the miRNAs. Two miRNAs, miR-1192 and miR-532-5p were identified in target filtering, 
along with 11 genes (Table 18). Downregulation of miR-532-5p is reported to alter the 
macrophage inflammatory response to lipopolysaccharide stimulation
368
. MiR-532-5p is also 
involved in suppression of a Runt-related transcription factor (RUNX), which is involved in a 
variety of cellular processes including: cell differentiation, development, angiogenesis, cell 
adhesion and invasion, DNA repair, and immunity
369,370
. A RUNX transcription factor (TF) is a 
downstream effector of the Transforming growth factor beta (TGF-β) signaling pathway371. The 
role of miR-532-5p may be relevant to the development and/or maintenance of 
neurodevelopmental abnormalities, specifically those that are related to cellular maintenance and 
signal transduction, particularly if its target gene is involved in one of these processes. In my 
thesis, the upregulation of miR-532-5p was confirmed using qRT-PCR. The second disrupted 
miRNA, miR-1192, was previously reported to be upregulated in PPARγ dominant negative 
individuals
372
. PPARs are involved in lipid metabolism; PPARγ and PPARα are hubs in T1-L 
network analysis (Figure 19). Given that I have identified fatty acid synthesis as a disrupted 
process following trimester one ethanol exposure, the involvement of miR-1192 in FASD is 
intriguing. However, miR-1192 was not confirmed using qRT-PCR. 
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Of the 14 miRNA:mRNA interactions, ten of these have decreased mRNA fold changes 
and increased miRNA fold changes (Table 18). These results demonstrate that one microRNA 
(i.e. miR-532-5p) has the potential to target multiple genes (i.e. Atf1, Cspp1, Itpripl2, Nat2, 
Stxbp6). Similarly, one gene (i.e. Atf1) can be targeted by multiple miRNAs (i.e. miR-1192 and 
miR-532-5p). Other researchers have found that a single gene can be targeted by various 
miRNAs
373
. Predicted genes that may be disrupted by miR-1192 and miR-532-5p include Atf1, 
Itpripl2, and Stxbp6. From gene functional analysis, Atf1 was found to be involved in TNF/stress 
related signaling (Tables 10). Atf1’s role in cell differentiation, immunity, cell survival, and 
neurite outgrowth during early mouse development is well-established in the literature
374,375
. 
Atf1’s function is relevant to the elucidated roles of miR-532-5p, and was a meaningful candidate 
for confirmation by qRT-PCR. Another role for Atf1 is its involvement in the cellular fatty acid 
homeostasis
376
. Atf1’s downregulation ― particularly in the context of upregulation of miR-
1192, which is involved in fatty acid biosynthesis ― would be relevant to FASD. However, 
given that miR-1192 was not confirmed by qRT-PCR, no direct conclusions can be made. A 
model for the molecular interaction between each of miR-1192 and miR-532-5p with Atf1, 
Itpripl2, and Stxbp6 is shown in Figure 28.  
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Figure 28.  The molecular interaction between each of miR-1192 and miR-532-5p with Atf1, 
Itpripl2, and Stxbp6, and their potential implication for FASD-relevant cellular processes 
and behaviours. Alignment sequences of microRNAs 1192 (miR-1192) and 532-5p (miR-532-
5p) with Activating transcription factor 1 (Atf1), Inositol 1,4,5-triphosphate receptor interacting 
protein-like 2 (Itpripl2), and Syntaxin binding protein 6 (amisyn) (Stxbp6) were idenitifed using 
the microRNA.org – Targets and Expression database 
(http://www.microrna.org/microrna/home.do/). Prediction of binding between microRNAs and 
targets was performed using microRNA.org. Red arrows indicate expression. A red “X” 
indicated blocking. Dashed arrows indicate a potential correlation. UTR = untranslated region. 
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4.2.4 Ethanol exposure during trimester two (T2-L) leads to long-term maintenance of 
molecular changes in the adult brain 
a) Long-term (T2-L) process 1: unfolded protein response 
 Functional, pathway, and network analysis of T2-L ethanol-responsive genes resulted in 
a variety of disrupted biological processes. Second trimester treatment with ethanol resulted in 
alterations to UPR, which occurs in the ER. The ER quality control system recognizes unfolded 
or misfolded proteins and activates stress-signaling pathways (UPR pathways) via ER stress 
sensors
377
. Altered ER stress response signaling, resulting from promoter polymorphisms in 
HSPA5, has been previously implicated in bipolar disorder
378
. Changes in ER-related stress 
response have also been implicated in a variety of other neurodevelopmental disorders including 
myopathy and Alzheimer’s Disease379,380. Presence of Homer1 in the third IPA network (Figure 
24), along with Homer1’s vast roles in working memory and spatial navigation, make this gene a 
suitable candidate for FASD. Isoforms of Homer1 are involved in mediation of behaviour, 
maintenance of basal extracellular glutamate, and regulation of the prefrontal cortex (PFC) 
glutamate release relevant to schizophrenia and stimulant abuse comorbidity
381
. Modulation of 
glutamatergic transmission by ethanol has also been demonstrated in a rat model of FASD
382
. 
Perinatal alcohol exposure induces subtle differences in hippocampus-dependent spatial learning, 
accompanied by glutamate transmission-related gene expression in the adult hippocampus
383
. 
The UPR regulates glutamate receptor export in the ER
384
; glutamate regulation is important for 
FASD-related behaviours. Genes such as Homer1 are relevant in the maintenance of FASD-
related phenotypes, such as spatial learning. The ER is also involved in storing and releasing 
calcium for the biosynthesis of lipids and sterols. This is relevant given that calcium signaling 
was identified as a disrupted process in T2-L using IPA and Pathway Express. Tbxa2r, Ighg, and 
162 
 
 
 
Troponin C type 1 (slow) (Tnnc1) are each implicated in calcium signaling. Calcium signaling is 
related to FASD since prenatal ethanol exposure alters calcium signaling in neurons that are 
responsible for directing cellular activity and survival, thereby leading to apoptosis in the 
developing brain
385
. Given that neural cell proliferation and migration occurs in the second 
trimester, it is likely that calcium signaling may be disturbed. The top IPA network contains 
most of the genes that were characterized in ER- and protein-related functions including: Hspa5, 
Dnajb11, Pdia4, Pdia6, Xbp1, and FK506 binding protein 2, 12kDa (Fkbp2) (Figure 22). In this 
network, it appears that the downregulation of Xbp1 may lead to the downregulation of other 
genes including, Hspa5, Sdf2l1, Pdia4, Pdia6, Dnajb11 and Fkbp2. Given these interactions, 
Xbp1’s regulation may be important in the maintenance of FASD-related phenotypes. A 
network-based model for this interaction is shown in Figure 29. XBP1 is reported to regulate a 
subset of ER resident chaperone genes, including Hsp40-like genes (Dnajb11), in the UPR
386
. 
Given that Xbp1 is highly expressed in neurites during neurodevelopment, through the induction 
of Brain-derived neurotropic factor (BDNF)
387
, its role in the maintenance of FASD is possible. 
ER stress plays a role in the pathogenesis of several other neurological diseases such as 
Alzheimer’s Disease and Parkinson’s Disease388,389. As a key TF in the UPR pathway, XBP1 has 
been implicated in the pathophysiology of many neurodevelopmental disorders, such as 
schizophrenia
390
. Another gene, Manf, is downregulated in the second IPA network (Figure 23). 
Given that MANF acts as a neuroprotective molecule by reducing ER stress
240
, MANF’s 
downregulation could contribute to maintenance of FASD-related features impacted by ER 
stress.  
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Figure 29. A network-based model for the interaction of second-trimester disrupted 
molecules and their implication in FASD-relevant cellular processes and behaviours. Black 
arrows indicate a molecule’s interaction. A dashed arrow represents a correlation between a 
molecule and a behaviour. Red arrows indicate downregulation. Redox = reduction/oxidation. 
ER = endoplasmic reticulum. Molecular symbols are generated from Ingenuity Pathway Analysis 
(IPA). Refer to Appendix F for a full legend of molecular shapes from Ingenuity Pathway 
Analysis. X-box binding protein (XBP1) is represented by a “transcription factor” IPA symbol. 
FK506 binding protein 2, 13kDa (FKBP2), Protein disulfide isomerase family A, member 6 
(PDIA6), Protein disulfide isomerase family A, member 4 (PDIA4), and Heat shock 70kDa 
protein 5 (glucose-regulated protein, 78kDa) (HSPA) are represented by an “enzyme” IPA 
symbol. Stromal cell-derived factor 2-like 1 (SDF2L1) and DnaJ (Hsp40) homolog, subfamily B, 
member 11 (DNAJB11) are represented by an “other” IPA symbol. 
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  b) Long-term (T2-L) process 2: immunity 
Immune system response is another disrupted process following second trimester ethanol 
exposure. Given that the immune response is also compromised following ethanol treatment in 
the first trimester (T1-L), and immediately following ethanol administration in the second 
trimester (T2-S), this may represent a general process that is disputed no matter the timing or 
developmental stage of exposure. Figure 30 illustrates the T2-S, T1-L, and T2-L DEGs that 
were involved in immune response. DAVID clustering analysis resulted in “systemic lupus 
erythematosus” as a significantly affected KEGG pathway, which included several histone 
genes, Ighg, and Ptpn22 (Table 19). These results are consistent with IPA functional analysis 
that implicated SLE as a top function under “Inflammatory Disease” (Table 21). T cells are 
defective in individuals with SLE
391
. Researchers have reported lowered T cell numbers in fetal 
mice exposed to ethanol; however, the ability of T cell levels to “catch up” to normal levels was 
reinstated in adulthood
392
. Other have reported that, as young adults, mice prenatally exposed to 
ethanol displayed immunological changes including depressed ability to produce cellular 
immune responses and altered synaptic transmission
393
. Such studies support my hypothesis that 
the immune system is compromised, even into adulthood, following in utero ethanol exposure. 
Of the top three networks in T2-L, the first network is relevant to immunity, and includes, 
Cdkn1a, Xbp1, Ptpn22, Hist1h3a and all other histone genes, which are all downregulated 
(Figure 22). XBP1 is a downstream target of Inositol-requiring transmembrane 
kinase/endonuclease-1 (IRE1α), which is a UPR element that senses bacterial proteins invading 
the ER to activate innate immune signaling
394
. Mice deficient in XBP1 show greater bacterial 
burden than control mice once infected with a pathogen, which implicates XBP1 in mammalian 
host defense
395
. Herein, Xbp1 ― possibly influenced by other factors such as IRE1α ― may be 
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an important player in maintaining a compromised immune system into adulthood. 
Downregulation of other genes resulting from downregulation of Xbp1 may represent an 
important cascade of events that together lead to compromised immunity in FASD. Another 
gene, Homer1, was downregulated in the third IPA network (Figure 24). Its interaction with IL-
5, which is a cytokine that participates in the regulation of immune response, may suggest that 
immunity is compromised by IL-5’s action on Homer1.  
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Figure 30. Immune genes altered in the fetal (immediate) and adult (late) brains following 
binge ethanol exposure in the first and second trimesters. Differentially-expressed genes 
identified using Partek Genomics Suite. Upregulated (green) and downregulated (red) genes are 
shown for each group. T2-S = trimester two treatment, short-term exposure. Fetuses were 
exposed to ethanol at gestational day (GD) 16, and fetal brains were isolated two hours post 
maternal injections. T2-S genes included: Chemokine (C-C motif) ligand 3 (Ccl3), Cyclin T1 
(Ccnt1), and Leukocyte-associated immunoglobulin-like receptor 1 (Lair1). T1-L = trimester one 
treatment, long-term exposure. Fetuses were exposed to ethanol at GD 8 and 11. T1-L genes 
included: (Atf1), Carcinoembryonic antigen-related cell adhesion molecular 1 (biliary 
glycoprotein) (Ceacam1), Eomesodermin (Xenopus laevis) homolog (Eomes), Major 
histocompatibility complex, class I, E (H2-T23), Mitogen-activated protein kinase kinase kinase, 
E3 ubiquitin protein ligase (Map3k1), Tumor necrosis factor receptor superfamily, member 19 
(Tnfrsf19), and pre-B lymphocyte 1 (Vpreb1). T2-L = trimester two treatment, long-term 
exposure. Fetuses were exposed to ethanol at GD 14 and 16. T2-L genes included: Core-binding 
factor, runt domain, alpha subunit 2; translocated to, 3 (Cbfa2t3), Cyclin-dependent kinase 
inhibitor 1a (Cdkn1a), Early growth response 3 (Egr3), Homer homolog 1 (Drosophila) 
(Homer1), Heat shock protein 90kDa alpha (cytosolic), class A member 1 (Hsp90aa1), Integrin, 
alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4), Protein tyrosine 
phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), Peroxiredoxin 1 (Prdx1), Sprouty-
related, EVH1 domain containing 2 (Spred2), Thromboxane A2 receptor (Tbxa2r), and X-box 
binding protein 1 (Xbp1). Adult brains from T1-L and T2-L were isolated at postnatal day (PD) 
70. 
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  c) Long-term (T2-L) process 3: chromatin stability 
Evidence for the role of epigenetics and histone modifications in FASD arises from T2-L 
functional and pathway analysis. As identified in the fetal brain following second trimester 
ethanol exposure (T2-S), chromatin stability is also a disrupted process in the adult brain 
following trimester two ethanol exposure (T1-L). Along with all histone genes, SWI/SNF related, 
matrix associated, actin dependent regulator of chromatin, subfamily A, member 5 (Smarca5) is 
involved in the maintenance of chromatin structures during DNA replication (Table 19). The 
histones, along with Cdkn1a, are also involved in “transcriptional misregulation in cancer” 
(Table 23). The role of chromatin remodeling has been implicated in genome stability
396
, and 
has been heavily discussed in terms of cancer
397,398
. Like cancer, damage to cellular development 
and organization occurs following prenatal alcohol exposure. Identification of pathways involved 
in cancer is reasonable. IPA network analysis of T2-L genes resulted in Cdkn1a, Smarca5, and 
several histones implicated in the first network (Figure 22). Given each of their interactions with 
the E2f transcription factor complex, their dysregulation may affect each other’s regulation. 
Smarca5 is upregulated and directly acts on E2f, which leads to a downregulation in histones. 
Cdkn1a indirectly acts on E2f, which may also lead to the downregulation of histones. The 
combination of a decrease in Cdkn1a and an increase in Smarca5 may, through E2f, lead to a 
disruption in histones. Given that E2f members play important roles in the cell cycle, it is 
presumable that histones, Cdkn1a, and Smarca5 ― which are involved in chromatin formation 
― would be disrupted. Mutations in SMARCB1, which is the a member from the same family as 
SMARCA5, leads to epigenetic dysregulation of chromatin in individuals with intellectual 
disabilities
399
. Similarly, Smarca5 could play a role in regulation of chromatin structure, which 
may be disrupted following damage due to ethanol. The role of chromatin remodeling in 
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neurodevelopmental disorders has not been extensively examined to date. Researchers have 
reported disruption of chromatin-remodeling factors in studies on prenatal alcohol exposure and 
FASD
400,401
. Only recently have researchers investigated epigenetic modification of chromatin 
structure ― which controls gene transcription ― in neurons, as a mechanism in the etiology of 
intellectual disability
399,402
. Further studies examining ethanol’s effect on chromatin stability may 
offer insight into the biological underpinnings of FASD.  
d) Long-term (T2-L) process 4: free radical signaling 
A final mechanism that is disrupted in the adult brain following second trimester ethanol 
exposure is free radical signaling. Proper cellular maintenance is disrupted following prenatal 
alcohol exposure. Pdia4, Pdia6 and Prdx1 have been implicated in reduction-oxidation (redox) 
processes from DAVID and GE analyses (Tables 19-20). Knockout of Prdx1 results in an 
increased need for double stranded break repair due to increased accumulation of highly reactive 
OH• radicals403. Given Prdx1’s role in erythrocyte antioxidant defence and tumor suppression404, 
its downregulation as a result of ethanol exposure is reasonable. Researchers have yet to examine 
whether ethanol disrupts Prdx1 levels directly. Polymorphisms in another gene, Itga4, have been 
associated with susceptibility to multiple sclerosis (MS) and autism, which show comorbidity 
with FASD
405,406
. Both MS and autism have been linked to oxidative damage
407,408
. The 
PI3K/AKT signaling pathway was implicated as a top canonical pathway from IPA (Table 24). 
Reactive oxygen species (ROS) via redox signaling to the PI3K/AKT pathway contribute to 
mammalian growth of epithelial cells
409
. The PI3K/AKT pathway may be an important disrupted 
process in the adult brain following gestational ethanol exposure. Alterations to free radical 
signaling, associated with oxidative stress, are mechanisms by which ethanol exerts its long-term 
effects on the brain following mid-gestation ethanol exposure. The role of oxidative stress in 
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FASD is well-established in the literature
44,45,410,411
. Prenatal ethanol exposure causes an increase 
in oxidative stress, particularly in the brain
410,411
. Even a brief exposure to ethanol during 
gestation can produce an imbalance in the brain’s intracellular redox state412. Such imbalances in 
proper brain-related redox maintenance correlate with FASD-relevant spatial learning deficits
413
. 
Therefore, FASD-related behavioural deficits may result from damage to cellular redox, 
including ROS. 
e) Confirmation of T2-L-specific genes using qRT-PCR 
Quantitative RT-PCR resulted in confirmation of DEGs from T2-L analysis (Table 28). 
The downregulation of Calcium/calmodulin-dependent protein kinase 1G (Camk1g), Cdkn1a
158
, 
Manf
158
, Egr3, Ccdc6, Xbp1, and Hspa5 was confirmed. Although statistically significant by 
qRT-PCR, Homer1 and Hsp90aa1 were increased in ethanol samples compared to control 
samples, which is opposite to the array results. Tbxa2r was the only gene that did not confirm. 
Other researchers suggest that qRT-PCR is not sensitive to detect fold changes lower than 
2.0
414,415
, which could be a potential contributing factor to these results.  
f) Alteration of microRNAs following second-trimester ethanol exposure 
i. General trends in alteration of mouse-specific miRNAs  
 The results from mouse miRNA arrays show that second trimester ethanol exposure 
affects miRNA expression in the adult brain. Since only 20 mature, mouse-specific miRNAs out 
of ~1000 were significantly affected (± 1.2-fold change, p < 0.05), the results are not stringent 
enough to make conclusions on array data, as discussed for T1-L. The results from T1-L and T2-
L analyses suggest that alterations to specific miRNAs are dependent on the timing of gestational 
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ethanol exposure. There were no miRNAs in common between T1-L and T2-L, which signified 
the timing-specific effects of ethanol on miRNA expression.  
ii. Candidate mouse-specific miRNAs in T2-L 
In T2-L, target filtering using IPA resulted in six differentially-expressed miRNAs 
known to interact with mRNAs (Table 30). Ten genes were identified to interact with these six 
miRNAs, all of which were downregulated. Twelve interactions were found between genes and 
miRNAs. Only one interaction exhibited an inverse relationship between mRNA and miRNA: 
decreased Ccdc6 and increased miR-302c. The upregulation of miR-302c was confirmed by 
qRT-PCR. Similar to T1-L, one miRNA (i.e. miR-449b) can have multiple target mRNAs (i.e. 
Cbfa2t3, Galnt7, and Xbp1), and one gene (i.e. Ccdc6) can be regulated by multiple miRNAs 
(i.e. miR-146b and miR-302c). Unlike T1-L miRNA results, most miRNAs in target filtering 
analysis were downregulated. This inconsistency lends to the timing-specific effects of prenatal 
ethanol exposure. The downregulation of miRNAs as a result of ethanol exposure has been 
reported by other researchers
174,367
.  
Given that in T2-L analysis, Ccdc6 is the only gene with an inverse relationship to a 
miRNA, its confirmation by qRT-PCR was pursued. Recently, Merolla and colleagues identified 
CCDC6, a pro-apoptotic phosphoroprotein, to be responsive to genotoxic stress; genotoxic stress 
is defined as damage to the genome of an organism as a result of a genotoxin
234
. Increased 
genotoxic stress has been linked to teratogenic substances, including ethanol
416
. Increased stress 
can lead to disruption of signal transduction pathways that regulate cell cycle progression and 
DNA stability
417
. DNA stability, specifically chromatin stability, and cellular redox, were 
disrupted processes following prenatal ethanol administration during the second trimester. As the 
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only target-filtered miRNA, miR-302c was confirmed using qRT-PCR (Figure 27). The miR-
302 cluster has been identified as a key family of miRNAs involved in embryonic stem cell-
specific cell cycle regulation and reprogramming of both human and mouse embryonic 
fibroblasts
418,419
. MiR-302c and Ccdc6 are involved in DNA damage and stability, which is 
impacted in trimester two following in utero ethanol exposure; thus, their relationship is relevant 
to FASD. MiR-302c directly contributes to regulation of p21 (CKDN1A) expression in human 
embryonic stem cells, thus illuminating its role in governing G1/S transition checkpoint during 
DNA damage
420
. Cdkn1a, whose expression was confirmed by qRT-PCR, was also identified in 
target filtering analysis, albeit not for its relationship with miR-302c.  
4.2.5 Hub genes may identify gene sets altered following prenatal ethanol exposure  
Following the interpretation of specific cellular processes that are disrupted in each 
treatment (T2-S, T1-L, and T2-L), I further examined the hub molecules in a merged network 
analysis of each group. An investigation of these hubs, and their interactions with DEGs, may 
illuminate potential cellular processes that are relevant to FASD. Some of the mechanisms of 
these hub genes may overlap with processes identified in functional, pathway, and network 
analyses. Examination of hubs may help to identify any overarching gene sets that are disrupted 
following prenatal ethanol exposure. Identification of specific gene sets and processes via hub 
molecules may help to elucidate the underlying mechanisms governing FASD.   
a) Short-term hub molecules following second-trimester ethanol exposure (T2-S) 
The top two merged networks from short-term analysis with > 10 genes showed that FOS 
and HTT were hub molecules (Figure 17). FOS was found to directly interact with PIP5K1B, 
which is involved in postsynaptic neuronal signaling and has been implicated in autism spectrum 
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disorders
222
. HTT directly interacts with two factors: HPCA and BCAP31. Bcap31 is involved in 
a variety of cellular processes including fragmentation of mitochondria, mitochondrial calcium 
ion concentration, embryonic development, free radical scavenging, apoptosis, and immune 
response. Given that HTT directly affects both upregulated (HPCA) and downregulated 
(BCAP31) molecules, this lends to the complexity of gene expression alterations underlying 
FASD. FOS and HTT are involved in apoptosis in the developing brain, and neuronal survival 
during brain development, respectively; their immediate responses to heavy doses of ethanol are 
expected. 
Another hub molecule from T2-S is Interleukin 4 (IL-4), which is an inflammatory 
interleukin linked with autism
421
. Disruption of proinflammatory cytokines may impair 
cognition
422,423
. Compromised immune activity in the CNS is considered detrimental to cognitive 
function. An IL-4 deficiency in mice leads to severe cognitive impairment and reductions of 
BDNF mRNA production in astrocytes
424
. IL-4 acts on Small proline-rich protein 2A 
(SPRR2A) and CCL3, which are upregulated in the merged network. Ccl3 is involved in many 
functions including: muscular dystrophy; microglial, astrocyte and dendrite development; and 
immune response. CCL3’s interaction with interleukins may be an important mechanism by 
which ethanol exerts its effects. Or, IL-4 may result in increased expression of Sprr2a and Ccl3 
as a protective mechanism against ethanol teratogenicity.  
Other hubs in the T2-S network, such as TNF, NFkB, and Amyloid beta (A4) precursor 
protein (APP) also act on the upregulated factor, CCL3. TNF, NFkB and APP are involved in 
regulation of hippocampal synaptic plasticity and synapse formation
425,426
. Studies suggest that 
NFkB and APP also have important roles in learning and memory in mice by modulation of 
synaptic plasticity and growth of dendrites
426,427
. Because of their roles in hippocampal memory 
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formation, TNF, NFkB, and APP are prime candidates for FASD. Cellular processes related to 
TNF, NFkB, and APP are consistent with the known processes of disrupted genes (eg. Ccl3). 
APP’s well-defined role in cognitive decline in Alzheimer’s disease also makes it a suitable 
candidate for other neurodevelopmental disorders
428
. Both TNF and NFkB also interact with 
Crem, which is one of the few downregulated genes in the IPA network. The interactions 
between these genes point to the complexity in immediate responses of the fetal brain as a result 
of ethanol exposure. Another apoptosis factor affected in T2-S, Tumor protein 53 (TP53), has 
direct effects on TDG, which is upregulated. TP53 is a tumor suppressor protein that functions in 
apoptosis and genomic stability, and is often associated with cancer
429
. This hub directly affects 
TDG, an enzyme that corrects DNA mismatches. An upregulation in Tdg likely occurs 
immediately following ethanol exposure, particularly if cells are attempting to increase this 
repair enzyme. Ethanol exposure can result in DNA damage
430
. An increase in Tdg, which 
interacts with a central regulator of DNA damage (TP53), may be beneficial to the fetus, as an 
attempt to decrease DNA damage.      
b) Long-term hub molecules following first-trimester ethanol exposure (T1-L)  
Merged network analysis of T1-L was not carried out, given that only one network with > 
10 genes was implicated (Figure 19). Network one contained three hub molecules, one of which 
was IFNG. IFNG has 18 interactions with other genes, three of which include the downregulated 
molecules, CEACAM1, MAP3K1and HLA-E (i.e. H2-T23). H2-T23 acts indirectly on IFNG. 
IFNG itself acts indirectly on CEACAM1 and MAP3K1. Along with interleukins, Interferon 
gamma, an inflammatory cytokine, has been implicated in neurodevelopmental disorders 
including autism and schizophrenia
431–433
. IFNG is increased at mid-gestation in women bearing 
children with autism
421
. The immune system is compromised in children with FASD
353,434
, and in 
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animal models of FASD
435,436
. Given its role in immunity, IFNG may be a key player in the 
maintenance of alcohol-related transcriptome changes. H2-T23 and MAP3K1 are involved in 
HTLV-I Infection, while CEACAM1 and MAP3K1 are involved in regulation of MAPK 
activity. Downregulation of H2-T23 and MAP3K1 in this network, through IFNG, may lead to 
compromised cell immunity.  
Also considered as hubs in T1-L, PPARα and PPARγ have > 10 interactions with other 
genes in the network. The upregulated molecule, Major urinary protein 5 (Mup5), is directly 
acted upon by PPARα, whereas Mup5, itself, acts indirectly on PPARγ. PPARα and PPARγ both 
act directly on HMGCS2, which is downregulated, and PPARγ also acts directly on PCNA. 
PPARs function in metabolic pathways as transcription regulators of gene expression, and play 
important roles in cellular differentiation, development, tumorigenesis, and metabolism
437
. 
PPARs provide nuclear control of lipid metabolism and inflammation
437,438
. PPARs have been 
implicated in cancer, and, most recently, childhood obesity
439,440
. Following prenatal ethanol 
exposure, these hub molecules could disrupt other genes. In this network, PPARs may contribute 
to the downregulation of HMGCS2 and PCNA. HMGCS2 and PCNA are involved in 
ketogenesis (fatty acid breakdown) and base-excision repair (DNA damage, cancer), 
respectively. Tumor Necrosis Factor-alpha, Extracellular signal-regulated kinases (ERK), c-Jun 
NH(2)-terminal kinases (JNK) and p38 MAPKs each regulate PPARs. The regulation between 
these factors adds to PPARs’ diverse roles in cell signaling441. Mup5, which is involved in fatty-
acid binding, is upregulated in coordination with the downregulation of PPARs. This relationship 
further illustrates the complexity of adult genetic interactions disrupted following prenatal 
ethanol exposure in the first trimester. 
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c) Long-term hub molecules following second-trimester ethanol exposure (T2-L) 
Merged network analysis of the top three networks from T2-L by IPA included a list of 
11 hub molecules (Figure 25). The hubs included CDKN1A and XBP1. Previous functional 
analysis identified that CDKN1A plays a role in PI3K/AKT signaling. PI3K/AKT signaling is an 
important pathway for apoptosis, so CDKN1A’s importance as a central hub molecule is relevant 
especially since neuronal apoptosis occurs following prenatal ethanol exposure
50,53,54,442
. XBP1 is 
important for initiating UPR in neurites
242
. Dysregulation of XBP1 can affect neurite outgrowth 
during the first trimester. In the merged network, CDKN1A was found to bind to HSP90AA1, 
and interact indirectly with Prolyl 4-hydroxylase, alpha polypeptide I (P4HA1). XBP1 was found 
to interact directly with six genes (Figure 25). The downregulation of XBP1 may be influencing 
the downregulation of multiple genes, some of which are involved in ER-related functions, 
particularly ER stress response. This cascade would likely contribute to ER-induced damage 
following mid-gestation ethanol exposure, which is maintained into adulthood.  
Similar to T1-L, IFNG is a hub molecule in T2-L analysis that includes interactions with 
three downregulated genes including: GCHFR, CDKN1A, and EGR3. Given its previously 
discussed role in inflammation, it is logical that prenatal ethanol exposure at any gestational time 
during would compromise the immune system. Of the hub molecules in Figure 25, FOS, HTT, 
ERK1/2, IL5, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neruo/glioblastoma 
derived oncogene homolog (avian) (ERBB2), and Polyketide synthase (Pkc) interacted with give 
or more input genes (DEGs), signifying the dynamic reach of each of these hubs. Erbb2 is a 
receptor for neuregulins. Erbb2 has been implicated as a regulator of neuromuscular synapse 
formation and is an essential component for muscle spindle development
443
. In T2-L functional 
analysis, muscle spindle development was a disrupted process. As described for T1-L and T2-S, 
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interleukins are important for proper immune system response
431
. In addition to IL-4 (T2-S), IL-
5 was implicated in children with autism
421
. Given that IL5 has been associated with 
neurobehavioural and motor disturbances upon neonatal infection
444
, its role as a central hub 
molecule in second trimester ethanol exposure is reasonable. Another set of hubs includes the 
PKS genes, which are involved in fatty acid biosynthesis
445,446
, which is an affected process in 
T1-L. The PKS hub genes may be relevant in establishing ethanol-induced abnormalities in the 
fetus following both early and late-gestation exposure.  
ERK1 and ERK2 are part of another hub in T2-L (Figure 25). These kinases comprise a 
specific subset of MAPKs that are involved in cell proliferation and growth signaling
447
. 
Disruption of ERK genes is common in cancers
448
. Trimester two is an important time for cell 
growth and proliferation. Some of the merged network interactions between ERK1/2 and DEGs 
involve those implicated in cellular development, cell death and cellular compromise (Xbp1, 
Cdkn1a, Hspa5). The importance of the ERK pathway is relevant in the maintenance of 
neurodevelopmental outcomes.  
Commonly referred to as c-Fos, FOS is also a central hub molecule in this merged T2-L 
network. FOS was also a hub in T2-S. Given that ethanol was administered at GD 16 for both 
treatments, this similarity is understood. It is interesting to find that the same hub genes are 
affected during the fetal stage, and even into the adult stage. As a proto-oncogene, c-Fos 
contributes to apoptosis in the frontal cortex and hippocampus
449
. Apoptosis in these brain 
regions is relevant to the pathogenesis of schizophrenia, particularly in negative symptoms 
including decreases in reactivity, volition (will) and goal-directed activity upon stress
450,451
. In 
the merged network, FOS interacts with XBP1, in which polymorphisms have been implicated in 
the pathogenesis of schizophrenia in humans
390,452
 and in mouse models of schizophrenia
243
. 
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Given that XBP1 may downregulate other genes implicated in neurodevelopmental disorders, it 
is reasonable that its apoptotic properties are important in the development and maintenance of 
FASD.  
Another interesting hub molecule in T2-L, HTT, interacts directly with five DEGs, and 
binds with P4HA1 (Figure 25).  HTT is involved in neuronal migration and survival during 
brain development
453
; its implication as a central hub in FASD is both novel, and not surprising, 
given its brain-related role. Its interaction with HOMER1, which is involved in working memory 
and spatial navigation, along with its implication in behavioural despair and anxiety, further adds 
to the evidence surrounding its importance in the pathogenesis of neurodevelopmental 
disorders
237
. Each of the T2-L hub molecules play relevant roles in brain-related functions and 
their implications in FASD are well-founded. 
4.3 Limitations of molecular studies on FASD 
 Using a mouse model to study molecular mechanisms underlying complex disorders, i.e. 
FASD, has limitations. Although minimal guidelines are set out for microarray-based gene 
expression studies
454,455
, it is difficult to find consistency in array design. For instance, I used two 
biological replicates (arrays) for my experimental design, whereas three biological replicates are 
considered as the minimum standard amongst researchers. To overcome such limitations, I 
pooled three samples on each array. In addition to biological replicates, the industry standard 
requires technical replicates. It was not feasible to include more than one technical replicate in 
the array design. However, qRT-PCR of specific genes included three technical replicates per 
biological sample, which offers reproducibility of results
456
. Another caveat to my study includes 
the exclusion of one biological replicate (ethanol, T2-L) in qRT-PCR confirmation experiments. 
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I chose to discount this sample due to a low A260/A280, indicating possible contamination or 
degradation of RNA. Given that six samples are standard in qRT-PCR confirmation
456
, my 
results from this analysis do not meet industry guidelines. A final caveat to molecular studies 
includes disuse of a FDR-corrected p-value to create the ANOVA gene lists. A FDR is a 
standard correction for multiple testing (i.e. false positives), which is a key issue in 
microarrays
457
. The exclusion of a FDR was necessary in my study because there were no 
differentially-expressed genes using a 1.1-fold change cut-off with an FDR-corrected p < 0.05. 
Because I did not use a multiple testing correction strategy, my array results likely contain > 5% 
false positives. Although these sources of error may impact the results, I have attempted to 
overcome these limitations, and caution the reader on the existence of such caveats.    
Other than the technical limitations of my study, it should also be noted that a different 
set of genes was identified in a downstream analysis of 12 arrays. These 12 arrays included my 
eight long-term arrays (n=4 trimester one, n=4 trimester two) that were analyzed in Partek with 
another set of four long-term (trimester three) arrays. A 12-array analysis was pubished by our 
group in the Journal of Neurodevelopmental Disorders (see Co-authorship statement for 
details)
158
. Although the methods in this publication included the use of the same eight long-term 
arrays that were discussed in this thesis, the 12-array analysis resulted in the identification of 
substantially more DEGs. Since 12-array data was included in a single analysis in the publication 
― whereas data from each trimester was generated separately for this thesis  ―  the results 
differ. Even with a FDR correction for multiple testing, our publication reported 195 and 231 
DEGs in trimester one and two, respectively, using the same cut off criteria (p < 0.05, ± 1.2-fold 
change). Given the inconsistency of the results, it is relevant to comment on why such 
differences may be observed. A 12-array comparison across ethanol and control arrays would 
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provide greater statistical power to generate real differences between groups. The specific genes 
that were differentially-expressed were largely different from those reported in this thesis. This 
inconsistency reflects increased statistical power in detecting real differences that resulted from 
increased sample size (3-fold). It must also be noted that, although the number of DEGs was 
increased in our publication, the fold-changes were subtle (most 1.1-1.5-fold), which is similar to 
the pattern of differential expression in my thesis. Also, a 12-array comparison is more robust 
than a 4-array comparison. The findings from our publication may represent a more robust gene-
set, whereas those from my thesis may represent a more relaxed gene-set, with increased 
potential for false positives.   
It is difficult to rectify the discrepany across results from two different sets of analyses. 
However, although different gene-sets were established, a comparison at the network-level (IPA) 
may offer an encouraging explanation. In both 12-array and 4-array analyses, trimester one 
pathways and networks were involved in cellular development, cell death, G-protein coupled 
receptor signaling, and fatty acid biosynthesis. Again in both sets of analyses, trimester two 
networks were involved in neurological disease, with APP, HTT and FOS as hub molecules. 
Furthermore, common trimester two canonical pathways included ER stress response and 
calcium signaling. Given the comprehensive nature of the results using a 12-array analysis, one 
may expect larger networks with a greater number of hub genes. The results from my thesis are 
functionally similar to those in our publication, but on a smaller scale. The downstream network 
analyses in my thesis are therefore consistent with those in our publication. It should also be 
noted that the results from both sets of analyses represent subtle changes to the brain 
transcriptome, affecting similar functions, pathways, networks, and cellular processes. Given the 
robust nature of our publication results, one might expect that confirmation of specific genes 
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using qRT-PCR would be more in-line with our publication results. However, the opposite may 
also be true. Comparing my 4-array analyses with the 12-array analysis, there were four genes 
(Tnfrsf19, Trdn, Vpreb1, Zfp763) in common for trimester one, and three genes (Cdkn1a, 
Hist1h2bm, Manf) in common for trimester two. Therefore, one must interpret microarray data 
with caution, no matter the stringency of the criteria. It is possible that false positives may occur 
regardless of statistical procedures. Given the inconsistent nature of microarray data, 
confirmation techniques are necessary to provide reliable and reproducible results. Ultimately, 
the main goal of microarrays is to identify functional relationships and cellular processes that are 
disrupted following a specific treatment, and not necessarily the identification of specific genes. 
4.4 Prenatal ethanol exposure and its relevance to behaviours, genes, and miRNAs 
In the long-term analyses, a relationship between FASD-relevant behaviours and changes 
in the transcriptome can be inferred. Behavioural deficits including, developmental milestones, 
activity, and spatial learning are generally impaired no matter the timing of gestational ethanol 
exposure. However, there are some behavioural differences. Trimester two ethanol exposure 
resulted in timing-specific behaviours including decreased anxiety-like behaviours and consistent 
spatial learning deficits in ethanol versus control mice. Whereas, trimester one ethanol mice had 
no changes in anxiety-related behaviours compared to control counterparts. In T1-L, specific 
genes (Atf1 and Stxbp6) were found to have an inverse relationship with miR-532-5p. Given that 
miR-532-5p is involved in inflammatory response
368
, and may downregulate a variety of genes 
including Atf1, Stxbp6, and Itpripl2, this may lead to the overwhelming support for compromised 
immune system following early gestational ethanol exposure.  Compromised immune system has 
been associated with a range of cognitive and emotional effects in offspring
458
. Given the 
disruptions in activity-related traits in trimester one ethanol mice, these results may point to 
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maintained transcriptome changes, including specific miRNAs, which may govern these 
behaviours into adulthood. In T2-L, only one gene, Ccdc6, was found to have an inverse 
relationship with the upregulated miRNA, miR-302c. Given miR-302c’s role in DNA damage, 
specifically in the maintenance of embryonic stem-cell cycle regulation of fibroblasts
419,459
, this 
miRNA can interfere with second trimester specific processes that involve cellular maintenance 
and development. Also, the upregulation of miR-302c could lead to a downregulation in specific 
genes such as Ccdc6. Given Ccdc’s role as a pro-apoptotic phosphoprotein in response to 
genotoxic (i.e. ethanol) stress
234
, the commonality of DNA damage in this miRNA:mRNA 
relationship is apparent. Furthermore, researchers have suggested that DNA damage in brain 
cells can produce locomotor disturbances and learning and memory delays
460
. My results are 
consistent with these findings, and point to a relationship between specific behaviours 
(locomotor activity, learning and memory), genes (Ccdc6), and miRNAs (miR-302c) that may 
play a role in maintaining disrupted cellular processes (DNA damage). A model of the 
interaction between miR-302c and Ccdc6, and their potential influence of neurodevelopment and 
behaviour is shown in Figure 31. 
 
 
 
 
 
 
182 
 
 
 
 
 
 
 
 
Figure 31.  The molecular interaction between miR-302c and Ccdc6, and their potential 
implication for FASD-relevant cellular processes and behaviours. Alignment equences of 
microRNA 302c (miR-302c) and Coiled-coil domain containing 6 (Ccdc6) were idenitifed using 
TargetScanMouse 5.2 (http://www.targetscan.org/mmu_50/). Binding of miR-302c to Ccdc6 was 
predicted using TargetScanMouse. Red arrows indicate expression. A red “X” indicates 
blocking. Dashed arrows indicate correlation. Dark red line represents miR-302c. UTR = 
untranslated region.  
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4.5 Conclusions and implications 
4.5.1 Prenatal ethanol exposure leads to behavioural and transcriptomic alterations in 
the mouse brain  
 From the behavioural experiments gathered in this report, prenatal alcohol exposure, 
independent on timing of exposure, leads to FASD-relevant behavioural abnormalities in B6 
mice. These mice are delayed in the achievement of developmental milestones, particularly those 
related to motor coordination, and show increased activity levels in response to their placement 
in a novel environment. Although all ethanol mice exhibit deficits in spatial learning and 
memory, their extent depends on timing of gestational alcohol exposure. It appears that, when 
exposed at late-gestation, ethanol young adults can “catch up” following repeated learning trials. 
Anxiety-related traits are not consistent between treatments, with second trimester exposed mice 
showing lowered anxiety-like behaviour compared to control mice; meanwhile, first trimester 
ethanol and control mice are not significantly different. Such a marked difference in timing of 
exposure is consistent with the spectrum of disabilities observed in individuals with FASD.  
The second set of experiments provided evidence that prenatal ethanol exposure leads to 
general alterations in the brain transcriptome, independent of timing of exposure. However, the 
specific genes that are altered are dependent upon timing of exposure. Furthermore, the 
characterized functions, pathways, and networks associated with the DEGs are consistent with 
disruptions of cellular and neurodevelopmental processes that occur at comparable stages of 
brain development. When comparing transcript levels between immediate exposure (fetal brain) 
and long-term (adult brain) effects of exposure, common processes related to DNA/chromatin 
stability, apoptosis, and inflammation are affected. Functioning of the immune system is a 
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disrupted process in all three treatments, indicating that it is compromised no matter of the 
timing or term of ethanol exposure. The confirmation of specific long-term genes involved in 
neurodevelopment and FASD-related behavioural phenotypes lends evidence to the functions 
that are maintained into adulthood. The results from gene expression analysis in this report 
provide further evidence that no time during gestation is safe from the teratogenic effects of 
alcohol on gene expression, and subsequent behavioural dysfunction.  
The final sets of experiments in this thesis included the analysis of global miRNA levels 
in the long-term brains of ethanol mice and resulted in relatively low numbers of affected 
miRNAs. However, given that miRNAs can target multiple genes, it is not unlikely that only a 
few key miRNAs would be affected, particularly long after ethanol had been introduced to the 
fetus. The relationship between miRNAs and their target mRNAs revealed the importance of 
processes involved in cellular development, proliferation, differentiation, and repair in the 
pathogenesis of FASD. Although these processes peak in middle to late gestation, the results 
show that they are extremely important developmental mechanisms that can be disrupted at any 
time following prenatal alcohol exposure and may lead to FASD-related abnormalities. The 
experiments completed in this thesis could be adapted to studying other complex disorders.  
 4.5.2 Implications for FASD: from mouse models to humans 
 The comprehensive nature of these results, which include behavioural testing and 
transcriptome ― including miRNA ― analysis of multiple treatment groups, allow for some 
conclusions to be made regarding the implications to FASD. The results generated from this 
study have helped to elucidate the molecular mechanisms that may take place immediately 
following gestational ethanol exposure, and transform into changes in adulthood. Genes and 
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processes affected in the short-term exposure may represent direct effects of ethanol. Meanwhile, 
genes and processes disrupted in the long-term may result from the indirect effect of ethanol on 
gene expression via microRNAs. These long-term alterations may lead to a molecular “footprint” 
in the adult. These results help to provide evidence that no time is safe from the consumption of 
alcohol during pregnancy. Furthermore, although there are differences in timing of ethanol 
exposure, the results still point to deficits in cognitive functions and brain-related transcriptome 
alterations that have the potential to last a lifetime. The developing brain undergoes an 
immediate response to an environmental teratogen (ethanol), and will never be the same, thereby 
leading to life-long impairments in motor skills, activity, and spatial learning in mice. Some of 
these abnormalities are reminiscent to those characterizing children with FASD. Also, certain 
brain-related processes, including inflammation and DNA damage, are disrupted in the fetal 
brains of mice exposed to ethanol in the womb. The results may further help to elucidate the 
molecular mechanisms underlying FASD-related abnormalities. Given that these experiments 
were successful in determining functions, networks, and miRNAs that are disrupted following 
ethanol exposure, they could be developed as biomarkers for identifying individuals with FASD.  
 4.5.3 Future directions  
 The results included in this thesis implicate gene expression alterations and miRNA 
disruptions in FASD-related abnormalities in mice. Such results offer novel approaches toward 
unraveling the biological mechanisms underlying FASD. The identified miRNAs and mRNAs 
related to the behavioural abnormalities may present novel targets for understanding of the 
mechanism involved in FASD. The disrupted miRNAs and mRNA may lead to the development 
of biological diagnosis, via biological markers, and subsequent therapies for individuals affected 
with this disorder. Biological markers such as hub genes or disrupted cellular processes, coupled 
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with maternal education and early, multidisciplinary intervention, may provide avenues to better 
prognosis of families and children with FASD. Early intervention, including environmental 
enrichment and improved maternal care have been reported to ameliorate some of the deficits 
associated with prenatal alcohol exposure
35,71,187
. Multidisciplinary therapy refers to the 
participation of multiple individuals in helping a child with FASD. Such individuals may include 
parents, teachers, psychologists, and other health care professionals. Children with FASD who 
have a strong, multidisciplinary support-system have improved performance in the classroom
30
. 
The coupling of maternal education, and early and multidisciplinary intervention, with a 
molecular seach for biological markers in FASD will lead to better diagnosis and prognosis for 
individuals suffering from this disorder. This approach can be applied to other complex disorders 
with fetal origin. 
I hypothesize that the observed changes in behaviours such as spatial learning are likely 
specific to particular brain regions. One of the candidate regions involves the hippocampus, 
which has been implicated in learning and memory
290,461
. Performing histological analysis of 
specific brain regions, staining for apoptotic neurons, and measuring transcriptomic and 
behavioural changes between control and ethanol-treated mice in a specific brain region may 
help to identify regional cell processes involved in specific behaviours. Once specific genes (eg. 
disrupted hubs) and microRNAs are identified, luciferase reporter assays or 
immunohistochemistry techniques, along with qRT-PCR confirmation, would provide evidence 
for specific miRNA:mRNA relationships altered as a result of prenatal ethanol exposure. 
Subsequent knockdown and transient overexpression experiments would further our 
understanding of specific molecular consequences on the developing fetal brain. Another brain 
region disrupted following prenatal ethanol exposure includes the cerebellum
53
.The cerebellum 
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is involved in motor control and cognitive functions including attention and language
259
. 
Performing a similar protocol on cerebellum samples from control and ethanol-exposed adult 
mice may help to explain the prolonged molecular effects of ethanol on life-long motor skill 
disabilities related to FASD. 
As mentioned, my findings may open avenues of correction by molecular manipulation 
of specific cellular pathways or network hubs (eg. MAPK signaling, PI3K/AKT signaling) in 
specific brain regions. Such manipulations may involve epigenetic regulation, as already 
suggested by other researchers
42,95,462,463
. Along with the disrupted miRNAs identified during the 
course of this research, additional results of DNA methylation and histone modifications could 
be insightful. Indeed, the involvement of miRNAs, DNA methylation, and histone modifications 
in prenatal ethanol exposure has been reported
95,464,465
. Epigenetic modifications may help to 
explain the underlying cause(s) of FASD, given their regulation of gene expression. In my study, 
I was able to identify and correlate specific neurodevelopmental genes and microRNAs with 
potential contributions to disruption in cellular processes and FASD-relevant behaviours. This 
brought-together a unifying theory that involved gene expression changes and gene regulation at 
the transcriptional level by microRNAs. It is well-known that the central dogma of molecular 
biology includes multiple gene regulatory levels. DNA methylation and histone modifications 
exert their effects on gene regulation at the post-transcriptional level. Post-translational 
modifications may also impact the stability of a protein once it is translated from a mRNA. An 
altered set of proteins may have consequences on neurodevelopment. It would be relevant to 
assess specific protein functioning following prenatal ethanol exposure using a Western blot. 
Additionally, a yeast-2-hybrid screen may provide relevant information regarding protein-protein 
dynamics, and how such interactions may lead to altered behaviours.  
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For inclusion in this thesis, I have examined the behavioural and gene expression changes 
associated with prenatal ethanol exposure. Furthermore, I have assessed gene regulation at the 
transcriptional level (miRNAs).  As outlined, an important next step would be to investigate 
other epigenetic mechanisms at differing levels of gene regulation. Epigenetic manipulation of 
genetic pathways that are disrupted following prenatal ethanol exposure may be useful in the 
development of novel corrective measures for individuals with FASD. 
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Appendix B. Differentially expressed genes (DEGs) in the fetal brain following prenatal 
ethanol exposure during the second trimester equivalent (T2-S). 
Transcript 
ID 
Gene Symbol
a
 mrna_assignment p-value Fold-
Change
b
 
10599884 
 
Slitrk2 
 
NM_001161431 // RefSeq // Mus 
musculus SLIT and NTRK-like family, 
member 2  
0.046 
 
1.429 
 
10592186 
 
Gm9896 
 
ENSMUST00000065197 // Gm9896 // 
predicted gene 9896  
0.004 
 
1.392 
 
10510191 
 
Zfp600 
 
NM_001177545 // RefSeq // Mus 
musculus zinc finger protein 600  
0.049 1.355 
 
10546706 
 
Rybp 
 
NM_019743 // RefSeq // Mus musculus 
RING1 and YY1 binding protein 
0.030 
 
1.351 
 
10600024 
 
Gpr50 
 
NM_010340 // RefSeq // Mus musculus 
G-protein-coupled receptor 50 
0.020 
 
1.336 
 
10473224 
 
Dusp19 
 
ENSMUST00000028384 // ENSEMBL // 
cdna:known 
chromosome:NCBIM37:2:80457202:804
71818:1gene 
0.045 
 
1.302 
 
10387816 
 
Rnasek 
 
NM_173742 // RefSeq // Mus musculus 
ribonuclease, RNase K (Rnasek) 
0.010 
 
1.301 
 
10460582 
 
AI837181 
 
ENSMUST00000159759 // ENSEMBL // 
cdna:known 
chromosome:NCBIM37:19:5425157:542
7313:1 gene 
0.036 
 
1.296 
 
10445107 
 
Gm4831 
 
ENSMUST00000174626 // ENSEMBL // 
cdna:pseudogene 
chromosome:NCBIM37:17:37250800:37
25139 
0.022 
 
1.279 
 
10519219 
 
Gltpd1 
 
NM_024472 // RefSeq // Mus musculus 
glycolipid transfer protein domain 
containing 1 
0.034 
 
1.276 
 
10548565 
 
Magohb 
 
NM_025564 // RefSeq // Mus musculus 
mago-nashi homolog B (Drosophila) 
0.047 
 
1.249 
 
10559486 
 
Lair1 
 
NM_001113474 // RefSeq // Mus 
musculus leukocyte-associated Ig-like 
receptor 1  
0.019 
 
1.247 
 
10493860 
 
Sprr2b 
 
NM_011469 // RefSeq // Mus musculus 
small proline-rich protein 2B  
0.030 
 
1.242 
 
10516544 
 
Hpca 
 
ENSMUST00000095807 // ENSEMBL // 
cdna:known 
chromosome:NCBIM37:4:128788814:12
8796211:-1 
0.033 
 
1.234 
 
10455112 
 
Pcdhb17 
 
NM_053142 // RefSeq // Mus musculus 
protocadherin beta 17  
0.008 
 
1.234 
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10473464 
 
Olfr1015 
 
NM_146571 // RefSeq // Mus musculus 
olfactory receptor 1015 
0.032 
 
1.229 
 
10378855 
 
Ssh2 
 
NM_177710 // RefSeq // Mus musculus 
slingshot homolog 2 (Drosophila)  
0.049 
 
1.228 
 
10389231 
 
Ccl3 
 
NM_011337 // RefSeq // Mus musculus 
chemokine (C-C motif) ligand 3  
0.034 
 
1.225 
 
10361818 
 
Nmbr 
 
ENSMUST00000020015 // ENSEMBL // 
cdna:known 
chromosome:NCBIM37:10:14480027:14
490389:1 gene 
0.040 
 
1.223 
 
10605507 
 
Zc3h18 
 
NM_001029993 // RefSeq // Mus 
musculus zinc finger CCCH-type 
containing 18  
0.042 
 
1.223 
 
10432180 
 
Ccnt1 
 
NM_009833 // RefSeq // Mus musculus 
cyclin T1  
0.014 
 
1.223 
 
10498500 
 
Vmn2r1 
 
NM_019918 // RefSeq // Mus musculus 
vomeronasal 2, receptor 1 
0.036 
 
1.222 
 
10373944 
 
Zmat5 
 
NM_026015 // RefSeq // Mus musculus 
zinc finger, matrin type 5  
0.022 
 
1.218 
 
10598169 
 
4930449I24Rik 
 
NM_001243109 // RefSeq // Mus 
musculus predicted gene 3404 
0.023 
 
1.218 
 
10584252 
 
Gm9513 
 
NM_001128510 // RefSeq // Mus 
musculus predicted gene 9513 
0.026 
 
1.214 
 
10352119 
 
Pppde1 
 
NM_024282 // RefSeq // Mus musculus 
PPPDE peptidase domain containing 1  
0.004 
 
1.212 
 
10350188 
 
Tmem9 
 
NM_025439 // RefSeq // Mus musculus 
transmembrane protein 9 
0.003 
 
1.208 
 
10606554 Nap1l3 NM_138742 // RefSeq // Mus musculus 
nucleosome assembly protein 1-like 3 
0.028 1.207 
10360664 
 
Gm10001 
 
NM_001081227 // RefSeq // Mus 
musculus RIKEN cDNA 6330403A02 
gene  
0.037 
 
1.206 
 
10430871 
 
Tdg 
 
NM_011561 // RefSeq // Mus musculus 
thymine DNA glycosylase  
0.042 
 
1.203 
 
10362426 
 
Trdn 
 
NM_029726 // Trdn // triadin // 10 A4 // 
76757 
0.032 
 
-1.907 
 
10457778 
 
Gm10551 
 
AK162814 // GenBank HTC // Mus 
musculus 16 days neonate thymus cDNA, 
RIKEN full-length  
0.007 
 
-1.333 
 
10398388 
 
Mir380 
 
NR_029881 // RefSeq // Mus musculus 
microRNA 380, microRNA  
0.006 
 
-1.331 
 
10398336 
 
Mir540 
 
NR_030260 // RefSeq // Mus musculus 
microRNA 540, microRNA  
0.042 
 
-1.323 
 
10436600 
 
Mir99a 
 
NR_029535 // RefSeq // Mus musculus 
microRNA 99a, microRNA  
0.003 
 
-1.309 
 
10411126 Jmy NM_021310 // RefSeq // Mus musculus 0.023 -1.302 
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  junction-mediating and regulatory protein    
10423505 
 
Cmbl 
 
NM_181588 // RefSeq // Mus musculus 
carboxymethylenebutenolidase-like 
(Pseudomonas)  
0.039 
 
-1.298 
 
10398334 
 
Mir337 
 
NR_029765 // RefSeq // Mus musculus 
microRNA 337, microRNA  
0.008 
 
-1.296 
 
10398338 
 
Mir665 
 
NR_030425 // RefSeq // Mus musculus 
microRNA 665, microRNA 
0.021 
 
-1.271 
 
10605081 
 
Bcap31 
 
NM_012060 // RefSeq // Mus musculus 
B cell receptor associated protein 31 
0.026 
 
-1.229 
 
10457834 
 
Nol4 
 
NM_199024 // RefSeq // Mus musculus 
nucleolar protein 4  
0.015 
 
-1.222 
 
10466779 
 
Pip5k1b 
 
NM_008846 // RefSeq // Mus musculus 
phosphatidylinositol-4-phosphate 5-
kinase, type 1 b 
0.014 
 
-1.222 
 
10513082 
 
D730040F13R
ik 
 
NM_175518 // D730040F13Rik // 
RIKEN cDNA D730040F13 gene // 4 B3 
// 242474 /// E 
0.033 
 
-1.214 
 
10577152 
 
E330037G11R
ik 
 
AK087889 // E330037G11Rik // RIKEN 
cDNA E330037G11 gene // 8 A1.1 // 
102220 
0.027 
 
-1.214 
 
10449111 Wdr90 NM_001163766 // RefSeq // Mus 
musculus WD repeat domain 90 
0.012 -1.211 
10457205 
 
Crem 
 
NM_001110856 // RefSeq // Mus 
musculus cAMP responsive element 
modulator 
0.047 
 
-1.211 
 
10598381 
 
Gpkow 
 
NM_173747 // RefSeq // Mus musculus 
G patch domain and KOW motifs 
0.002 
 
-1.205 
 
10579508 
 
Ano8 
 
NM_001164679 // RefSeq // Mus 
musculus anoctamin 8 
0.032 
 
-1.203 
 
 
a
List of DEGs generated using Partek Genomics Suite Software with a ± 1.2-fold change cut off and p < 0.05. 
b
DEGs are listed from highest to lowest fold change. 
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Appendix C. Differentially expressed genes (DEGs) in the adult brain following prenatal 
ethanol exposure during the first trimester equivalent (T1-L). 
Transcript 
ID 
Gene Symbol
a
 mrna_assignment p-value Fold-
Change
b
 
10417371 Gm3696 NM_001024712 // RefSeq // Mus 
musculus predicted gene 3696  
0.035 1.438 
10367497 
 
Olfr787 
 
NM_001011822 // RefSeq // Mus 
musculus olfactory receptor 787  
0.044 
 
1.325 
 
10362428 
 
Trdn NM_029726 // RefSeq // Mus musculus 
triadin  
0.015 
 
1.308 
 
10433902 
 
Gm12191 
 
NR_028101 // RefSeq // Mus musculus 
predicted gene 12191, non-coding  
0.027 
 
1.302 
 
10406452 
 
Gm10759 
 
AY344585 // GenBank // Mus musculus 
hypothetical protein (Arzc) 
0.024 
 
1.301 
 
10604342 
 
Gm4987 
 
NM_001085510 // RefSeq // Mus 
musculus predicted gene 4987  
0.006 
 
1.291 
 
10546238 
 
Vmn1r48 
 
NM_053218 // RefSeq // Mus musculus 
vomeronasal 1 receptor 48  
0.008 
 
1.266 
 
10344805 
 
Cspp1 
 
NM_026493 // RefSeq // Mus musculus 
centrosome and spindle pole associated 
protein 1 
0.036 
 
1.217 
 
10513514 
 
Mup5 
 
NM_008649 // RefSeq // Mus musculus 
major urinary protein 5  
7.5E-4 
 
1.213 
 
10369890 
 
Cisd1 
 
XR_032286 // RefSeq // PREDICTED: 
Mus musculus similar to 
phosphoribosylaminoimine 
0.038 
 
1.204 
 
10461391 
 
Pcna 
 
NM_011045 // RefSeq // Mus musculus 
proliferating cell nuclear antigen  
0.049 
 
-1.391 
 
10403658 
 
Gng4 
 
NM_010317 // RefSeq // Mus musculus 
guanine nucleotide binding protein  
0.032 
 
-1.344 
 
10438064 
 
Vpreb1 
 
NM_016982 // RefSeq // Mus musculus 
pre-B lymphocyte gene 1  
0.023 
 
-1.329 
 
10494643 
 
Hmgcs2 
 
NM_008256 // RefSeq // Mus musculus 3-
hydroxy-3-methylglutaryl-Coenzyme A 
synthase 
0.007 
 
-1.323 
 
10426875 
 
Atf1 
 
NM_007497 // RefSeq // Mus musculus 
activating transcription factor 1  
0.012 
 
-1.319 
 
10472994 
 
Mtx2 
 
NM_016804 // RefSeq // Mus musculus 
metaxin 2, nuclear gene encoding  
0.026 
 
-1.316 
 
10595805 
 
Rasa2 
 
NM_053268 // RefSeq // Mus musculus 
RAS p21 protein activator 2  
0.045 
 
-1.285 
10421972 
 
Rpl36a 
 
NM_019865 // RefSeq // Mus musculus 
ribosomal protein L36A  
0.003 
 
-1.280 
 
10577444 
 
Defb11 
 
NM_139221 // RefSeq // Mus musculus 
defensin beta 11  
0.026 
 
-1.277 
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10360460 
 
Chml 
 
NM_021350 // RefSeq // Mus musculus 
choroideremia-like  
0.002 
 
-1.268 
 
10361651 
 
Nup43 
 
NM_145706 // RefSeq // Mus musculus 
nucleoporin 43  
0.049 
 
-1.264 
 
10587633 
 
Mrap2 
 
NM_001177731 // RefSeq // Mus 
musculus melanocortin 2 receptor 
accessory protein 
0.035 
 
-1.263 
 
10406777 
 
Gcnt4 
 
NM_001166065 // RefSeq // Mus 
musculus glucosaminyl (N-acetyl) 
transferase 4 
0.0383 
 
-1.263 
 
10570029 
 
Myo16 
 
NM_001081397 // RefSeq // Mus 
musculus myosin XVI  
0.039 
 
-1.257 
 
10469571 
 
Otud1 
 
NM_027715 // RefSeq // Mus musculus 
OTU domain containing 1  
0.049 
 
-1.251 
 
10412719 
 
Synpr 
 
NM_028052 // RefSeq // Mus musculus 
synaptoporin  
0.039 
 
-1.250 
 
10410115 
 
1110018J18Ri
k 
NM_025370 // RefSeq // Mus musculus 
RIKEN cDNA 1110018J18 gene  
0.005 
 
-1.249 
 
10412100 
 
Map3k1 
 
NM_011945 // RefSeq // Mus musculus 
mitogen-activated protein kinase kinase 
kinase 1 
0.043 
 
-1.247 
 
10449971 
 
Zfp763 
 
NM_028543 // RefSeq // Mus musculus 
zinc finger protein 763  
0.026 
 
-1.244 
 
10466423 
 
Cep78 
 
NM_198019 // RefSeq // Mus musculus 
centrosomal protein 78  
0.010 
 
-1.244 
 
10572085 
 
Nat1 
 
NM_008673 // RefSeq // Mus musculus N-
acetyl transferase 1  
0.024 
 
-1.240 
 
10588582 
 
6430571L13Ri
k 
 
BC116708 // GenBank // Mus musculus 
RIKEN cDNA 6430571L13 gene, mRNA 
(cDNA clone) 
0.023 
 
-1.240 
 
10520355 
 
Htr5a 
 
NM_008314 // RefSeq // Mus musculus 5-
hydroxytryptamine (serotonin) receptor 5A 
0.022 
 
-1.238 
 
10566237 
 
Olfr624 
 
NM_001011865 // RefSeq // Mus 
musculus olfactory receptor 624  
0.003 
 
-1.237 
 
10351277 
 
Nme7 
 
NM_138314 // RefSeq // Mus musculus 
non-metastatic cells 7 
0.014 
 
-1.236 
 
10475946 
 
Zc3h6 
 
NM_178404 // RefSeq // Mus musculus 
zinc finger CCCH type containing 6  
0.004 
 
-1.232 
 
10400143 
 
Stxbp6 
 
NM_144552 // RefSeq // Mus musculus 
syntaxin binding protein 6 (amisyn)  
0.028 
 
-1.225 
 
10594044 
 
Islr 
 
NM_012043 // RefSeq // Mus musculus 
immunoglobulin superfamily containing 
leucine-rich repeat 
0.030 
 
-1.224 
 
10368495 
 
Rspo3 NM_028351 // RefSeq // Mus musculus R-
spondin 3 homolog (Xenopus laevis) 
0.047 -1.219 
 
10450682 H2-T23 NM_010398 // RefSeq // Mus musculus 0.003 -1.217 
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  histocompatibility 2, T region locus 23    
10588083 
 
Faim 
 
NM_001122851 // RefSeq // Mus 
musculus Fas apoptotic inhibitory 
molecule 
0.007 
 
-1.217 
 
10379028 
 
Mir451 
 
NR_029971 // RefSeq // Mus musculus 
microRNA 451, microRNA 
0.024 
 
-1.215 
 
10547088 
 
Mbd4 
 
NM_010774 // RefSeq // Mus musculus 
methyl-CpG binding domain protein 4   
0.013 
 
-1.213 
 
10567299 
 
Itpripl2 
 
NM_001033380 // RefSeq // Mus 
musculus inositol 1,4,5-triphosphate 
receptor  
0.036 -1.211 
10561008 
 
Ceacam1 
 
NM_001039185 // RefSeq // Mus 
musculus carcinoembryonic antigen-
related cell adhesion 
0.038 
 
-1.209 
 
10546430 
 
Adamts9 
 
NM_175314 // RefSeq // Mus musculus a 
disintegrin-like and metallopeptidase  
0.006 
 
-1.208 
 
10469108 
 
Gm10857 
 
NR_033470 // RefSeq // Mus musculus 
predicted gene 10857  
0.002 
 
-1.206 
 
10347106 Rpe 
 
NM_025683 // RefSeq // Mus musculus 
ribulose-5-phosphate-3-epimerase  
0.047 
 
-1.206 
 
10462346 
 
Rcl1 
 
NM_021525 // RefSeq // Mus musculus 
RNA terminal phosphate cyclase-like 1  
0.017 
 
-1.206 
 
10589994 
 
Eomes 
 
NM_010136 // RefSeq // Mus musculus 
eomesodermin homolog (Xenopus laevis)  
0.039 
 
-1.204 
 
10420596 
 
Tnfrsf19 
 
NM_013869 // RefSeq // Mus musculus 
tumor necrosis factor receptor superfamily 
0.024 
 
-1.203 
 
10589587 
 
Setd2 
 
NM_001081340 // RefSeq // Mus 
musculus SET domain containing 2  
0.005 
 
-1.202 
 
10484457 
 
Clp1 
 
ENSMUST00000028475 // ENSEMBL // 
Polyribonucleotide 5'-hydroxyl-kinase  
0.023 -1.202 
 
10380210 
 
Sfrs1 
 
NM_173374 // RefSeq // Mus musculus 
splicing factor, arginine/serine-rich 1  
0.028 
 
-1.202 
 
10492757 
 
Plrg1 
 
NM_016784 // RefSeq // Mus musculus 
pleiotropic regulator 1, PRL1 homolog 
(Arabidopsis) 
0.029 
 
-1.200 
 
a
List of DEGs generated using Partek Genomics Suite Software with a ± 1.2-fold change cut off and p < 0.05. 
b
DEGs are listed from highest to lowest fold change. 
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Appendix D. Differentially expressed genes (DEGs) in the adult brain following prenatal 
ethanol exposure during the second trimester equivalent (T2-L). 
Transcript 
ID 
Gene Symbol
a
 mrna_assignment p-value Fold-
Change
b
 
10469320 
 
Gm9875 
 
ENSMUST00000064229 // ENSEMBL 
// Putative uncharacterized protein gene 
0.044 
 
1.337 
 
10557229 
 
LOC100134980 
 
BC016578 // GenBank // Mus musculus 
hypothetical LOC100134980, mRNA  
0.033 
 
1.304 
 
10461152 
 
Snhg1 
 
AK051045 // GenBank HTC // Mus 
musculus 9 days embryo whole body 
cDNA, RIKEN  
0.010 
 
1.265 
 
10436200 
 
Gm8824 
 
XR_034572 // RefSeq // PREDICTED: 
Mus musculus hypothetical protein 
LOC100048225 
0.049 
 
1.260 
 
10491060 
 
Spin3 
 
XR_031023 // RefSeq // PREDICTED: 
Mus musculus similar to spindlin 
(LOC675593) 
0.012 
 
1.254 
 
10552570 
 
Klk1b11 
 
NM_010640 // RefSeq // Mus musculus 
kallikrein 1-related peptidase b11  
0.049 
 
1.254 
 
10579915 
 
Smarca5 
 
NM_053124 // RefSeq // Mus musculus 
SWI/SNF related, matrix associated, 
actin  
0.047 
 
1.243 
 
10418604 
 
Phf7 
 
NM_027949 // RefSeq // Mus musculus 
PHD finger protein 7  
0.038 1.242 
 
10473125 
 
Itga4 
 
NM_010576 // RefSeq // Mus musculus 
integrin alpha 4  
0.029 
 
1.235 
 
10593095 
 
Cep164 
 
NM_001081373 // RefSeq // Mus 
musculus centrosomal protein 164  
0.009 
 
1.235 
 
10398286 
 
Mir342 
 
NR_029771 // RefSeq // Mus musculus 
microRNA 342, microRNA 
0.041 
 
1.232 
 
10544106 
 
Zc3hav1 
 
ENSMUST00000121946 // ENSEMBL 
// cdna:pseudogene 
chromosome:NCBIM37:6:38492303:3 
0.049 
 
1.231 
 
 
10567450 
 
Dnahc3 
 
BC051401 // GenBank // Mus musculus 
dynein, axonemal, heavy chain 3 
0.029 
 
1.229 
 
10474335 
 
Immp1l 
 
NM_028260 // RefSeq // Mus musculus 
IMP1 inner mitochondrial membrane 
peptidase-like (S. cerevisiae) 
0.023 
 
1.229 
 
 
10358621 
 
Hmcn1 
 
NM_001024720 // RefSeq // Mus 
musculus hemicentin 1 
0.036 1.225 
 
10513920 
 
Gm11488 
 
ENSMUST00000117277 // ENSEMBL 
// cdna:pseudogene 
chromosome:NCBIM37:4:73158649:7 
0.045 
 
1.225 
 
10603005 
 
Gm15204 
 
ENSMUST00000119454 // ENSEMBL 
// cdna:pseudogene 
0.008 1.224 
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chromosome:NCBIM37:X:158789528 
10584582 
 
Gm10694 
 
ENSMUST00000098870 // ENSEMBL 
// Putative uncharacterized protein gene 
0.006 
 
1.223 
 
10491877 
 
D3Ertd751e 
 
NM_028667 // RefSeq // Mus musculus 
DNA segment, Chr 3, ERATO Doi 751, 
expressed 
0.038 
 
1.22 
 
10399314 
 
Mfsd2b 
 
NM_001033488 // RefSeq // Mus 
musculus major facilitator superfamily 
domain containing 2B 
0.045 
 
1.216 
 
10365098 
 
Tbxa2r 
 
NM_009325 // RefSeq // Mus musculus 
thromboxane A2 receptor  
0.033 
 
1.209 
 
10371842 
 
Uhrf1bp1l 
 
NM_029166 // RefSeq // Mus musculus 
UHRF1 (ICBP90) binding protein 1-
like  
0.041 
 
1.205 
 
10362937 
 
Gm6983 
 
XR_033422 // RefSeq // PREDICTED: 
Mus musculus similar to ribosomal 
protein S8 
0.019 
 
1.204 
 
10474915 
 
Gchfr 
 
NM_177157 // RefSeq // Mus musculus 
GTP cyclohydrolase I feedback 
regulator  
0.012 
 
1.203 
 
10545079 
 
A530053G22Rik 
 
NR_015565 // RefSeq // Mus musculus 
RIKEN cDNA A530053G22 gene 
0.049 1.202 
10413596 
 
Sfmbt1 
 
NM_001166532 // RefSeq // Mus 
musculus Scm-like with four mbt 
domains 1  
0.015 
 
1.201 
 
10423733 
 
Vps13b 
 
GENSCAN00000007934 // ENSEMBL 
// cdna:Genscan 
chromosome:NCBIM37:15:35501834:3
56 
0.044 
 
1.201 
 
10438098 Sdf2l1 NM_022324 // RefSeq // Mus musculus 
stromal cell-derived factor 2-like 1 
0.009 -1.783 
10403943 
 
Hist1h2bm 
 
NM_178200 // RefSeq // Mus musculus 
histone cluster 1, H2bm  
0.023 
 
-1.467 
 
10394735 
 
Pdia6 
 
NM_027959 // RefSeq // Mus musculus 
protein disulfide isomerase associated 6  
0.014 
 
-1.465 
 
10443463 
 
Cdkn1a 
 
NM_007669 // RefSeq // Mus musculus 
cyclin-dependent kinase inhibitor 1A 
(P21)  
0.021 
 
-1.425 
 
10544525 
 
Pdia4 
 
NM_009787 // RefSeq // Mus musculus 
protein disulfide isomerase associated 4  
0.012 
 
-1.414 
 
10374035 
 
Xbp1 
 
NM_013842 // RefSeq // Mus musculus 
X-box binding protein 1 
0.028 -1.367 
 
10471586 
 
Hspa5 
 
NM_022310 // RefSeq // Mus musculus 
heat shock protein 5 
0.005 
 
-1.365 
 
10596575 
 
Manf 
 
NM_029103 // RefSeq // Mus musculus 
mesencephalic astrocyte-derived 
0.009 
 
-1.349 
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neurotrophic 
10374464 
 
Spred2 
 
BC040462 // GenBank // Mus musculus 
sprouty-related, EVH1 domain 
containing 2 
0.031 
 
-1.336 
 
  
10397966 
 
Otub2 
 
NM_001177841 // RefSeq // Mus 
musculus OTU domain, ubiquitin 
aldehyde binding 2  
0.047 
 
-1.314 
 
10408202 
 
Hist1h3f 
 
NM_013548 // RefSeq // Mus musculus 
histone cluster 1, H3f  
0.023 
 
-1.307 
 
10408083 
 
Hist1h3g 
 
NM_145073 // RefSeq // Mus musculus 
histone cluster 1, H3g  
0.030 
 
-1.303 
 
10404049 
 
Hist1h3d 
 
NM_178204 // RefSeq // Mus musculus 
histone cluster 1, H3d  
0.041 
 
-1.292 
 
10404065 
 
Hist2h3b 
 
NM_178215 // RefSeq // Mus musculus 
histone cluster 2, H3b  
0.029 
 
-1.283 
 
10520862 
 
Fosl2 
 
NM_008037 // RefSeq // Mus musculus 
fos-like antigen 2  
0.040 
 
-1.281 
 
10403073 
 
Ighg 
 
X70423 // GenBank // M.musculus 
mRNA for monoclonal antibody heavy 
chain gamma 2 
0.022 
 
-1.280 
 
10361250 
 
Camk1g 
 
NM_144817 // RefSeq // Mus musculus 
calcium/calmodulin-dependent protein 
kinase 1G 
0.023 
 
-1.266 
 
10434675 
 
Dnajb11 
 
NM_026400 // RefSeq // Mus musculus 
DnaJ (Hsp40) homolog, subfamily B, 
member 11 
0.003 
 
-1.254 
 
10363845 
 
Ccdc6 
 
NM_001111121 // RefSeq // Mus 
musculus coiled-coil domain containing 
6  
0.019 
 
-1.254 
 
10408246 
 
Hist1h3a 
 
NM_013550 // RefSeq // Mus musculus 
histone cluster 1, H3a  
0.026 
 
-1.245 
 
10468980 
 
Fam107b 
 
BC021353 // GenBank // Mus musculus 
family with sequence similarity 107, 
member b 
0.040 
 
-1.245 
 
10413726 
 
Tnnc1 
 
NM_009393 // RefSeq // Mus musculus 
troponin C, cardiac/slow skeletal  
0.021 
 
-1.245 
 
10507328 
 
Prdx1 
 
NM_011034 // RefSeq // Mus musculus 
peroxiredoxin 1  
0.049 
 
-1.230 
 
10535369 
 
Gm15770 
 
ENSMUST00000117498 // ENSEMBL 
// cdna:pseudogene 
chromosome:NCBIM37:5:143614295: 
0.017 
 
-1.230 
 
10578984 
 
Tufm 
 
NM_172745 // RefSeq // Mus musculus 
Tu translation elongation factor, 
mitochondrial 
0.048 
 
-1.225 
 
10447594 
 
Dynlt1a 
 
NM_001166629 // RefSeq // Mus 
musculus dynein light chain Tctex-type 
0.005 
 
-1.223 
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1A  
10424213 
 
Zhx2 
 
NM_199449 // RefSeq // Mus musculus 
zinc fingers and homeoboxes 2  
0.012 
 
-1.221 
 
10516765 
 
Serinc2 
 
NM_172702 // RefSeq // Mus musculus 
serine incorporator 2 
0.016 
 
-1.221 
 
10419525 
 
A930018M24Rik 
 
BC144873 // GenBank // Mus musculus 
cDNA clone MGC:178429 
IMAGE:9053421 
0.042 
 
-1.217 
 
10524234 
 
Galnt9 
 
NM_198306 // RefSeq // Mus musculus 
UDP-N-acetyl-alpha-D-
galactosamine:polypeptidase 
0.015 
 
-1.217 
 
10494978 
 
Ptpn22 
 
NM_008979 // RefSeq // Mus musculus 
protein tyrosine phosphatase, non-
receptor type 22 (lymphoid) 
0.033 
 
-1.216 
 
10490946 
 
Hsp90aa1 
 
NM_010480 // RefSeq // Mus musculus 
heat shock protein 90, alpha (cytosolic) 
0.041 
 
-1.215 
 
10465553 
 
Fkbp2 
 
NM_008020 // RefSeq // Mus musculus 
FK506 binding protein 2 
0.042 
 
-1.214 
 
10578771 
 
Galnt7 
 
NM_144731 // RefSeq // Mus musculus 
UDP-N-acetyl-alpha-D-galactosamine: 
polypeptidase 
0.019 
 
-1.212 
 
10448676 
 
Slc9a3r2 
 
NM_023055 // RefSeq // Mus musculus 
solute carrier family 9 
(sodium/hydrogen exchange), isoform 3 
regulator 2 
0.006 
 
-1.211 
 
10548785 
 
Dynlt1c 
 
NM_001166630 // RefSeq // Mus 
musculus dynein light chain Tctex-type 
1C  
0.039 
 
-1.208 
 
10396237 
 
2700049A03Rik 
 
NM_001163378 // RefSeq // Mus 
musculus RIKEN cDNA 2700049A03 
gene  
0.007 
 
-1.205 
 
10416251 
 
Egr3 
 
NM_018781 // RefSeq // Mus musculus 
early growth response 3  
0.040 
 
-1.205 
 
10363350 
 
P4ha1 
 
NM_011030 // RefSeq // Mus musculus 
procollagen-proline, 2-oxoglutarate 4-
dioxygenase subunit alpha-1 
 
0.003 
 
-1.205 
 
10406626 
 
Homer1 
 
NM_147176 // RefSeq // Mus musculus 
homer homolog 1 (Drosophila)  
0.021 
 
-1.203 
 
10582429 
 
Cbfa2t3 
 
NM_009824 // RefSeq // Mus musculus 
core-binding factor, runt domain, alpha 
subunit 
0.043 
 
-1.203 
 
 
a
List of DEGs generated using Partek Genomics Suite Software with a ± 1.2-fold change cut off and p < 0.05. 
b
DEGs are listed from highest to lowest fold change. 
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Heterogeneity of Behavioral Deficits in a Mouse Model of Fetal Alcohol Spectrum Disorder 
(FASD) 
 
Katarzyna Mantha, Morgan Kleiber, Shiva Singh 
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Best Wishes 
 
Karen Zhang 
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Appendix F. Ingenuity Pathway Analysis network legend for relationship types, molecular 
shapes, and relationships. 
Relationship types Molecular shapes Relationships 
A Activation 
 
Cytokine/Growth 
factor  
Binding 
B Binding 
 
Enzyme 
 
Inhibition 
C Causes/Leads to 
   
G-protein coupled 
receptor 
 Acts on 
CC 
Chemical-chemical 
interaction  
Ion channel 
 
Inhibits and 
acts on 
CP 
Chemical-protein 
interaction    
Kinase  
Leads to 
E 
Expression (includes 
metabolism/synthesis 
for chemicals) 
  
Ligand-dependent 
nuclear receptor 
 Translocates 
to 
EC Enzyme Catalysis 
 
Peptidase  Reaction 
I Inhibition  Phosphatase 
 
Direct 
interaction 
L 
Proteolysis (includes 
degradation for 
Chemicals) 
 
Transcription 
regulator 
 Indirect 
interaction 
LO Localization  
Translation 
regulator 
  
M 
Biochemical 
Modification  
Transmembrane 
receptor 
  
MB 
Group/complex 
Membership 
 
Transporter   
P 
Phosphorylation/Depho
sphorylation 
 microRNA   
PD Protein-DNA binding 
 
Complex/Group   
PP Protein-Protein binding  
Other   
PR Protein-RNA binding     
RB Regulation of binding     
RE Reaction     
RR RNA-RNA Binding     
T Transcription     
TR Translocation     
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